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Early intervention strategies (e.g., psychological debriefing and exposure therapy) are 
thought to rely on extinction-like mechanisms to reduce pathological fear. These therapies 
attempt to reduce or prevent the development of stress- and trauma-related disorders such 
as posttraumatic stress disorder (PTSD). Despite this, disorders of fear and anxiety are 
prevalent in our society, due in part to a lack of empirically-driven treatment options. For 
example, both animal models and human data suggest early interventions after a traumatic 
event may actually undermine long-term recovery. In the laboratory, Pavlovian fear 
conditioning procedures in rats have provided fundamental knowledge regarding the brain 
circuits mediating learned fear. However, less is known about the mechanisms of 
extinction learning, a process intended to reduce conditional fear, which is highly sensitive 
to stress. We aimed to examine how stress, and the stress hormone norepinephrine, act to 
impair extinction learning. We show that fear conditioning produces rapid and sustained 
changes in both the medial prefrontal cortex (mPFC) and the basolateral complex of the 
amygdala (BLA) which impinges upon extinction learning when extinction training occurs 
soon after conditioning, a phenomenon called the immediate extinction deficit (IED). We 
demonstrate that this stress-induced suppression of mPFC and simultaneous excitation in 
the BLA soon after conditioning can be normalized with systemic propranolol, a beta-
blocker.  In addition, we further show that local application of propranolol into the BLA, 
but not the mPFC, enables extinction learning under stress, where it normally fails. We 
point to a role for the locus coeruleus norepinephrine system (LC-NE) using cell-specific 




stronger footshock activation of BLA activity, which may lead to extinction deficits. 
Lastly, we demonstrate that the LC-NE system is also involved in fear relapse. That is, LC 
excitation resulted in elevated conditioned fear responses to a previously extinguished cue. 
Overall, the data suggest a complex circuit in which LC-NE modulates both the mPFC 
and BLA to toggle high and low fear states. The LC-NE system represents a promising 
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Pavlovian fear conditioning is a form of learning that serves as a robust model to explore 
the neurobiological underpinnings of disorders of fear and anxiety, including post-
traumatic stress disorder (PTSD). In a typical rodent experiment, an innocuous 
conditioned stimulus (CS; e.g., an auditory tone) is paired with an aversive unconditioned 
stimulus (US; e.g., a mild electric footshock). After one or more conditioning trials, 
presentation of the CS alone comes to elicit a conditioned fear response (CR) that includes 
freezing behavior (i.e., immobility except that necessary for respiration), changes in heart 
rate and respiration, and potentiated acoustic startle (Davis, 1992; LeDoux, 2000; Maren, 
2001).  Importantly, these fear CRs can be extinguished by repeated presentations of the 
CS in the absence of the US.  In rodents and humans alike, CRs to an extinguished CS 
tend to return under a number of conditions including the passage of time (spontaneous 
recovery), when the CS is presented outside the extinction context (renewal), or with 
exposure to an unsignaled US (reinstatement) (Bouton, 2000, 2002; Goode and Maren, 
2014; Hermans et al., 2006; Maren et al., 2013; Vervliet et al., 2013). These recovery or 
relapse phenomena suggest that extinction does not erase fear memories, but generates a 
new safety memory that inhibits the expression of fear. In addition, extinction learning 




conditioning (Maren, 2014; Maren and Chang, 2006; Myers et al., 2006) and stress (Maren 
and Holmes, 2016; Giustino and Maren, 2018; Giustino et al., 2016b).  
While learned fear serves an adaptive purpose aiding survival, pathological fear 
states are thought to underlie various stress and trauma-related disorders such as PTSD, 
which has a lifetime prevalence of nearly 8% in the general population (Kessler et al., 
2005, 1995).  Not surprisingly, this number increases to as high as 30% in combat-exposed 
veterans (Koenen et al., 2008), amplifying the need for more effective therapies. PTSD 
has been described as the only mental health disorder with a known cause (i.e., a traumatic 
experience) (Pitman et al., 2012) and is characterized by heightened arousal and resistance 
to extinction learning (Rauch et al., 2006). Many have argued that PTSD may, at least in 
part, be a disorder of the fear circuitry (Shin and Handwerger, 2009) and an enhanced 
understanding of learned fear is relevant to the psychological processes underlying this 
disorder (Liberzon and Sripada, 2008; VanElzakker et al., 2014). It is possible that PTSD 
patients exhibit exaggerated fear conditioning, resistance to extinction, or both; ultimately, 
they exhibit persistent fear CRs (Pitman, 1988).  
Due to the prevalence and debilitating nature of stress and trauma-related 
disorders, there has been a surge in interest in understanding the neural processes 
subserving learned fear and its subsequent extinction (Maren et al., 2013; Milad and Quirk, 
2012; Quirk and Mueller, 2008).  A triad of brain regions, including the amygdala, 
hippocampus and medial prefrontal cortex (mPFC) has been heavily studied in relation to 
fear (Dejean et al., 2015; Herry et al., 2010; Maren and Quirk, 2004). Importantly, 




norepinephrine (NE) (Kosten et al., 1987; Geracioti et al., 2001; Pervanidou and Chrousos, 
2010; Yehuda et al., 1992; Naegeli et al., 2017; Southwick et al., 1999c). The vast majority 
of central norepinephrine is produced by and released from the locus coeruleus (LC) and 
NE has profound effects on the amygdala, prefrontal cortex, and hippocampus (Jodo et 
al., 1998; Sabban et al., 2018; Giustino et al., 2017, 2016b; Fitzgerald et al., 2015; Giustino 
and Maren, 2018; Arnsten and Li, 2005; Arnsten, 2009; Ramos and Arnsten, 2007; 
Robbins and Arnsten, 2009). Below I discuss past work on the fear circuit and the locus 
coeruleus norepinephrine system which has largely informed the direction of my doctoral 
work.  
1.2 The fear circuit 
It is well established that both the acquisition and extinction of fear memories requires 
synaptic plasticity within the amygdala (Duvarci and Pare, 2014; Fanselow and LeDoux, 
1999; Herry et al., 2010; LeDoux, 2003; Lee et al., 2013; Maren and Quirk, 2004; Pape 
and Pare, 2010).  The amygdala is a node of highly interconnected nuclei; the basolateral 
complex of the amygdala (BLA; consisting of the lateral, basal and basomedial nuclei) 
and the central nucleus of the amygdala (CeA; consisting of lateral and medial 
components) play critical roles in the acquisition of both fear and extinction memories. It 
has been suggested that inhibitory interneurons within the amygdala play a role in 
regulating fear output.  These include 1) the intercalated cell masses (ITCs) positioned 
between the BLA and CeA (Duvarci and Pare, 2014; Lee et al., 2013; McDonald and 
Augustine, 1993; Nitecka and Ben-Ari, 1987; Paré and Smith, 1993; Royer et al., 1999), 




2014), and 3) inhibitory interneurons in CeL that project to CeM (Haubensak et al., 2010; 
Ciocchi et al., 2010).  
How one structure supports the formation and storage of opposing memories is not 
fully understood, although it appears that distinct cell populations within the BLA may 
preferentially encode low and high fear states (Goosens et al., 2003; Hobin et al., 2003; 
Herry et al., 2008; Senn et al., 2014).  For example, lesions of the lateral amygdala (LA), 
a locus for CS and US convergence, or the CeA disrupt fear conditioning (Goosens and 
Maren, 2001; LeDoux et al., 1990; Wilensky et al., 2006). Similarly, reversible 
inactivation of the BLA prevents the acquisition and expression of conditioned fear 
(Helmstetter and Bellgowan, 1994; Muller et al., 1997), suggesting a large degree of 
overlap between the subnuclei of the amygdala. Studies using overtraining procedures 
have demonstrated that amygdala lesions disrupt fear memories, not the ability of animals 
to emit conditioned fear responses (Maren, 1998, 1999).  Single-unit recordings have 
demonstrated learning-related changes in short-latency (less than 15 ms) CS-evoked 
responses in the LA after fear conditioning, suggesting that these changes are mediated by 
direct thalamo-amygdala projections (Maren, 2000; Quirk et al., 1995).  Moreover, these 
conditioning-induced changes in spike firing are specifically related to the associative 
nature of the CS, indicating that the LA is a crucial site of plasticity for fear memories 
independent of freezing behavior (Goosens et al., 2003). In contrast, the CeA is primarily 
thought of as an output station, relaying information to the brain stem, hypothalamus and 
periaqueductal gray to initiate fear responses such as freezing (Paré et al., 2004). Whereas 




2010; Haubensak et al., 2010).  Curiously, while the LA encodes CS-US information, 
there are no direct connections between the LA and CeA to directly mediate fear output, 
suggesting that the BL or BM or both may act as an interface (Amano et al., 2011).   
Interestingly, post-conditioning lesions of the basal nuclei block fear expression while 
leaving learning intact (Anglada-Figueroa and Quirk, 2005; Amano et al., 2011). Selective 
inactivation of either BM or BL alone was not sufficient to mimic this effect, whereas 
inactivation of both BM and BL was sufficient.  This implies that some level of functional 
overlap exists between these two regions (Amano et al., 2011).    
Additionally, several studies have shown that BLA synaptic plasticity is crucial 
for the acquisition of extinction (Falls et al., 1992; Herry et al., 2006, 2008; Kim et al., 
2007; Lu et al., 2001; Sotres-Bayon et al., 2007).  Upon extinction learning, LA neurons 
typically show a reduction in CS-evoked neural activity (Quirk et al., 1995; Repa et al., 
2001).  However, a distinct population of LA cells maintain CS-evoked responding 
throughout extinction learning (Repa et al., 2001).  Interestingly, after extinction, patterns 
of CS-evoked neural activity in LA are mediated by the context and reflect the level of 
freezing (i.e., larger responses occur when fear renews) (Hobin et al., 2003).  In summary, 
there is compelling evidence to support the notion that the amygdala is a crucial locus for 
the acquisition and extinction of learned fear with both ‘fear’ and ‘extinction’ neurons 
existing within the same subnuclei whose CS-evoked activity strongly correlates with the 
level of fear expression (Goosens et al., 2003; Herry et al., 2008; Quirk et al., 1995; Repa 




The hippocampus has also been identified as a key mediator of learned fear. Given 
the role of the hippocampus in encoding contextual and spatial information it is not 
surprising this region plays a substantial role in the fear circuit. Numerous studies have 
shown that hippocampal lesions dampen fear to a context previously associated with a 
shock US (Kim and Fanselow, 1992; Phillips and LeDoux, 1992; Selden et al., 1991).  
Importantly, hippocampal lesions produce larger deficits when made soon after context 
conditioning, suggesting that recent memories rely more heavily on the integrity of the 
hippocampus (Anagnostaras et al., 1999; Maren et al., 1997). Interestingly, hippocampal 
lesions do not necessarily interfere with context conditioning when damage is made prior 
to training (Maren et al., 1997; Frankland et al., 1998), although deficits in the acquisition 
of contextual fear can be obtained with single-trial procedures (Wiltgen et al., 2006). 
Collectively, these results suggest that the hippocampus is required for forming and 
storing memories of the context, but not necessarily context-US associations (Young et 
al., 1994). These findings support the notion that hippocampus plays a key role in both the 
acquisition and expression of conditioned fear to a particular context.   
As mentioned above, the extinction of fear is highly context-dependent, that is, 
fear returns or “renews” when the CS is presented outside the extinction context.  
Considerable evidence indicates that the renewal of fear is mediated by the hippocampus 
(Bouton, 2000, 2002; Bouton et al., 2006; Goode and Maren, 2014; Hermans et al., 2006; 
Maren et al., 2013; Vervliet et al., 2013). For example, many studies have shown that 
hippocampal inactivation dampens fear renewal when the CS is presented outside of the 




Marek et al., 2018a; Maren and Hobin, 2007; Zelikowsky et al., 2012).  In addition, 
disconnections of the hippocampus from the amygdala or prefrontal cortex impair renewal 
(Orsini et al., 2011; Marek et al., 2018a), amygdala neurons engaged during fear renewal 
receive hippocampal and prelimbic input (Knapska et al., 2012) and individual 
hippocampal neurons expressing Fos after fear renewal preferentially project to both the 
amygdala and prefrontal cortex (Jin and Maren, 2015a). These data suggest that the 
hippocampus integrates contextual information during conditioning and likely regulates 
the context dependent recall of fear after extinction learning.  
Fear regulation must be tightly controlled and this is thought to depend on the 
mPFC.  Two subdivisions of mPFC in rodents, and their human homologs, have been 
identified as having distinct roles within the fear circuit. The prelimbic cortex (PL) is 
thought to regulate fear expression, whereas the infralimbic cortex (IL) mediates fear 
suppression (Milad and Quirk, 2012; Quirk and Beer, 2006; Riga et al., 2014; Sotres-
Bayon and Quirk, 2010).  A similar division of labor has been proposed in humans, 
indicating that the neural mechanisms of extinction learning may be conserved across 
species (Milad and Quirk, 2012; Linnman et al., 2012; Phelps et al., 2004; Schiller et al., 
2008; Sehlmeyer et al., 2009; Vervliet et al., 2013).  The prefrontal cortex is thought to be 
responsible for “higher order” executive functions; however, cortical activity is highly 
sensitive to stress and elevated levels of the stress neurotransmitter, norepinephrine, which 
may play a critical role in regulating fear memories and their extinction (Giustino and 
Maren, 2015; Mueller et al., 2008; Giustino and Maren, 2018; Raio et al., 2014; Arnsten 




1.3 The locus coeruleus norepinephrine system 
The locus-coeruleus norepinephrine (LC-NE) system has numerous functions including 
regulating the sleep-wake cycle, arousal, respiration, motivation, cognition, and learning 
and memory. In particular, NE plays a broad role in the formation and retrieval of 
emotional memories. As such, NE is a candidate molecule for the treatment of trauma- 
and stressor-related disorders and a number of studies suggest that the NE system may be 
dysregulated in posttraumatic stress disorder (PTSD); (Southwick et al., 1999c; Morilak 
et al., 2005; Yehuda et al., 1992; Southwick et al., 1999a, 1997; Bremner et al., 1996; 
Southwick et al., 1999b; Giustino et al., 2016b; Arnsten, 2009, 2015; Arnsten et al., 2015; 
Kroes et al., 2016a; Raio and Phelps, 2015; Rodrigues et al., 2009). Despite the extensive 
research on this topic, the use of NE-altering drugs for PTSD treatment remains 
controversial. 
1.3.1 The LC-NE system anatomy and physiology 
The LC is a bilateral brainstem nucleus located adjacent to the fourth ventricle. While the 
LC is small in terms of cell count (~1,500 in rats and ~15,000 in humans) it has been 
implicated in a range of behavioral phenomenon (Sara, 2015, 2009; Arnsten, 2009; 
Robbins and Arnsten, 2009; Arnsten, 2015; Aston-Jones and Waterhouse, 2016; Aston-
Jones and Cohen, 2005). The LC was first described in detail by Dahlstrom and Fuxe in 
1964 (Dahlström and Fuxe, 1964). This discovery led to a surge of interest into this small 
nucleus in the subsequent decades. Below we review the broad afferent and efferent 






The LC projects broadly throughout the brain and is largely thought to be the sole source 
of cortical NE. Due to its vast projections, it is not surprising that NE has an important 
role in many aspects of behavior and cognition. LC neurons fire at low basal rates (~1-3 
Hz) and can fire in two modes: phasic states of firing (i.e., bursts of activity) occur in 
response to relevant environmental stimuli whereas the LC fires tonically during periods 
of stress.  Increased tonic firing rates are associated with less phasic activity (Aston-Jones 
et al., 1999; Aston-Jones and Cohen, 2005).  How these distinct firing modes affect 
aversive learning and memory is not well characterized. The LC consists of at least two 
cell types with the smaller fusiform cells being found in more dorsal portions of the 
nucleus whereas larger multipolar cells tend to be located more ventrally (Swanson, 1976; 
Grzanna and Molliver, 1980).  Because this review is largely focused on fear conditioning 
and extinction, we restrict our focus to projections to the medial prefrontal cortex (mPFC), 
the basolateral amygdala (BLA, encompassing all nuclei), the central amygdala (CeA), 
and the hippocampus (HPC) all of which are heavily innervated by the LC (Swanson and 
Hartman, 1975; Swanson, 1976; Amaral and Sinnamon, 1977; Foote et al., 1983; Segal 
and Landis, 1974; Pickel et al., 1974; Gerfen and Clavier, 1979; Descarries and Lapierre, 
1973; Lapierre et al., 1973; Descarries et al., 1977; Morrison et al., 1979; Jones and Moore, 
1977; Fallon et al., 1978; Loughlin et al., 1982; Moore and Bloom, 1979).  Recent work 
has led to an increasingly complex view of LC function based on the discovery of target-
specific subpopulations within this small nucleus. I will discuss the contribution of distinct 




1.3.3 Homogeneous or heterogeneous output? 
Upon the initial discovery of the LC it was determined that all neurons within this nucleus 
were noradrenergic (Dahlström and Fuxe, 1964). Further anatomical work on the 
extensive projections of the LC promoted the idea that this nucleus was largely 
homogenous, serving to distribute NE throughout the forebrain to coordinate global brain 
states. For example, several tracing studies describe collateralization of LC projections 
(Swanson and Hartman, 1975; Steindler, 1981; Jones and Yang, 1985; Nagai et al., 1981; 
Room et al., 1981). In addition, physiological evidence supported this idea -- LC firing 
properties were found to be topographically homogeneous, phasic activity was 
synchronized amongst neurons, and local field potentials also displayed high 
synchronization (Aston-Jones and Bloom, 1981a; Ishimatsu and Williams, 1996). How 
could the LC-NE system dynamically modulate so many different aspects of behavior and 
cognition which depend on distinct brain regions/systems if its effects are global, rather 
than task and target specific? 
Indeed, others have argued that the LC is comprised of distinct target-specific 
subpopulations. Several tracing studies have shown the LC consists of largely non-
overlapping populations of neurons that can be defined based on their downstream target 
(Loughlin et al., 1986, 1982; Uematsu et al., 2015, 2017; Waterhouse and Chandler, 2016; 
Chandler et al., 2014; Chandler and Waterhouse, 2012; Chandler et al., 2013; Waterhouse 
et al., 1983; Agster et al., 2013; Hirschberg et al., 2017). Waterhouse and colleagues have 
provided extensive anatomical and physiological evidence to suggest that the LC does not 




retrograde tracers infused into different cortical regions, they have shown strong evidence 
for separate populations of cells within the LC (Waterhouse and Chandler, 2016; Chandler 
et al., 2014; Chandler and Waterhouse, 2012; Chandler et al., 2013; Agster et al., 2013; 
Waterhouse et al., 1983). Moreover, they have recorded from these distinct LC 
populations and demonstrated that LC neurons projecting to the mPFC (compared to 
motor cortex) show different molecular properties that promote increased excitability. The 
cellular properties of target-specific LC populations may be related to the functional needs 
of their unique downstream targets (Waterhouse and Chandler, 2016; Chandler et al., 
2014). A recent study has further confirmed the LC has highly divergent projections (i.e., 
it is not completely homogeneous) and suggests that small subpopulations may be 
selective for target regions, but propose that the LC may still serve to dictate brain-wide 
states (Schwarz and Luo, 2015; Schwarz et al., 2015). Moving forward, it will be important 
to examine the target specificity of the LC as well as how phasic vs tonic firing in these 
discrete populations affect their downstream target to influence learning and memory. 
1.3.4 Synaptic or volume transmission? 
A second issue regarding how the LC influences both brain-wide states, as well as distinct 
target regions, revolves around the potential mechanism of NE transmission. How the LC 
releases NE has been an area of debate with two possible mechanisms receiving attention. 
Traditional synaptic release of NE being one possibility and the other being volume 
transmission, or nonsynaptic release. Some evidence suggests that LC terminals release 
NE at traditional synapses (Papadopoulos et al., 1987, 1989; Papadopoulos and 




volume transmission (i.e., nonsynaptic or extrasynaptic release) (Descarries and Lapierre, 
1973; Lapierre et al., 1973; Descarries et al., 1977; Agster et al., 2013). It is likely that the 
LC-NE system supports both synaptic and nonsynaptic release and this may be area 
specific (Olschowka et al., 1981; Farb et al., 2010). It is possible that volume transmission 
preferentially influences brain-wide states/NE-tone whereas synaptic release is dependent 
upon local needs of specific target regions, though these ideas remain to be tested.  
1.3.5 Afferents 
Complementing its widespread projections throughout the forebrain, the LC receives 
dense reciprocal feedback from many of its targets. Indeed the LC is highly interconnected 
with the mPFC, BLA, CeA, and HPC (Arnsten and Goldman-Rakic, 1984; Cedarbaum 
and Aghajanian, 1978; Jodo et al., 1998; Sara and Hervé-Minvielle, 1995; Schwarz and 
Luo, 2015; Schwarz et al., 2015; Valentino and Van Bockstaele, 2008; Van Bockstaele et 
al., 1998; Aston-Jones et al., 1986). The LC expresses several peptides including, but not 
limited to, vasopressin, somatostatin, neuropeptide y, enkephalin, neurotensin, 
corticotropin releasing hormone, galanin, glutamate, acetycholine, and serotonin (Aston-
Jones et al., 2004; Berridge and Waterhouse, 2003; Schwarz and Luo, 2015; Schwarz et 
al., 2015). These observations suggest that the LC is highly responsive to numerous 
transmitter and peptide systems and likely integrates information from several incoming 
sources. A recent study has shown that the LC receives direct projections from 111 brain 
regions (Schwarz et al., 2015). How the LC integrates this information is a subject of great 
interest. The LC has extensive dendritic arborization extending into the periocoerulear 




nearby GABAergic cells within this dendritic zone likely serve to regulate LC function 
(Aston-Jones et al., 2004).  Understanding how the LC reciprocal network affects both LC 
signaling and target regions remains an important question.  
1.3.6 Receptor subtypes 
NE exerts its function via action at three G-protein coupled receptor subtypes with the α2-
adrenoceptors (ARs; A, B, and C subtypes) having the highest affinity, followed by α1-
ARs (A, B, and D), and the lowest affinity β-ARs (1, 2, and 3); (Ramos and Arnsten, 2007; 
Berridge and Waterhouse, 2003). The heterogeneous distribution, distinct subtypes, and 
differing affinities of each class of receptor provide yet another mechanism by which NE 
may exert target-specific effects. The α2-ARs are Gi-coupled leading to the inhibition of 
cAMP and thereby reducing neuronal excitability and primarily serve as presynaptic 
autoreceptors, although they are also expressed postsynaptically (Ramos and Arnsten, 
2007; Ramos et al., 2006; MacDonald et al., 1997). Several studies have demonstrated 
strong expression patterns in the mPFC, HPC, and amygdala using in situ hybridization 
(McCune et al., 1993; Nicholas et al., 1993b; Scheinin et al., 1994; Wang et al., 1996; 
Zeng and Lynch, 1991), radioligand binding (Boyajian et al., 1987; Unnerstall et al., 
1984), and immunohistochemical techniques (Rosin et al., 1996a, 1996b; Aoki et al., 
1994).  
 The α1-ARs are generally thought to be excitatory in nature and are Gq-coupled. 
Activation of these receptors acts via phospholipase C and phosphatidyl inositol 
intracellular signaling mechanisms, activating protein kinase C and subsequent release of 




Minneman, 1985; Marshall et al., 1999). This class of ARs can also be found throughout 
the cortex, HPC, and amygdala (McCune et al., 1993; Pieribone et al., 1994; Day et al., 
1997; Domyancic and Morilak, 1997; Rainbow and Biegon, 1983; Young and Kuhar, 
1980; Jones et al., 1985; Palacios et al., 1987); however, α2-ARs tend to be more 
widespread than α1-ARs (McCune et al., 1993). This may serve as a mechanism for target 
regions to regulate NE action to reduce signaling by having densely expressed, high-
affinity autoreceptors.   
 Lastly, the lowest-affinity β-ARs are Gs-coupled to adenylyl cyclase resulting in 
increased cAMP and enhanced cellular excitability (Ordway et al., 1987; Ferry et al., 
1999a, 1999b; Zhang et al., 2005). β-ARs show high expression levels throughout the 
brain, particularly in the HPC, mPFC, and amygdala (Nicholas et al., 1993a; Summers et 
al., 1995; Booze et al., 1993; Rainbow et al., 1984; Milner et al., 2000). Interestingly, β-
ARs are also expressed on astrocytes which may indirectly influence neural signaling 
(Milner et al., 2000).  Signaling via α1- and β-ARs has been proposed to have opposing 
effects on the mPFC and BLA. High levels of NE may bias instinctive and reflexive 
responses mediated by NE action at α1- and β-ARs in the BLA and whereas activation of 
these receptors may impair mPFC function. This has important implications for aversive 
learning and memory (Arnsten, 2009, 2015; Arnsten et al., 2015).  
1.4 Stress, the LC-NE system, and the fear circuit 
The LC responds to both appetitive and aversive stimuli (Sara and Segal, 1991; Aston-
Jones and Bloom, 1981b; Ventura et al., 2008; Bouret and Sara, 2004; Aston-Jones and 




focus of this section will be to examine how NE affects key nodes in the fear circuit. 
Footshock serves as the US in the majority of Pavlovian fear conditioning experiments, 
and it is well document that footshock and other acute stressors increase LC activity 
(Passerin et al., 2000; Pezzone et al., 1993; Smith et al., 1992; Thierry et al., 1968; Chen 
and Sara, 2007; George et al., 2013; Uematsu et al., 2017; Sara and Segal, 1991; Sved et 
al., 2002). Below we discuss how LC activity and NE affects the fear circuit. 
1.4.1 NE and the amygdala 
The BLA plays a crucial role in the formation and retrieval of fear conditioning and 
extinction memories (Maren and Quirk, 2004; Dejean et al., 2015; Johansen et al., 2011; 
Herry and Johansen, 2014; Maren, 2011, 2001; LeDoux, 2000; Myers and Davis, 2007). 
NE signaling in the amygdala appears to be critical for most aspects of Pavlovian fear 
conditioning and extinction (see below). Increased LC activity in response to acute 
stressors (including footshock) produces robust increases in amygdalar NE content 
(Galvez et al., 1996; Quirarte et al., 1998; Morilak et al., 2005; Arnsten, 2009, 2015; 
Ramos and Arnsten, 2007; McGaugh, 2004, 2000). How increased NE affects BLA 
signaling is therefore a fundamental question when studying emotional learning and 
memory. It has been proposed that heightened NE levels in the amygdala promote 
instinctive and reflexive responses to environmental stimuli (which would presumably 
bias responses for emotional events and memories); (Arnsten, 2009; Southwick et al., 
1999a; Arnsten, 2015; Arnsten et al., 2015; Ramos and Arnsten, 2007). For example, one 
study found that footshock-induced increases in LC and BLA Fos were significantly 




Moreover, drugs that increase NE efflux (such as the α2 autoreceptor antagonist 
yohimbine) produce robust increases in BLA Fos expression (Singewald et al., 2003). This 
suggests that heightened noradrenergic activity in the BLA promotes excitability which 
would likely strengthen fear memories. However, a pair of studies has demonstrated that 
footshock, LC stimulation, or iontophoresis of NE (or NE-increasing drugs) into the BLA 
produced heterogeneous responses in BLA single-unit activity, although the BLA was 
generally suppressed in response to increased NE (Buffalari and Grace, 2007; Chen and 
Sara, 2007). This is perhaps counterintuitive if increased amygdalar excitability is 
associated with fear memory formation and recall, but NE did increase the spontaneous 
firing rate of a smaller subpopulation of BLA neurons (Buffalari and Grace, 2007). 
Interestingly, the suppression of BLA firing is dependent upon α2-AR signaling insofar 
as iontophoresis of clonidine mimicked the effects of NE and these inhibitory effects are 
potentiated with the systemic administration of propranolol (Buffalari and Grace, 2007). 
It is possible that the smaller population of BLA cells that showed excitation is sufficient 
for memory formation or that higher levels of NE (that engaged the lower affinity 
receptors) would result in more excitation. 
 The central amygdala (CeA) is viewed as the output region of the amygdala that 
drives fear expression, although mounting data indicate it too plays a role in the acquisition 
of fear conditioning (Yu et al., 2017; Goosens and Maren, 2003). That said, CeA 
microcircuits and projections to downstream targets such as the periaqueductal grey are 
particularly important for generating freezing behavior (Ciocchi et al., 2010; Haubensak 




LC (Valentino and Van Bockstaele, 2008; Van Bockstaele et al., 1998).  Under stress, the 
CeA activates the LC via corticotropin-releasing hormone (McCall et al., 2015; Van 
Bockstaele et al., 1998; Prouty et al., 2017) which may act as a positive feedforward 
mechanism to maintain high levels of LC activity and NE transmission, particularly in the 
amygdala. This circuit could provide a way to generate sustained fear responses, 
particularly in the aftermath of conditioning. 
1.4.2 NE and the hippocampus 
The hippocampus is critical for integrating and processing spatial information which is 
important in context fear conditioning among other types of learning and memory (Chen 
et al., 2017; Maren et al., 2013; Bouton et al., 2006; Hansen, 2017; Jin and Maren, 2015b) 
and LC input to the hippocampus has been shown to impact learning about a novel context 
(Wagatsuma et al., 2018). Indeed, NE has a major influence on hippocampal function and 
LC stimulation, footshock, and other acute stressors increase hippocampal NE levels 
(Hajós-Korcsok et al., 2003; Abercrombie et al., 1988; Yavich et al., 2005). In addition, 
drugs that increase NE levels, such as yohimbine, amplify this effect whereas drugs that 
reduce NE levels, such as clonidine, blunt stress-induced hippocampal NE release 
(Abercrombie et al., 1988).  Moreover, a number of studies suggest that NE enhances 
hippocampal long-term potentiation (LTP), particularly in the dentate gyrus and CA1, 
which is dependent upon both α1 and β-AR mechanisms (Bliss et al., 1983; Neuman and 
Harley, 1983; Lacaille and Harley, 1985; Chaulk and Harley, 1998; Segal et al., 1991; 
Harley, 2007; Stanton and Sarvey, 1985b, 1985a, 1987; Dahl and Sarvey, 1989; Hopkins 




1992; Yang et al., 2002). For example, NE applied either directly to the dentate gyrus or 
applied to the perforant pathway increases excitatory postsynaptic potentials, decreases 
spike onset latency, and increases the population spike amplitude; these effects promote 
LTP induction and may be important for memory formation (Neuman and Harley, 1983; 
Lacaille and Harley, 1985; Harley, 2007). However, NE effects on LTP may depend on 
stimulation parameters and the areas being stimulated which suggests that NE can 
dynamically modulate HPC function (Dahl and Sarvey, 1989; Harley, 2007). In line with 
this idea, restraint stress and tail shock (which would presumably increase hippocampal 
NE) have been shown to impair hippocampal LTP (Foy et al., 1987). It may be that stress-
induced increases in HPC-NE are beyond optimal levels and exceed the levels used in 
many of the recording studies showing that NE enhances HPC-LTP. Despite these 
possibilities, it appears NE generally enhances hippocampal synaptic efficacy which may 
function to enhance emotional learning and memory. Of course, this may be sensitive to 
the prevailing level of NE and the subregions being examined, allowing NE to 
bidirectionally modulate HPC function.  
1.4.3 NE and the mPFC 
The prelimbic (PL) and infralimbic (IL) subdivisions of the mPFC are thought to regulate 
the expression and suppression of fear, respectively (Giustino and Maren, 2015; Quirk and 
Mueller, 2008; Milad and Quirk, 2012; Dejean et al., 2015; Herry et al., 2010; Knapska 
and Maren, 2009). Several studies have examined the effects of NE and stress on 
prefrontal function. Footshock and other acute stressors increase NE levels in the mPFC 




et al., 1995; Morilak et al., 2005; Girotti et al., 2017).  Similar to other brain regions, NE 
effects on PFC function are highly dependent upon the prevailing level of NE and the task 
requirements. Lower levels of NE (engaging postsynaptic α2-ARs) appear to promote 
cortical function such as cognitive flexibility and working memory, whereas high levels 
impair prefrontal signaling via α1- and β-AR dependent mechanisms (Arnsten, 2009, 
2015; Ramos and Arnsten, 2007; Ramos et al., 2006; Arnsten and Li, 2005). Interestingly, 
the PFC has more dopamine-β hydroxylase (DβH) varicosities relative to sensory cortical 
areas (Agster et al., 2013).  This raises the possibility that prefrontal regions might be 
subjected to greater release of NE (via volume transmission in addition to synaptic 
transmission), which may help explain why the PFC is highly sensitive to stress. An 
important topic for future research will be to address differences in LC projections to PL 
and IL and how these affect fear expression.  
1.5 Stress and NE are key components regulating extinction deficits 
Overall, there is substantial evidence that suggests NE plays a prominent role in stressor- 
and trauma-related disorders, including PTSD. My doctoral work has focused on 
understanding the neurobiology of the immediate extinction deficit (IED). As described 
above, the IED is a phenomenon in which animals and humans alike fail to show a 
successful reduction in fear when extinction occurs soon after (minutes to hours) after 
trauma exposure (Maren, 2014; Maren and Chang, 2006; Merz et al., 2016). My doctoral 
work has hypothesized that this extinction deficit is due to high levels of stress (and NE) 
in the wake of trauma which may subsequently impede mPFC activity, while promoting 




behavioral approaches with systemic and intracranial pharmacology, chemogeneitcs, 
immunohistochemistry, and in vivo recordings in anesthetized and freely moving rats to 
examine how altered NE signaling affects the mPFC and BLA in relation to the IED.  
* Reprinted with permission from PNAS Fitzgerald PJ, Giustino TF, Seemann JR, and Maren S (2015). 
Noradrenergic blockade stabilizes prefrontal activity and enables fear extinction under stress. Proc. 
Natl. Acad. Sci., 201500682. doi:10.1073/pnas.1500682112.   
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2. NORADRENERGIC BLOCKADE STABILIZES PREFRONTAL ACITIVTY AND
ENABLES FEAR EXTINCTION UNDER STRESS* 
2.1 Introduction 
Individuals exposed to extreme psychological stress, such as combat-related 
trauma or sexual abuse, are at risk for developing anxiety and trauma disorders, including 
post-traumatic stress disorder (PTSD).   Although the etiology of PTSD is complex, it is 
widely believed that associative learning processes, including Pavlovian fear conditioning, 
contribute to its genesis.  Moreover, an inability to suppress or extinguish fear memories 
may sustain pathologically high levels of fear in patients with PTSD years after the trauma 
(Kessler et al., 1995; Weston, 2014; Guthrie and Bryant, 2006; Milad et al., 2009; Blechert 
et al., 2007; Jovanovic et al., 2010).  A variety of clinical interventions to facilitate fear 
extinction in patients with PTSD are currently being explored, although effective 
treatment for many afflicted individuals remains elusive (Fitzgerald et al., 2014a; Oznur 
et al., 2014). 
One promising therapeutic target for facilitating extinction in PTSD patients is the 
noradrenergic system.  Norepinephrine (NE) not only plays an important role in mood and 
arousal, but also in the encoding, retrieval, and reconsolidation of emotional memories 
(McGaugh, 2004; Debiec and Ledoux, 2004; Soeter and Kindt, 2011b; van Stegeren et al., 
2010; Bos et al., 2012).  Endogenous NE signaling is elevated in PTSD and drugs that 




PTSD, including its symptoms of hyperarousal and nightmares (Southwick et al., 1997, 
1999a; Pervanidou and Chrousos, 2010; Brunet et al., 2008, 2014). Clinically effective 
noradrenergic drugs include the 1-adrenoceptor antagonist, prazosin, and the 1/2-
adrenoceptor antagonist, propranolol (Brunet et al., 2008; Koola et al., 2014; Writer et al., 
2014; Vaiva et al., 2003).  The neural mechanisms underlying the efficacy of these drugs 
remain poorly understood. 
 It has previously been suggested that stress-induced changes in prefrontal cortical 
structure and function observed in animal models may contribute to the extinction deficits 
observed in patients with PTSD (Farrell et al., 2013; Chang et al., 2010; Fitzgerald et al., 
2014b).  Given the abundant literature implicating NE signaling in prefrontal cortical 
function (Arnsten, 2009; Robbins and Arnsten, 2009), it is conceivable that stress-induced 
elevations in prefrontal NE release (Finlay et al., 1995; Dazzi et al., 2005; Gresch et al., 
1994) contribute to extinction impairments associated with PTSD.  The mPFC, comprising 
the prelimbic (PL) and infralimbic (IL) subdivisions in rodents, plays a key role in the 
regulation of emotional behavior in both humans and rats (Farrell et al., 2010; Rive et al., 
2013).  Previous studies have suggested that PL plays an important role in fear expression, 
whereas IL is preferentially involved in fear extinction (Vidal-Gonzalez et al., 2006; 
Corcoran and Quirk, 2007; Burgos-Robles et al., 2009).  Stress-induced alterations in the 
balance of neuronal activity in PL and IL as a consequence of noradrenergic hyperarousal 
might therefore contribute to extinction impairments and the maintenance of PTSD.  To 
address this question, we combine in vivo microelectrode recording in freely moving rats 




noradrenergic receptors mediate stress-induced alterations in mPFC neuronal activity.  
Further, we examine whether systemic propranolol treatment, given immediately after an 
aversive experience, rescues stress-induced impairments in fear extinction.   
2.2 Results  
2.2.1 Propranolol stabilizes medial prefrontal activity after footshock stress  
To investigate the effect of systemic noradrenergic blockade on stress-induced changes in 
the mPFC, we performed single-unit recordings in freely moving rats (see Materials and 
Methods).  Animals were first surgically implanted with a 16-channel microelectrode 
array (Innovative Neurophysiology) that spanned both PL and IL (8 wires in each) in the 
right hemisphere of each animal.  Array placements in each rat are shown in Figure 2.1a.  
The recording sites varied somewhat in their mediolateral (i.e., laminar) or dorsoventral 
position within PL and IL across rats.  However, there were no significant differences in 
single-unit firing or bursting as a function of mediolateral or dorsoventral position within 
these brain regions.  Representative single-unit waveforms and their corresponding 






Figure 2.1 In vivo mPFC recordings in freely moving rats.  a) Histological localization 
of the center of each electrode array in the mPFC; each array targeted both PL (8 wires) 
and IL (8 wires).  Right hemisphere, coronal sections represent (left to right) coordinates 
+3.2 and +2.7 relative to bregma in the anteroposterior plane.  Six rats received 
propranolol (PROP) treatment, and 5 received vehicle (VEH) treatment.  In one of the 
propranolol rats, recordings were obtained only from PL.  b) Example voltage trace from 
an electrode in PL (top panel) and IL (bottom panel), showing an action potential and its 




After a one-week recovery period, rats were transported to the recording chamber 
for the first of two recording sessions.  During the first recording session, the animals 
received a standard Pavlovian fear conditioning procedure after systemic administration 
of either vehicle or propranolol (10 mg/kg, i.p.); the second session served as a retention 
test for conditioned fear.  For both recording sessions, rats were connected with a flexible 
headstage cable to a multichannel OmniPlex recording system (Plexon), and their freezing 
behavior was monitored inside a standard conditioning chamber using a load-cell 
transducer and amplifier (Maren, 1998). We recorded from a total of 220 mPFC neurons 




PROP-IL, n = 49] and 185 neurons on Day 2 [VEH-PL, n = 47; VEH-IL, n = 34; PROP-
PL, n = 63; PROP-IL, n = 41].  Although some of the units recorded on Day 2 may have 
been the same as those recorded on Day 1, we did not assume that they were and treated 
them as a separate population of neurons.  The baseline firing rates of the units recorded 
on Day 1 (mean ± SEM; 3-min pre-drug baseline) were: VEH-PL = 5.15 ± 0.78 Hz (range: 
0.26 -26.21 Hz); VEH-IL = 5.59 ± 0.88 Hz (range: 1.39 - 21.13 Hz); PROP-PL = 7.52 ± 
0.75 Hz (range: 0.28 - 41.09 Hz); PROP-IL = 8.60 ± 1.41 Hz (range: 0.46 - 55.90 Hz).  
Although 23 cells had firing rates (>15 Hz; 10% of the sample) typical of those observed 
in inhibitory interneurons, it was not clear that these cells reflected a different population 
when various rate and waveform parameters were examined and they were consequently 
included in all analyses.  
 Drug administration prior to Pavlovian fear conditioning on Day 1 (Figure 2.2a) 
did not significantly alter the spontaneous firing rate of PL or IL neurons.  Although firing 
rates decreased slightly in all animals over the pre-conditioning recording period, this 
decrease was similar in vehicle- and propranolol-treated rats [main effect of time, F(2,432) 
= 15.57, p < 0.01; time x drug interaction ns; time x drug x brain region interaction ns]; 
this contrasts with a previous report that found a significant decrease in PL firing with 
propranolol (Rodriguez-Romaguera et al., 2009).  Average firing rates in the final 3-min 
block of the post-injection period were: VEH-PL = 4.73 ± 0.71 Hz; VEH-IL = 4.79 ± 0.92 
Hz; PROP-PL = 7.17 ± 0.75 Hz; PROP-IL = 7.36 ± 1.14 Hz.  
Eighteen minutes after drug administration, the rats received 5 pairings of an 




footshock unconditioned stimulus (US; 0.5 sec, 1.0 mA); trials were separated by a 1-min 
inter-trial interval (ITI).  Fear conditioning was followed by a 60-min stimulus-free period 
during which the neural and behavioral effects of conditioning were recorded.  Not 
surprisingly, fear conditioning yielded robust increases in freezing behavior in vehicle-
treated rats.  Interestingly, post-shock freezing was significantly blunted by propranolol 
treatment [main effect of drug, F(1,9) = 22.97, p < 0.01] (Figure 2.2b).  Correspondingly, 
fear conditioning produced dramatic changes in the spontaneous firing rate of PL and IL 
neurons and these conditioning-induced changes in firing rate were dampened in 
propranolol-treated rats.  Figure 2.2c shows firing rate histograms for representative 
single-units in PL and IL from vehicle- and propranolol-treated rats.  In vehicle-treated 
rats, fear conditioning produced substantial changes in the firing rate in both PL and IL; 
these changes were minimal in single-units from propranolol-treated rats.  This is 
particularly evident in heat maps illustrating the normalized firing rate in the entire 
population of single-units recorded on Day 1 (Figure 2.2d).  A much greater proportion of 
neurons recorded in vehicle-treated rats exhibited either markedly enhanced (light orange) 
or suppressed (light blue) firing rates soon after fear conditioning (t > 0) relative to units 






Figure 2.2 Propranolol stabilizes single-unit firing in mPFC neurons after footshock 
stress.  a) Day 1 experimental design.  b) Propranolol-treated rats (red circles) exhibited 
reduced freezing throughout the Day 1 recording session relative to vehicle-treated 
controls (white circles).  c) Four representative histograms (20-sec bins) showing 
spontaneous firing rate from neurons recorded in PL (left panels) and IL (right panels).  
Fear conditioning (blue bar) altered the firing rate of the PL and IL neurons obtained from 
vehicle-treated rats (black traces, top panels) and propranolol administration mitigated this 
effect (red traces, bottom panels). d) Normalized firing rate heat maps showing post-
conditioning increases (light orange) and decreases (light blue) relative to baseline (pre-
conditioning) firing rate (black) for all of the units recorded in each group and brain region.  
Only the 3 minutes prior to conditioning and the first 5 minutes after conditioning are 
shown for clarity.  In both PL and IL, single-units in vehicle-treated rats exhibited 
increases or decreases in firing rate after conditioning, and propranolol treatment mitigated 
these effects.  Injection (INJ) is denoted by green vertical bar; conditioning (tone-shock 
pairings) is denoted by blue vertical bar.  Data during the conditioning period were not 




 To assess group differences in spontaneous firing rate, we generated average firing 
rate histograms for all of the units recorded in each area and treatment condition (Figure 
2.3).  In vehicle-treated rats, fear conditioning massively, but transiently, increased the 
spontaneous firing rate among mPFC neurons in the minutes following fear conditioning.  




2.3a; drug x time interaction, F(178,24030) = 4.36, p < 0.01] and IL [Figure 2.3b; drug x 
time interaction, F(178,14418) = 2.82, p < 0.01].  For example, propranolol significantly 
attenuated conditioning-related increases in PL in the first immediate post-shock period 
[Figure 2.3a inset, t(135) = 2.26, p < 0.05] and IL [Figure 2.3b inset, t(81) = 1.98, p = 





Figure 2.3 Propranolol stabilizes single-unit firing in the population of mPFC 
neurons.  Spontaneous firing rates were averaged across all neurons and normalized to 
the pre-conditioning baseline for each brain region and treatment group. Fear conditioning 
(blue arrow) induced a dramatic increase in average spontaneous firing rate in PL neurons 
from vehicle-treated rats [a, black trace; inset shows first 20-sec post-shock bin, 
comparing vehicle (white bar) with drug (red bar)] that was mitigated by propranolol 
treatment (a, red trace).  Conditioning induced a weaker post-shock increase in 
spontaneous firing in IL neurons from vehicle-treated rats (b, black trace; inset shows first 
20-sec post-shock bin), and produced an enduring suppression of this activity.  Propranolol 
treatment (b, red trace) counteracted both types of firing rate changes in IL.  Injection 
(INJ) is denoted by green vertical bar; conditioning (tone-shock pairings) is denoted by 
blue vertical bar.  Data during the conditioning period were not recorded.  *p < 0.05 versus 







In addition to the rapid increases in IL and PL firing rate after conditioning, IL neurons 
exhibited a sustained decrease in spontaneous firing that persisted (on average) for roughly 
30 minutes after conditioning.  This corresponds to a time window within which rats are 
resistant to extinction (Chang et al., 2010), and suggests that shock-induced depression of 
IL activity may, at least in part, account for this stress-induced “immediate extinction 
deficit” (IED). 
Bursting of mPFC neurons has been implicated in both extinction learning (Chang 
et al., 2010; Robbins and Arnsten, 2009) and the IED (Chang et al., 2010).  We therefore 
examined whether burst firing in PL and IL was modulated by footshock stress and 
noradrenergic blockade. Although normalized burst firing mirrored the patterns observed 
for overall firing rate (Figure 2.4), propranolol treatment did not reliably alter shock-
induced changes in burst firing in the immediate post-shock period in PL neurons.  This 
does not however, rule out the possibility that shock-induced changes in spontaneous 








Figure 2.4 Propranolol stabilizes single-unit bursting in the mPFC after footshock 
stress.  a, b) Spontaneous bursting rates averaged across all neurons and normalized to the 
pre-conditioning baseline for each brain region and treatment group.  Fear conditioning 
(blue bar) induced an increase in average spontaneous bursting rate in PL neurons from 
vehicle-treated rats (a, black trace; inset shows first 20-sec post-shock bin in vehicle- and 
propranolol-treated rats) that was mitigated by propranolol treatment (a, red trace).  The 
inset graph reveals no drug-induced difference in PL bursting, unlike for Day 1 firing rate; 
red bar indicates propranolol and white bar indicates vehicle.  Conditioning also induced 
a post-shock increase in spontaneous bursting in IL neurons from vehicle-treated rats (b, 
black trace; inset shows first 20-sec post-shock bin comparing vehicle and drug), and 
produced an enduring suppression of this activity.  Propranolol treatment (b, red trace) 
mitigated this effect.  Injection (INJ) is denoted by green vertical bar; conditioning (tone-
shock pairings) is denoted by blue vertical bar.  Data during the conditioning period were 




2.2.2 Propranolol mitigates shock-induced increases and decreases in mPFC firing 
rate 
Fear conditioning induced robust changes in the average spontaneous firing rate of mPFC 
neurons.  Nonetheless, individual single-units exhibited considerable diversity in their 
firing rate after fear conditioning (Figure 2.2d).  We were interested in whether 
propranolol altered the proportion of neurons that increased or decreased their firing rate 




populations differed in the treatment conditions.  We therefore categorized units in both 
PL and IL according to their response bias in the immediate post-shock interval (i.e., the 
20-sec period after the final tone-shock pairing), as well as during a 20-sec period at the 
end of the 60-min post-shock recording session.   
There were no significant differences in the proportion of neurons increasing or 
decreasing their firing rates in vehicle- compared to propranolol-treated rats at either the 
immediate (Figure 2.5a) or remote time points (Figure 2.6). Yet despite increasing their 
firing rates after conditioning, the majority of single-units in both PL and IL exhibited a 
suppression of firing 60-min after conditioning (Figure 2.6). This increase in the 
proportion of neurons with suppressed firing rates across the recording session was 
observed in both the PL [X2(1) = 3.90, p < 0.05] and IL [X2(1) = 4.98, p < 0.05] of vehicle-
treated rats.  In propranolol-treated rats, this effect was only observed in PL neurons [X2(1) 
= 10.38, p < 0.01], insofar as IL neurons were already more likely to be suppressed 
immediately after conditioning.   Overall, these data indicate that the tendency for many 
neurons to show a transient increase in firing rate in the immediate post-shock period gave 








Figure 2.5 Propranolol stabilizes both increases and decreases in mPFC firing rate.  
a) Proportion of neurons in each of the four groups exhibiting immediate post-conditioning 
(first 20-sec bin) increases (z > 0, ‘excited’) or decreases (z < 0, ‘suppressed’) in 
spontaneous firing rate.  Regardless of drug treatment, PL neurons tended to increase their 
firing rate after shock more so than IL neurons.  b, c) Normalized firing rate histograms 
for PL (left panels) and IL (right panels) neurons that were ‘excited’ (b) or ‘suppressed’ 
c) in the immediate post-shock period in vehicle- (black traces) and propranolol-treated 
(red traces) rats.  Inset graphs show the values for the first 20-sec post-shock bin in vehicle- 
(white bars) and propranolol-treated (red bars) rats.  Injection (INJ) is denoted by green 
vertical bar; conditioning (tone-shock pairings) is denoted by blue vertical bar.  Data 
during the conditioning period were not recorded. *p < 0.05 versus vehicle.  All values 




 Although the proportion of neurons showing immediate post-shock changes in 
firing was similar in vehicle- and propranolol-treated rats, there were considerable 
differences in the firing rate of these neurons (Figure 2.5b, c).  “Excited” PL neurons in 




large, but transient increase in firing in the post-conditioning period; this effect was 
counteracted by propranolol treatment [drug x time interaction, F(178,15308) = 5.68, p < 
0.01] (Figure 2.5b, left panel).  Indeed, shock-induced increases in firing in the first 
immediate post-shock bin were significantly attenuated by propranolol treatment [t(86) = 
2.56, p < 0.05] (Figure 2.5b, left inset).  Similarly, “excited” IL neurons exhibited a 
transient increase in firing in the post-conditioning period that was attenuated in 
propranolol-treated rats [drug x time interaction, F(178,6230) = 2.71, p < 0.01] (Figure 
2.5b, right panel).  However, this effect only approached statistical significance in the first 
post-shock bin [t(35)=1.92, p = 0.06] (Figure 2.5b, right inset).    
 Conditioning-induced decreases in firing were also sensitive to propranolol 
treatment (Figure 2.5c).  In vehicle-treated rats, “suppressed” PL neurons that exhibited 
immediate post-shock decreases in rate showed a decrease in firing in the post-
conditioning period that was mitigated in propranolol-treated rats [drug x time interaction, 
F(178,8366) = 1.33, p < 0.01] (Figure 2.5c, left panel).  Firing during the immediate post-
shock bin was significantly greater in propranolol-treated rats [t(47) = 2.19, p < 0.05] 
(Figure 2.5c, left inset).  Similarly, propranolol treatment limited the magnitude of firing 
rate suppression in IL neurons [drug x time interaction, F(178,7832) = 2.90, p < 0.01] 
(Figure 2.5c, right panel), although this only approached significance in the first 
immediate post-shock bin [t(44) = 1.84, p = 0.07] (Figure 2.5c, right inset).  In summary, 
noradrenergic blockade stabilizes fear conditioning-induced changes in mPFC firing rate 
by limiting both increases and decreases in spontaneous firing rate.    







Figure 2.6 Single-unit firing rates tend to be suppressed after 60 minutes.  At the 60 
min time point of Day 1, the proportion of neurons with suppressed firing was significantly 
increased relative to the immediate post-shock period in all of the regions and conditions, 




2.2.3 Expression of conditional freezing is not sufficient to increase mPFC firing 
rate 
Twenty-four hours after the first recording session, a second session (Day 2) was 
conducted to examine whether the neural changes observed immediately after aversive 
conditioning also occurred during the expression of fear to the CS. To this end, rats were 
returned to the recording chamber, which was modified to create a context that was distinct 
from that used for conditioning (Figure 2.7; see Materials and Methods for details).   After 
a 3-min baseline period, rats received five CS-alone trials (i.e., without footshocks; 1-min 
ITI), and a subsequent 60-min stimulus-free period. Both groups of rats exhibited high 
levels of conditioned freezing in the 3-min period immediately after presentation of the 
tones, indicating that systemic administration of propranolol prior to fear conditioning the 




no significant effect of pre-conditioning drug treatment on Day 1 on conditioned freezing 
behavior on Day 2 (Fs < 1). 
 
 
Figure 2.7 Propranolol stabilizes single-unit firing in IL after CS delivery.  a) Day 2 
experimental design. b) Propranolol-treated rats (red circles) did not exhibit altered 
freezing relative to vehicle-treated rats (white circles) when averaged across the entire 
session.  c) After CS presentation, the majority of mPFC neurons in vehicle-treated rats 
showed decreases in firing rate, and this was most pronounced in IL neurons.  A 
significantly greater proportion of IL neurons was suppressed in the vehicle- compared to 
propranolol-treated animals. (d, e) Unlike Day 1, the normalized firing rate of PL neurons 
in both vehicle- and propranolol-treated rats exhibited little change after presentation of 
the aversive CS.  Interestingly, IL firing rate was depressed by CS presentations and this 
effect was mitigated by propranolol. Insets show normalized firing in the first 20-sec bin 
after the last CS for neurons from vehicle- (white bars) and propranolol-treated rats (red 
bars).  Gray bars denote the CS period.  *p < 0.05 versus vehicle.  All error bars indicate 







 Importantly, CS presentations on Day 2 produced qualitatively different changes 
in spontaneous firing rate relative to Day 1 despite yielding high levels of conditioned 
freezing behavior (Figure 2.7). After CS presentation, the majority of mPFC neurons in 
rats that had been treated with vehicle the previous day showed decreases in firing rate 
(Figure 2.7c), and this was most pronounced in IL neurons.  A significantly greater 
proportion of IL neurons was suppressed in the vehicle- compared to propranolol-treated 
animals [X2(1) = 5.45, p < 0.05].  This pattern was also reflected in the normalized firing 
rates across the recording session (Figure 2.7d,e).  Spontaneous firing tended to decrease 
in both PL and IL after CS presentation, and propranolol administration prior to fear 
conditioning on Day 1 reliably dampened this effect in IL [drug x time interaction, 
F(179,13067) = 2.25, p < 0.01].  This latter effect was particularly robust in the 20-sec 
period immediately after delivery of the last tone [t(73) = 2.14, p < 0.05] (Figure 2.7, 
inset).  Similar to Day 1, neuronal bursting largely mirrored the spontaneous firing rate 
data.  In addition to influencing spontaneous firing rate on Day 2, propranolol 
administration prior to conditioning on Day 1 significantly affected CS-evoked firing 








Figure 2.8 CS-evoked responses in the mPFC are modulated by propranolol.  On Day 
2, CS-evoked activity was significantly different between vehicle- and propranolol-treated 
rats.  Peri-event time histograms (100-msec bins) computed on average normalized firing 
rate (post-CS firing normalized to 1-sec pre-CS baseline) across the five CS presentations 
revealed that both PL (a) and IL (b) neurons exhibited increased firing due to prior 
propranolol treatment [PL, drug x time interaction, F(29,2958) = 2.52, p < 0.01; IL, 




 The fact that CS presentations on Day 2 evoked robust freezing behavior, but 
minimally altered spontaneous firing in mPFC suggests that a transition from a low fear 
state to a high fear state is not responsible for the firing rate changes observed on Day 1. 
Figure 2.9 illustrates this observation by plotting freezing behavior and normalized firing 
rate across the two recording sessions.  Although the levels of freezing were similar 
immediately after either CS-US (Day 1) or CS-alone (Day 2) trials on each day, changes 
in neuronal activity were markedly different.  On Day 1, vehicle-treated rats showed a 
post-shock increase in spontaneous firing rate relative to propranolol-treated animals 
[main effect of drug, F(1,216) = 8.41, p < 0.01].  This contrasted with Day 2, where vehicle 
rats showed suppression of firing that was counteracted by propranolol [main effect of 
drug, F(1,181) = 7.18, p < 0.01].  Thus, on both days, propranolol treatment mitigated 




     
 
Figure 2.9 Freezing behavior does not alter mPFC firing rate.  Freezing behavior in 
both vehicle-treated (left panel) and propranolol-treated (right panel) rats was not 
markedly different during the immediate post-shock period on Day 1 compared with the 
immediate post-CS period on Day 2 [values represent the average freezing immediately 
following the last US (Day 1) or CS (Day 2)].  Despite similarities in Day 1 and Day 2 
freezing, normalized firing rate during the first 20 sec following the last US (Day 1) or CS 
(day 2) was dramatically elevated in both IL and PL on Day 1 relative to Day 2 in vehicle-
treated rats (left panel).  This effect was mitigated by propranolol treatment (right panel).  
Hence, marked differences in firing rate in the mPFC cannot be attributed to freezing 
behavior per se, because both post-trial periods (on Day 1 and Day 2) yielded similar and 




2.2.4 Propranolol facilitates extinction under stress 
We have previously established that extinction fails when given soon after footshock, 
when levels of acute psychological stress are high; that is, rats exhibit an “immediate 
extinction deficit” (IED) when extinction trials are delivered soon after fear conditioning 
(Chang et al., 2010; Maren and Chang, 2006; Chang and Maren, 2009; Maren, 2014) but 
also see (Myers et al., 2006; Norrholm et al., 2008). It is notable that we now show that 
fear conditioning is followed by a lasting suppression of IL firing (Figure 3b), a time at 
which CS-alone trials are ineffective at supporting long-term extinction (Maren and 




the IED results from a high state of fear that interferes with mPFC function.  Given that 
systemic propranolol reduces shock-induced freezing and stabilizes mPFC neural activity, 
we tested whether it would mitigate the IED.   
In this experiment, rats were systemically administered either vehicle (n = 7) or 
propranolol (n = 7) immediately after fear conditioning; an immediate extinction session 
consisting of 45 presentations of the CS (1-min ITI) was conducted 30 min after 
conditioning.  All rats were then given a retrieval test 48 hours after extinction using 
identical procedures to those used during the extinction session (i.e., 45 CS-alone “test” 
trials).  Both groups acquired fear conditioning and there were no differences in 
conditioned freezing prior to drug treatment [Figure 2.10a; F(1,12) < 1].  However, 
propranolol treatment prior to the immediate extinction session significantly reduced both 
pre-trial (BL) and within-session freezing during the extinction trials [Figure 2.10b; main 
effect of drug, F(1,12) = 8.40, p < 0.05] of the immediate extinction session.  Importantly, 
propranolol facilitated the acquisition of long-term extinction; freezing in propranolol-
treated rats was significantly lower during the first 9-trial block of the retention test [Figure 
2.10c, drug x time interaction, F(5,60) = 3.27, p < 0.05].  Thus, propranolol treatment 
before the immediate extinction procedure limited the spontaneous recovery of fear that 
characterizes the IED in vehicle-treated rats and promoted the retention of extinction under 





Figure 2.10 Propranolol mitigates the immediate extinction deficit. Propranolol 
administration immediately after fear conditioning (a) reduced both baseline (BL) and 
freezing during the immediate extinction session (b, 30 min after conditioning).  
Propranolol facilitated the recall of extinction during a retention test conducted 48 hours 
after extinction (vehicle, n=7; propranolol, n=7) (c).  This effect on freezing was not due 
to impaired consolidation of the fear conditioning memory.  Rats that were administered 
propranolol immediately after conditioning (d), but not extinguished exhibited reductions 
in freezing early in the no-extinction session (e, context exposure only) and high levels of 
freezing during the retention test that did not differ from vehicle-treated controls (vehicle, 
n=8; propranolol, n=8) (f).  Gray bars denote the 3-min baseline (BL) period prior to 
delivery of conditioning or extinction trials.  *p < 0.05 versus propranolol.  All values are 




Of course, in testing the effects of propranolol on the IED, it is possible that 
propranolol administered immediately after fear conditioning reduced conditioned 
freezing by impairing the consolidation of the fear memory, rather than facilitating 
extinction.  To address this possibility, we conducted an additional experiment in which 




not receive extinction trials (Figure 2.10d-f).  As before, both groups acquired fear 
conditioning and exhibited similar levels of conditioned freezing prior to drug treatment 
[Figure 2.10d; main effect of group, F(1,14) < 1].  Thirty minutes after conditioning, the 
rats were returned the conditioning chambers (context B), but no extinction trials were 
delivered.  Similar to the previous IED experiment, propranolol-treated rats exhibited 
reduced freezing early in the session [Figure 2.10e; drug x time interaction, F(5,70) = 2.88, 
p < 0.05].  Importantly, during the fear recall test 48 hrs after conditioning, there was no 
difference in conditioned freezing between the groups [Figure 2.10f; Fs < 1].  This 
indicates that post-conditioning propranolol did not impair consolidation of the fear 
memory, an effect that is consistent with a previous report (Debiec and Ledoux, 2004).  
These data support the view that post-conditioning propranolol facilitates immediate 
extinction by reducing post-shock fear and stabilizing mPFC firing.   
If propranolol facilitates extinction learning under conditions of high 
noradrenergic arousal, how might it affect learning when the psychological stress level is 
presumably lower?  To address this question, we conduced another experiment in which 
rats received vehicle or propranolol (n = 8 per group) prior to delayed extinction (24 hours 
after conditioning).  As shown in Figure 11, freezing behavior prior to the first CS trial 
during the extinction session was low (Figure 2.11b) in both vehicle- and propranolol-
treated rats.  This indicates that delayed extinction limits the high levels of sensitized fear 
observed with the immediate extinction procedure (Figure 2.10b, e). In addition, 
propranolol administration did not influence either the expression of fear or within-session 




arousal must be high in order for propranolol to limit freezing.    However, propranolol-
treated rats exhibited impairments in extinction recall during the retention test place 24 
hrs after extinction.  Specifically, rats in the propranolol group exhibited greater levels of 
freezing during the first block of 9 trials of the session relative to vehicle-treated rats 
[Figure 2.11c; drug x time interaction, F(5,70) = 2.84, p < 0.05].  Thus, propranolol given 
before delayed extinction impaired, rather than enhanced, learning during this putatively 





Figure 2.11 Propranolol impairs delayed extinction. In contrast to its effects on 
immediate extinction, propranolol given 30 min before a delayed extinction session, which 
took place 24 hrs after conditioning (a) did not significantly alter within-session extinction 
(b).  Moreover, propranolol-treated rats exhibited a deficit in extinction recall 24 hrs after 
extinction (c) (vehicle, n=8; propranolol, n=8).  Gray bars denote the 3-min baseline (BL) 
period prior to delivery of conditioning or extinction trials.  *p < 0.05 versus vehicle.  All 





Stress-induced extinction deficits, including the IED, have been posited to arise from 
dysregulation of mPFC function (Chang et al., 2010; Maren, 2014; Izquierdo et al., 2006).  




accompanying fear conditioning produces dramatic changes in both the firing rate and 
bursting profile of single-units recorded in PL and IL.  Systemic beta-adrenergic blockade 
by propranolol counteracts these effects by maintaining a relative “balance” in PL and IL 
neural activity after the footshock stressor.  In addition, propranolol administration 
rescued the IED, suggesting that noradrenergic stabilization of mPFC activity buffers 
against the deleterious effects of stress on extinction learning.  This novel finding has 
important implications for understanding how beta-noradrenergic interventions minimize 
the deleterious effects of marked psychological stress or trauma and improve 
psychotherapeutic outcomes (Brunet et al., 2008, 2014).  Moreover, these data suggest 
that propranolol may be particularly effective in facilitating fear reduction when prevailing 
stress at the onset of extinction training is high.  Thus, the timing of propranolol 
administration may be critical to maximizing its therapeutic efficacy in the treatment of 
stress- or trauma-related disorders such as PTSD.   
 It has previously been suggested that PL and IL have opposing roles in the 
regulation of fear (Chang et al., 2010; Vidal-Gonzalez et al., 2006; Corcoran and Quirk, 
2007; Burgos-Robles et al., 2009).  The present data lend some support to this view insofar 
as the expression of freezing behavior after conditioning was associated with distinct 
patterns of firing among simultaneously recorded neurons in PL and IL.  Immediately after 
the last fear conditioning trial on Day 1, PL neurons (on average) exhibited a massive, but 
transient increase in spontaneous firing rate. In contrast, IL neurons (on average) exhibited 
a weaker increase in firing rate, followed by a sustained decrease in firing that persisted 




accompanied both the induction and maintenance of freezing behavior in the aftermath of 
conditioning.   However, it is important to note that sustained decreases in IL firing, rather 
than sustained increases in PL firing, were associated with the maintenance of freezing 
behavior.  This observation suggests that regulation of IL-mediated inhibition of amygdala 
excitability, for example, is not only involved in the expression of extinction (Quirk et al., 
2003), but also the expression of conditioned fear.  Consistent with the sustained changes 
in firing rate we observed after footshock, a study of restraint stress in rats found that a 
population of mPFC neurons showed an increase in firing rate that persisted for over 2 
hours after the stressor (Jackson and Moghaddam, 2006).     
 Surprisingly, fear-related changes in mPFC firing were qualitatively different after 
fear conditioning than after the presentation of fear CSs.  Neurons in both IL and PL 
exhibited much more dramatic changes in spontaneous firing immediately after CS-US 
pairings on Day 1 than after presentation of the CS alone on Day 2, despite similar (and 
nearly asymptotic) levels of freezing behavior in each session, particularly in vehicle-
treated rats.  These results indicate that it is not high levels of fear per se that correlate 
with changes in mPFC neuronal firing (Chang et al., 2010; Fitzgerald et al., 2014b; Vidal-
Gonzalez et al., 2006; Corcoran and Quirk, 2007; Burgos-Robles et al., 2009), but rather 
the emotional context in which that fear is experienced (Goosens et al., 2003; Hobin et al., 
2003).  Specifically, our results suggest that mPFC firing is particularly sensitive to the 
acute effects of the footshock US, possibly reflecting unconditioned components of fear 
in the immediate aftermath of shock exposure.  Experiments examining the consequences 




immediate shock procedure that yields little freezing) would help to resolve this issue 
(Fanselow, 1980; Lattal and Abel, 2001).  Collectively, our results reveal that whereas 
recent exposure to footshock strongly modulates neuronal firing in mPFC, exposure to the 
CS alone does not.  It should also be noted that within-session spontaneous firing rates in 
PL and IL did not correlate with ongoing freezing behavior (and by inference, fear state).  
For example, firing rates in both PL and IL largely returned to baseline by the end of the 
first recording session, despite the fact that freezing behavior remained markedly elevated 
relative to the pre-shock baseline.  This suggests that circuits other than mPFC mediate 
the sustained freezing behavior we observed, although PL and IL may initiate or otherwise 
contribute to this effect.     
 Because beta-adrenergic receptors have previously been implicated in stress-
induced modulation of prefrontal function (Ramos and Arnsten, 2007), we next examined 
whether systemic propranolol administration affected shock-induced changes in PL and 
IL firing.  We found that propranolol administration prior to fear conditioning stabilized 
spontaneous activity in PL and IL after footshock, dampening the magnitude of shock-
induced spike firing changes observed among single-units in each area.  Specifically, 
propranolol both attenuated the immediate post-shock increases in firing rate in PL, as 
well as the decreases in IL firing that accompanied the expression of fear during the 
remainder of the session.  This suggests that propranolol may reduce fear after 
conditioning, at least in part, by stabilizing neuronal firing in PL and IL in the aftermath 




 Indeed, the stabilizing effect of propranolol on PL and IL spike firing may underlie 
the facilitation of extinction that we observed behaviorally when this drug was given prior 
to immediate extinction.  That is, propranolol administered immediately after fear 
conditioning reduced the expression of freezing behavior during the immediate extinction 
session and facilitated lasting extinction.  This effect was not due to an effect of 
propranolol on fear memory consolidation (see also (Debiec and Ledoux, 2004)) as the 
drug had no effect on conditioned freezing in animals that did not undergo extinction.  
Similar to our results, Quirk and colleagues observed decreases in freezing behavior after 
systemic propranolol administered before an extinction session that was conducted 
twenty-four hours after conditioning (Rodriguez-Romaguera et al., 2009).  Interestingly, 
however, they found no lasting effect of propranolol on extinction under these conditions 
(Rodriguez-Romaguera et al., 2009) and, in a related study, they reported extinction 
impairments after intra-IL propranolol infusion (Mueller et al., 2008).  We suggest that 
the disparities in these results are related to the timing of extinction and propranolol 
administration relative to fear conditioning.  Specifically, propranolol administration soon 
after conditioning facilitates immediate extinction by dampening shock-induced 
noradrenergic arousal (Gresch et al., 1994; Finlay et al., 1995; Dazzi et al., 2005; Galvez 
et al., 1996), whereas propranolol administration long after conditioning, when 
noradrenergic arousal is low, impairs extinction learning by reducing adrenergic 
transmission below optimal levels (Arnsten, 2009).  This latter hypothesis is consistent 




actually impairs learning.  Collectively, our data suggest that propranolol administered 
during stress stabilizes PL and IL activity and facilitates extinction learning.   
 Of course, a critical question is whether the beta-adrenergic receptors mediating 
the effects of systemic propranolol are located in the mPFC or in other brain regions that 
regulate the mPFC including the locus coeruleus (LC) and basolateral amygdala (BLA) 
(McIntyre et al., 2012).  Consistent with the former possibility, IL infusion of propranolol 
has been reported to influence extinction recall (Mueller et al., 2008); however, it is not 
known whether this manipulation facilitates immediate extinction.  Alternatively, 
noradrenergic modulation of BLA excitability (McIntyre et al., 2012) may influence 
mPFC firing to regulate extinction.  Consistent with this possibility, it has been found that 
induction of inflammatory pain decreases mPFC firing, a change that was mediated by 
hyperexcitability in the BLA (Ji et al., 2010).  Indeed, other stressors have also been 
reported to modulate mPFC through the amygdala (Maroun and Richter-Levin, 2003), and 
the BLA regulates fear and extinction through its long-range projections to mPFC (Senn 
et al., 2014).  Ultimately, stress-induced NE release from LC terminals, which has been 
broadly implicated in the regulation of memory and emotion (McIntyre et al., 2012), may 
influence mPFC spike firing either directly or through indirect modulatory circuits.    
 The present experiments have critical implications for developing 
pharmacotherapeutic interventions for anxiety- and trauma-related disorders in humans. 
For example, a commonly used, albeit controversial approach to prevent PTSD is so-called 
psychological debriefing, in which behavioral therapy is given soon after exposure to a 




noradrenergic pharmacological agents, such as propranolol, soon after trauma could 
enhance the effectiveness of debriefing or other early interventions by modulating 
prefrontal cortical activity as we have described here.  Consistent with this, it has been 
reported that propranolol treatment within days of trauma in humans reduces the incidence 
of PTSD (Vaiva et al., 2003).  Moreover, propranolol administered after trauma 
reactivation in patients with PTSD has a therapeutic effect on physiological responding to 
traumatic imagery weeks after the pharmacological intervention (Brunet et al., 2014, 
2008). Together, these studies suggest that propranolol administration may be particularly 
effective when trauma-related arousal is high (i.e., soon after trauma and after trauma 
reactivation).  The present data suggest that the efficacy of propranolol under these 
conditions would be greatly enhanced by concurrent exposure therapy.   
 In summary, exposure to footshock stress initiates pronounced signaling changes 
in mPFC and freezing behavior, and β-noradrenergic blockade by propranolol mitigates 
these effects.  Collectively, these findings shed light on prefrontal executive control of 
fear-related behavior, while also suggesting that propranolol treatment may enhance 
behavioral debriefing aimed at preventing PTSD development after recent exposure to 
trauma.        
2.4 Materials and Methods 
2.4.1 Subjects  
Adult male Long-Evans Blue Spruce rats (weighing 200-224 g; 50-57 days old) were 
obtained from a commercial supplier (Harlan Sprague-Dawley, Indianapolis, IN).  Upon 




housed in cages within a temperature- and humidity-controlled vivarium, and kept on a 
14:10 hr light/dark cycle (lights on at 7 am) with ad libitum access to food and water.  All 
experiments took place in the daytime during the light phase.  Rats were handled for ~30 
seconds a day for 5 days before any behavioral testing or surgical procedures were carried 
out to habituate them to the experimenter.  The number of rats used in each experiment is 
stated in the figure legends. All experiments were conducted at Texas A&M University 
with full approval from its Animal Care and Use Committee. 
2.4.2 Drugs  
 D,L-propranolol hydrochloride was obtained from a commercial supplier (Sigma-Aldrich, 
St. Louis, MO). The drug was dissolved in distilled water (5 mg/ml) and injected 
systemically (10 mg/kg, i.p.) in a volume of 2 ml/kg.   
2.4.3 In vivo electrophysiology 
Twelve rats (vehicle, n = 6; propranolol, n = 6) were used for the electrophysiological 
experiments; one rat in the vehicle group died prior to completing the experiment leaving 
five rats in that group.  Rats were assigned to each drug condition such that each condition 
was alternated across the experiment. For implantation of the recording array, rats were 
anesthetized with isoflurane (5% induction, 2% maintenance) and secured in a stereotaxic 
apparatus (Kopf Instruments, Tujunga, CA).  The scalp was incised and retracted; three 
burr holes were drilled for anchor and ground screws.  A portion of the skull overlying the 
medial prefrontal cortex (mPFC) was removed to allow for microelectrode implantation.  
The rat was implanted with a 16-channel microelectrode array (Innovative 




(IL; 8 wires) subdivisions of the mPFC in the right hemisphere.  The 2x8 wire microarray 
was constructed from two rows of 50 µm diameter tungsten wires of two different lengths 
(PL, 6.9 mm; IL, 8.0 mm); wires in each row and the rows themselves were spaced 200 
µm apart.  The array was positioned with its long axis parallel to the anterior-posterior 
plane.  The coordinates for the centermost wires of the array was:  PL, +2.7 mm AP, +0.55 
mm ML, -4.0 mm DV and IL, +2.7 mm AP, +0.35 mm ML, -5.1 mm DV (relative to 
bregma at skull surface). The mediolateral offset (200 µm) between the PL and IL 
electrode rows minimized damage to the overlying cortex during array implantation.  Also, 
the slightly more medial coordinate of the IL wires, relative to the PL ones, accommodates 
the slightly thinner IL cortex, allowing recordings in similar layers in the two brain areas 
within a given rat.  The array was secured to the skull with dental acrylic and one week 
was allowed for recovery before in vivo recordings began. 
 A standard rodent conditioning chamber (30x24x21 cm, Med Associates, St. 
Albans, VT) housed in a sound-attenuating cabinet was modified to allow for 
electrophysiological recordings.  The chamber consisted of two aluminum sides, a 
Plexiglas rear wall, and a hinged Plexiglas door.  The grid floor contained 19 stainless 
steel rods (4 mm diameter) spaced 1.5 cm apart (center-to-center).  Rods were connected 
to a shock source and solid-state grid scrambler (Med Associates) for the delivery of 
footshocks.  A loudspeaker mounted on the outside of a grating in one aluminum wall was 
used to play auditory tones.  Locomotor activity was transduced by a load-cell under the 




recording system (Plexon, Dallas, TX).  The experimenters were not blind to drug 
treatment group, but all behavioral and neural activity was recorded automatically. 
 Single-unit recordings occurred over two days in two distinct contexts. On Day 1, 
the rats were transported to the recording room in a black box, connected to the headstage 
cable, and placed in the recording chamber.  The chamber was cleaned with 1% 
ammonium hydroxide to provide a distinct olfactory cue, a black pan containing a thin 
layer of the same solution was placed under the grid floor, and the room was illuminated 
with ambient red lights (context A). After a 3-min stimulus-free baseline period, the rat 
was briefly removed from the chamber and injected with either propranolol (10 mg/kg, 
i.p) or vehicle (distilled water) and then immediately returned to the recording chamber.  
Neural and behavioral data were not recorded during injection (~1 min) due to the 
electrical noise associated with handling the rat.  Twenty minutes after the injection 
(Rodriguez-Romaguera et al., 2009), five tone (2 sec, 80 dB, 2 kHz)-footshock (0.5 sec, 1 
mA) trials were delivered (shock onset occurred at tone offset) with a 1-min inter-trial 
interval (ITI).  Behavioral and neuronal data were not recorded during the conditioning 
period due to the electrical noise associated with shock delivery; recordings commenced 
immediately after the last footshock.  The recording session continued for 60-min after the 
last footshock, after which the rat was returned to its home cage. 
 On Day 2, the transport and recording contexts were altered to reduce 
generalization of fear from the conditioning session to the test session.  The rat was 
transported in a white box.  The recording chamber was cleaned with 1% acetic acid to 




was placed under the grid floor, the grid floor was covered with a transparent rubber mat, 
the back wall was covered with an alternating black and white stripes, and the room was 
illuminated with ambient fluorescent lights (context B). After a 3-min stimulus-free 
baseline period, the rat was presented with five tone-alone trials (1-min ITI; all tone 
parameters were the same as on Day 1); the rat remained in the chamber for 60-min after 
the final tone and behavioral and neuronal data were recorded throughout the session.  
 Extracellular single-unit activity was recorded using a multichannel 
neurophysiological recording system (OmniPlex, Plexon, Dallas, TX).  Wideband signals 
recorded on each channel were referenced to one of the recording wires (resulting in 15 
channels of activity per rat), amplified (8,000x), digitized (40 kHz), and saved on a PC for 
offline sorting and analysis.  The recording reference wire was located in PL, and was 
randomly selected to optimize the quality of the recordings. After high-pass filtering the 
signal at 600 Hz, waveforms were sorted manually using 2-dimensional principal 
component analysis (Offline Sorter, Plexon). Only well-isolated units were used in the 
analysis.  If two units with similar waveforms and identical time stamps for their action 
potentials appeared on adjacent electrodes, only one unit was used. Sorted waveforms and 
their timestamps were then imported to NeuroExplorer (Nex Technologies, Madison, AL) 
for analysis. 
 The analysis of neuronal activity focused on spontaneous single-unit firing and 
bursting during each recording session; CS-evoked activity was also analyzed on day 2. 
To compute firing rate histograms, spike rates were binned (20 sec) and normalized (z-




normalized to the entire pre-conditioning period (3-min pre-injection and 20-min post- 
injection periods).  On day 2, the data were normalized to the 3-min baseline period prior 
to CS presentations. For the burst analyses, a burst was defined as two spikes with an inter-
spike interval of <25 msec followed by a third spike within 50 msec of the second spike 
(Burgos-Robles et al., 2007); bursts could continue if additional spikes occurred within 
50-msec intervals of one another. 
2.4.4 Immediate extinction deficit (IED) and delayed extinction experiments 
  Sixteen adult Long-Evans rats served as subjects.  All behavior training was conducted 
in two adjacent rooms, each containing eight identical conditioning chambers (same 
dimensions as for the in vivo recordings).  Video cameras mounted above the behavioral 
chambers were used to monitor the animals during each session.  Each chamber rested on 
a load-cell platform that transduced locomotor activity (Med Associates).  Load-cell 
activity was digitized (Threshold Activity Software, Med Associates) and transformed as 
previously described to measure freezing behavior.  Rats received three phases of training.  
They first received fear conditioning (context A, room 1) followed 30 minutes later by an 
“immediate” extinction session (context B, room 2).  An extinction retrieval test (Context 
B, room 2) was conducted 48 hours after extinction.  Contexts had distinct olfactory and 
visual cues, similar to those described above.   
Fear conditioning consisted of a 3-min stimulus-free baseline period, followed by 
5 tone (10 sec, 80 dB, 2 kHz)-shock (2 sec, 1 mA) pairings (1 min ITI); the rats remained 
in the chambers 3 minutes after the last trial.  Immediately after conditioning, half the rats 




received vehicle (n = 8, distilled water); after injection, they were returned to their home 
cages in the vivarium.  Thirty minutes after fear conditioning, the rats were returned to a 
novel room and context (context B) and presented with 45 tone-alone trials (1-min ITI; 
same tone parameters as during fear conditioning) after a 3-min baseline.   All rats were 
given a subsequent extinction retrieval session (retention test; context B; same tone 
parameters as before) 48 hours after conditioning to assess long-term extinction memory. 
One rat from each group exhibited levels of conditioned freezing during the retention test 
that was ±2 standard deviations from the group mean; these statistical outliers were 
excluded from the analysis.   
 In a second behavioral experiment (“no extinction”) with 16 adult Long-Evans 
rats, we examined whether post-conditioning propranolol treatment interferes with fear 
memory consolidation.  The experiment was identical to that described in preceding IED 
experiment, except that CS-alone trials were not delivered 30 minutes after conditioning, 
although rats were still placed in the extinction context.  Rats did receive a retention test 
48 hrs later, in which the CSs were administered.  
 A third experiment examined delayed extinction (16 adult Long-Evans rats), in 
which the extinction session took place 24 hrs after fear conditioning and propranolol or 
vehicle was given 30 min before extinction.  A retention test was then given 24 hrs after 
extinction. 
2.4.5 Histology 
 After the completion of experiments, recording rats were overdosed with pentobarbital, 




Instruments, Sarasota, FL) were generated through six of the recording wires to mark the 
location of the recording array in the medial prefrontal cortex.  The rats were then perfused 
transcardially with 0.9% saline followed by 10% formalin. Brains were extracted from the 
skull and post-fixed in a 10% formalin solution for 24 hours followed by 10% 
formalin/30% sucrose solution where they remained for a minimum of 48 hours.  After 
the post-fix period, brains were sectioned (50 µm) on a cryostat (-20o C), mounted on 
subbed microscope slides, and stained with thionin (0.25%) to visualize electrode 
placements. 
2.4.6 Statistics 
Data were analyzed with conventional parametric statistics (StatView, SAS Institute).  
Two-way analysis of variance (ANOVA) and repeated-measures ANOVA were used to 
assess general main effects and interactions (α = 0.05).  Unpaired student’s two-tailed t-
tests were also used for pairwise comparisons of means.  Results are shown as means ± 
SEMs. 
* Reprinted with permission from Neuropsychopharmacology Giustino TF, Seemann JR, Acca GM, 
Goode TD, Fitzgerald PJ, Maren S. (2017). β-Adrenoceptor Blockade in the Basolateral Amygdala, but 
not the Medial Prefrontal Cortex, Rescues the Immediate Extinction Deficit    . 
Neuropsychopharmacology doi:10.1038/npp.2017.89. 
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3. BETA-ADRENOCEPTOR BLOCKADE IN THE BASOLATERAL AMYGDALA,
BUT NOT THE MEDIAL PREFRONTAL CORTEX, RESCUES THE IMMEDIATE 
EXTINCTION DEFICIT* 
3.1 Introduction 
Early interventions (e.g., exposure therapy) after psychological trauma are aimed at 
reducing the development of stressor- and trauma-related disorders such as posttraumatic 
stress disorder (PTSD). The timing of these therapeutic interventions relative to trauma 
may be a key factor in their long-term success. For example, both human and animal 
research suggest that early interventions may actually worsen symptoms (Bryant, 2002; 
Maren and Chang, 2006) relative to delayed interventions. Using Pavlovian fear 
conditioning and extinction procedures in rats, we and others have similarly found that 
administering extinction trials soon (minutes to several hours) after conditioning yields 
little long-term extinction (Kim et al., 2010; MacPherson et al., 2013; Maren, 2014; Maren 
and Chang, 2006; Stafford et al., 2013). This “immediate extinction deficit” (IED) may be 
caused by stress-induced impairments of extinction learning and recall (Maren and 
Holmes, 2016), because it is not observed with weak conditioning procedures (Maren and 
Chang, 2006).  Thus, “extinction-like” therapies in humans may fail when administered 
soon after trauma (when victims are still under duress) and lead to fear relapse (Bouton, 




Considerable evidence indicates that stress-induced impairments in extinction 
learning are mediated by the medial prefrontal cortex (mPFC) (Holmes and Wellman, 
2009; Maren and Holmes, 2016), a brain area that is critical for extinction learning 
(Giustino and Maren, 2015; Milad and Quirk, 2012). In particular, activity in the 
infralimbic (IL) subdivision of the mPFC is thought to underlie extinction learning 
(Fitzgerald et al., 2014b; Do-Monte et al., 2015; Bukalo et al., 2015). One possibility is 
that stress-induced elevations in noradrenergic signaling dysregulate mPFC function and 
impair mPFC-dependent psychological processes, including extinction.  Consistent with 
this possibility, it has long been appreciated that norepinephrine (NE) is chronically 
elevated in patients with PTSD (Geracioti et al., 2001; Southwick et al., 1999a), and 
animal research has shown that stressors, including footshock, result in elevated prefrontal 
NE release (Hugues et al., 2007). Norepinephrine may also indirectly influence the mPFC 
by modulating its inputs (Arnsten et al., 2015), including the basolateral amygdala (BLA), 
another brain area implicated in stress-impaired extinction learning (Maren and Holmes, 
2016). 
In support of this model, we have recently shown that systemic administration of 
D,L propranolol, a non-selective β-adrenoceptor antagonist, immediately after fear 
conditioning (and just prior to immediate extinction) facilitated extinction retention and 
“rescued” the immediate extinction deficit (Fitzgerald et al., 2015). Propranolol also 
mitigated conditioning-induced suppression of IL spontaneous single-unit activity, which 
may have facilitated extinction learning under stress. In contrast, systemic propranolol 




retention (Fitzgerald et al., 2015).  Interestingly, recent work indicates that oral 
propranolol administration in humans also facilitates extinction learning under some 
conditions (Kroes et al., 2016b).  Little is known, however, concerning the brain areas 
mediating the effects of systemic propranolol on extinction learning. Indeed, there is some 
evidence that propranolol administered directly to the mPFC impairs delayed extinction 
(Mueller et al., 2008), but the brain regions mediating the effects of propranolol on 
immediate extinction are not known. Here we examine the contribution of β-adrenoceptor 
activity in either IL or BLA during immediate and delayed extinction, using bilateral 
intracranial infusions of propranolol.  
3.2 Results 
3.2.1 Intra-BLA Propranolol Rescues the IED 
This experiment sought to determine whether antagonizing β-adrenoceptors in the 
infralimbic division of the mPFC or BLA would facilitate extinction learning soon after 
conditioning.  Rats were first conditioned with 5 tone-shock pairings in Context A. 
Immediately after conditioning, rats received either intra-mPFC or intra-BLA propranolol 
(or vehicle) followed (~20 min) by extinction trials in a new context (Context B). Forty-
eight hours later, the animals were returned to Context B for an extinction retrieval session. 
There were no differences in the behavior of control rats receiving VEH infusions into the 
IL or BLA, so these groups were combined to form a single control group. Represenative 





Figure 3.1 Histology. A) Photomicrographs of representative thionin-stained coronal 
sections depicting cannula placements in the mPFC (left) or BLA (right).  B) Cannula 
placements for all the animals are depicted in schematic coronal sections. For ease of 
illustration, we plot placements across the three extinction manipulations (immediate 
extinction = triangles, no-extinction = squares, and delayed extinction = circles); the 




As shown in Figure 3.2a, rats exhibited low levels of freezing behavior during the 
baseline period prior to the first conditioning trial, and increased their freezing behavior 
across conditioning trials; there were no differences between the groups (the animals were 
drug-free during conditioning).  An ANOVA with a between-subjects variable of group 
and a within-subjects variable of trial revealed only a significant effect of trial [F(2,5) = 
32.9, p < 0.01]. During the extinction session (Figure 3.2b), intra-mPFC or intra-BLA 
propranolol infusions also did not affect freezing behavior.   Rats in each group showed 
modest levels of freezing during the pre-CS baseline period, which is typical of recently 
shocked animals (Maren and Chang, 2006).  Presentation of CS-alone trials augmented 







Figure 3.2 Intra-BLA propranolol rescues the immediate extinction deficit. A) 
Percentage of freezing behavior (means ± SEMs) during fear conditioning in animals that 
underwent immediate extinction (VEH, n = 18; mPFC, n = 5; BLA n = 14).  Intra-cranial 
injections were made immediately after fear conditioning. B) Percentage of freezing 
behavior (means ± SEMs) during the extinction session, which was conducted 20 minutes 
after fear conditioning.  Intra-cranial infusions of propranolol into the BLA or PFC did 
not affect freezing behavior during the extinction session. C) Percentage of freezing 
behavior (means ± SEMs) during a second drug-free extinction session, which served as 
an index of extinction retention. Rats that received intra-BLA propranolol immediately 
after fear conditioning exhibited lower levels of freezing than those receiving mPFC 
propranolol or vehicle infusions.  This suggests that intra-BLA propranolol facilitated 
extinction retention. D) Percentage of freezing behavior (means ± SEMs) during fear 
conditioning in control animals that received post-training intracranial drug injections, but 
did not undergo extinction (VEH, n = 19; mPFC, n = 6; BLA n = 14).  Intra-cranial 
injections were made immediately after fear conditioning. E) Percentage of freezing 
behavior (means ± SEMs) during the context exposure session, which was conducted 20 
minutes after fear conditioning; tones were not delivered during this session.  Intra-cranial 
infusions of propranolol into the BLA or mPFC did not affect freezing behavior during 
the exposure session. F) Percentage of freezing behavior (means ± SEMs) during a drug-
free extinction session, which served as an index of the retention of conditioned fear. Post-
conditioning intra-cranial propranolol infusions did not affect freezing behavior during the 
retention test; propranolol facilitated extinction retention (C) rather than disrupting the 






of extinction training. These impressions were confirmed in an ANOVA which revealed 
only a main effect of trials [F(2,5) = 14.72, p < 0.01]. 
Forty-eight hours later the rats received a drug-free retention test consisting of a 
second extinction session (i.e., 45 tone-alone trials in Context B).  All groups showed 
fairly low levels of baseline freezing (Figure 3.2c). CS presentations increased freezing in 
each group, and this decreased throughout the session [main effect of trials, F(2,9) = 10.06, 
p < 0.01]. Importantly, planned comparisons made on the first 5-trial block revealed that 
rats receiving intra-BLA, but not intra-mPFC, propranolol infusions prior to the immediate 
extinction session exhibited lower levels of freezing than rats in the other groups. Indeed, 
an ANOVA with a between-subjects variable of group run on the first 5-trial block 
revealed a main effect of group [Figure 3.2c, F(2,34) = 3.40, p < 0.05]. In other words, 
noradrenergic antagonism in the BLA attenuated the immediate extinction deficit and 
promoted long-term extinction retention. This is in agreement with an earlier report in 
which systemic propranolol facilitated extinction retention in the initial trials of the 
retrieval test (Fitzgerald et al., 2015). 
Of course, it is possible that post-conditioning propranolol infusions into the BLA 
simply interfered with consolidation of the conditioning memory. To examine this 
possibility, another group of animals underwent a protocol identical to that described 
above except that no extinction trials were delivered after drug infusion (i.e., “no-
extinction”; context exposure only). As expected, all groups displayed similar increases 
in freezing behavior across conditioning. An ANOVA revealed only a main effect of trials 




exhibited modest levels of freezing that decreased throughout the session. These 
observations were confirmed by an ANOVA which revealed only a main effect of trials 
[Figure 3.2e, F(2,5) = 7.8, p < 0.01].  Forty-eight hours later, rats received a retrieval 
session consisting of 45 CS-alone trials.  After the baseline period, all groups showed high 
levels of freezing to the CS which decreased throughout the session at a similar rate. These 
observations were confirmed by ANOVA which revealed only a main effect of trials 
[Figure 3.2f, F(2,9) = 17.4, p < 0.01]. Hence, post-conditioning propranolol in the absence 
of extinction training did not affect the consolidation of fear (Debiec and Ledoux, 2004; 
Fitzgerald et al., 2015; Schiff et al., 2017).  
3.2.2 Intra-BLA or Intra-mPFC Propranolol does not Affect Delayed Extinction 
Previous experiments have revealed that systemic (Fitzgerald et al., 2015) or intra-mPFC 
(Mueller et al., 2008) propranolol impairs extinction using a standard delayed protocol.  
Here we sought to compare the effects of intra-BLA and intra-mPFC propranolol using a 
delayed extinction procedure. Animals underwent a behavioral protocol similar to that in 
Experiment 1 except that drug infusion (and extinction) occurred 24 hours after fear 
conditioning (delayed extinction). Similar to the experiments above, all groups exhibited 
low levels of freezing during the pre-conditioning baseline period, and increased freezing 
over the course of conditioning. This was confirmed by an ANOVA which revealed only 
a main effect of trials [Figure 3.3a, F(2,5) = 37.34, p <0.01]. Twenty-four hours after 
conditioning, the rats received intracranial infusions prior to delayed extinction training. 
Intra-cranial propranolol administration did not affect freezing during the extinction 




the following day (Figure 3.3c). A repeated measures ANOVA revealed no effect of drug 
on extinction performance, and all groups showed a small increase in CS-elicited freezing 





Figure 3.3 Intra-BLA or Intra-mPFC propranolol does not affect delayed extinction. 
A) Percent of freezing behavior (means ± SEMs) during fear conditioning (VEH n = 1 , 
mPFC n = 7, BLA n = 6). B) Percentage of freezing behavior (means ± SEMs) during a 
delayed extinction session that occurred 24 hrs after conditioning (and immediately after 
intra-cranial infusions). Drug infusion did not alter freezing behavior between groups. C) 
Percentage of freezing behavior (means ± SEMs) during a drug-free extinction retrieval 
test that took place 24 hrs following extinction. Prior drug did not impact extinction 




 To compare the behavioral outcomes across the experiments, we analyzed the first 
5-trial block of the extinction retrieval test for each experimental condition.  As shown in 
Figure 3.4, rats that received VEH or propranolol infusions into the mPFC exhibited an 
immediate extinction deficit; they exhibited freezing that was no different from non-
extinguished controls (and substantially higher than that after delayed extinction). In 
contrast, rats that received intra-BLA propranolol infusions did not exhibit an IED, and 




confirmed in an ANOVA with variables of group and extinction condition which revealed 
a main effect of extinction condition [F(2,2) = 5.54, p < 0.01]. This supports the idea that 
the timing of extinction relative to conditioning is a key factor determining the long-term 
retention of extinction (i.e., immediate extinction is impaired relative to delayed). In 
addition, we observed a significant group x extinction condition interaction [F(2, 94) = 
2.59, p < 0.05],  which reveals the differential effect of intra-BLA propranolol on freezing 
in the IED relative to the other groups.  Interestingly, we did not find that intra-mPFC 






Figure 3.4 Summary and circuit model. A) Percentage of freezing behavior (means ± 
SEMs) plotting the average freezing for the first five trials (CS+ITI) during the retrieval 
test for all groups from each behavioral condition. All vehicle groups showed high 
freezing, characteristic of the immediate extinction deficit, which did not differ from no-
extinction controls. Rats that underwent immediate extinction following intra-BLA 
propranolol did not exhibit the IED, showing similarly low levels of freezing to animals 
that underwent delayed extinction. B) We propose a potential circuit underlying the IED 
where locus coeruleus (LC) norepinephrine preferentially increases BLA activity, which 






Fear extinction deficits, including the IED, are thought to reflect impaired mPFC function 
(Chang et al., 2010; Fitzgerald et al., 2015; Fucich et al., 2016; Giustino et al., 2016b; Kim 
et al., 2010; Maren, 2014) and this may relate to elevated noradrenergic signaling 
(Fitzgerald et al., 2015; Giustino et al., 2016b). We demonstrate here that selectively 
blocking β-adrenoceptors within the BLA enables extinction where it normally fails. This 
effect was not observed when propranolol was infused into the mPFC. Importantly, neither 
intra-mPFC nor intra-BLA propranolol altered fear memory consolidation or delayed 
extinction learning. These data suggest that heightened noradrenergic signaling in the 
BLA may be a particularly important component underlying stress-induced extinction 
deficits.  
 We and others have demonstrated that extinction learning is impaired when 
administered soon after conditioning  (Hollis et al., 2016; Kim et al., 2010; MacPherson 
et al., 2013; Maren, 2014; Maren and Chang, 2006; Merz et al., 2016). The IL is thought 
to underlie successful extinction learning (Bukalo et al., 2015; Do-Monte et al., 2015). 
Therefore, it has been suggested that aberrant mPFC activity may result in extinction 
deficits (Fucich et al., 2016; Giustino and Maren, 2015; Maren, 2014; Milad and Quirk, 
2012). Because immediate extinction takes place soon after conditioning, during a state of 
high psychological stress, we hypothesized that elevated NE (presumably released from 
the locus coeruleus) may subserve extinction deficits. Previous work suggests that NE 
levels are elevated during conditioning and delayed extinction in the mPFC and BLA 




that systemic propranolol rescues the IED and that this seemed to be due to stabilizing 
prefrontal activity soon after conditioning (Fitzgerald et al., 2015).  
Importantly, the effects of systemic propranolol on the IED do not appear to be 
due to antagonism of β-adrenoceptors in the mPFC. We show that intra-mPFC propranolol 
has no effect on the three conditions tested: immediate extinction, fear memory 
consolidation, and delayed extinction. During delayed extinction, animals that received 
intra-mPFC propranolol tended to show moderately elevated levels of freezing; however, 
this was not significantly different from vehicle controls or rats that received intra-BLA 
propranolol prior to delayed extinction. Our results contrast with others who have 
observed that intra-mPFC propranolol impairs delayed extinction learning (Mueller et al., 
2008).  However, there are several reasons that might explain this disparity. First, Mueller 
and colleagues (2008) trained rats to lever press for food in the conditioning chambers, 
and then measured freezing coincident with response suppression during the CS.  
Response suppression might engage mPFC to a greater extent than the standard fear 
conditioning procedure used here.  Second, Mueller and colleagues (2008) used much 
shorter and weaker footshocks than those used in the present study. It is conceivable that 
these procedures resulted in relatively lower levels of fear-induced NE release during 
extinction, thereby rendering it more sensitive to intra-mPFC propranolol. Lastly, it is also 
possible that strain differences in the contribution of the mPFC to extinction learning 
accounted for the disparity in these reports (Chang and Maren, 2010).  
 An important finding in the present experiment is that post-conditioning 




agreement with our systemic propranolol findings (Fitzgerald et al., 2015) and reveal that 
propranolol did not attenuate the IED by impairing the consolidation of the conditioning 
memory. This is in line with work that has demonstrated that β-adrenoceptor activity is 
critical for the acquisition, but not consolidation, of conditioned fear (Bush et al., 2010; 
Debiec and Ledoux, 2004; Roozendaal et al., 2006b; Schiff et al., 2017). Here, we confirm 
and extend these results. Our data suggest that while elevated noradrenergic activity may 
not be directly involved in the consolidation of the CS-US memory, heightened 
noradrenergic activity soon after conditioning appears to interfere with the successful 
acquisition and retention of a new and competing extinction memory.  Indeed, the IED 
may be due to a deficit in the consolidation of the extinction memory insofar as within-
session extinction proceeds normally during immediate extinction and is unaffected by 
intra-BLA propranolol infusions.  Nonetheless, systemic propranolol influences prefrontal 
cortical neuronal activity soon after fear conditioning, and this might influence encoding 
of long-term extinction memories.  
Interestingly, the present results reveal that β-adrenoceptors in the BLA mediate 
the effects of systemic propranolol on the IED and possibly shock-induced changes in 
mPFC spike firing (Fitzgerald et al., 2015). While our previous work suggested that the 
mPFC may be a key locus of action for propranolol, it is conceivable that shock-induced 
changes in mPFC activity are regulated by mPFC afferents (including the BLA). Indeed, 
heightened β-adrenoceptor activation promotes BLA excitability during conditioning 
(Skelly et al., 2017). This may modulate mPFC activity (Arnsten, 2009; Arnsten et al., 




showed that extinction deficits (caused by single-prolonged stress) are associated with 
increased NE in both the mPFC and amygdala. In addition, it has recently been shown that 
propranolol infusions in the BLA facilitate the induction of hippocampal-prefrontal 
synaptic plasticity (Lim et al., 2017), which has previously been implicated in extinction 
learning (Peters et al., 2010; Stafford et al., 2012; Deschaux et al., 2011).  Ultimately, the 
BLA is well positioned to modulate the contribution of the mPFC to extinction learning. 
Importantly, our data show that intra-BLA propranolol prior to delayed extinction had no 
effect on extinction retrieval. This time-dependent enhancement of extinction suggests NE 
levels may be beyond “optimal” soon after conditioning, impairing prefrontal processing 
and resulting in the IED. However, stress (and NE) may be relatively lower at the onset of 
delayed extinction, leading to decreased recruitment of low affinity β-adrenoceptors in 
either the mPFC or BLA. Considerable data reveal that stress increases the activity of 
locus coeruleus (LC) neurons (Bangasser et al., 2016; Valentino and Van Bockstaele, 
2008), and this is associated with increased noradrenergic release in the BLA and mPFC, 
which may play a role in learning and memory (Uematsu et al., 2015; Berridge and 
Waterhouse, 2003; Sara, 2015).   We propose that LC-driven increases in BLA excitability 
through activation of β-adrenoceptors might ultimately suppress mPFC activity, thereby 
undermining successful extinction when it occurs soon after conditioning (Figure 3.4b). 
Indeed, it is possible that different populations of BLA- and mPFC-projecting neurons in 
the LC are engaged during immediate and delayed extinction. 
 Overall, the present data contribute to a growing literature suggesting dissociable 




relative to conditioning. Our data suggest that elevated noradrenergic activity in the BLA, 
but not the mPFC, underlies extinction deficits during high psychological stress. Further 
work is required to explore this circuitry, but one possibility is that LC-NE enhances BLA 
excitability which ultimately suppresses mPFC activity, resulting in the IED. Propranolol 
may therefore be a useful adjunct to behavioral therapeutic interventions in recently 
traumatized individuals who are at risk for developing trauma-related disorders (Giustino 
et al., 2016b; Kroes et al., 2016b). 
3.4 Materials and Methods 
3.4.1 Subjects 
One hundred and twenty-eight experimentally naïve adult male Long-Evans rats (Blue-
Spruce strain; weighing 200-224 g; 50-57 days old) were obtained from a commercial 
supplier (Envigo, Indianapolis, IN). The rats were individually housed in cages within a 
temperature- and humidity-controlled vivarium, and kept on a 14:10 hr light/dark cycle 
(lights on at 7am) with ad libitum access to food and water.  All experiments took place 
during the light phase of the cycle.  Rats were handled for ~30 seconds a day for 5 days to 
habituate them to the experimenter before any behavioral testing or surgical procedures 
were carried out.  All experiments were conducted at Texas A&M University with full 
approval from its Animal Care and Use Committee. 
3.4.2 Surgical Procedures 
Rats were randomly assigned to experimental groups prior to surgical procedures. One 
week before behavioral testing took place, rats were anesthetized with isoflurane (5% 




Tujunga, CA).  The scalp was incised and retracted; three burr holes were drilled for 
anchor screws; additional holes were drilled in the skull overlying the medial prefrontal 
cortex or amygdala to allow for cannula implantation. The infralimbic cortex was targeted 
by a single cannula (8 mm, 26 gauge; Plastics One) implanted on the midline [AP: +2.7, 
ML: +1.0 (insertion point), DV: -4.9 at an 11-degree angle; all coordinates relative to 
bregma at skull surface]. This procedure has been used by other laboratories to 
pharmacologically manipulate the IL in both hemispheres of the brain (Mueller et al., 
2008). For the BLA, guide cannulae (10 mm, 26 gauge) were implanted bilaterally (AP: -
2.9, ML: +/- 4.8, DV: -8.55). Three jeweler’s screws were affixed to the skull, and the 
skull surface was covered with dental cement to secure the cannulae to the skull. Stainless 
steel dummy cannulae (30 gauge) were inserted into the guide cannulae (extending 1 mm 
beyond the end of the guide). Rats were allowed to recover on a warmed heating pad prior 
to returning to the vivarium.  Dummy cannulae were replaced twice in the week following 
surgery (prior to behavior) and again after the infusion session.  
3.4.3 Drug Infusions  
Intracranial infusions were made as previously described (Acca et al., 2017). Briefly, rats 
were transported to an infusion room (either from the conditioning room for immediate 
and no-extinction procedures or from the vivarium for delayed extinction). Dummies were 
then removed, and stainless steel injectors (33 gauge) connected to Hamilton syringes 
mounted in an infusion pump were inserted into the guide cannulae for intracranial 
infusions. All infusions were made approximately 20 min prior to the extinction or no-




supplier (Sigma-Aldrich) and was dissolved  in sterile saline (10 µg/µl for mPFC and 5 
µg/µl for BLA). Infusions (0.5 µl/target) were made at a rate of 0.25 µl/min for 2 min and 
the injectors were left in place for 1 min to allow for diffusion (mPFC: 5 µg along midline; 
BLA: 2.5 µg/hemisphere). The propranolol dose and volume were chosen based on 
previous reports (Dębiec et al., 2011; Debiec and Ledoux, 2004; Mueller et al., 2008). 
After the infusions clean dummies were secured to the guide cannulae.  
3.4.4 Behavioral Apparatus and Procedures 
The behavioral procedures were conducted in 16 standard rodent conditioning chambers 
(30x24x21 cm, Med Associates, St. Albans, VT) housed in sound-attenuating cabinets.  
Each chamber consisted of two aluminum sides, a Plexiglas rear wall and top, and a hinged 
Plexiglas door.  The grid floor contained 19 stainless steel rods (4 mm diameter) spaced 
1.5 cm apart (center-to-center).  Rods were connected to a shock source and solid-state 
grid scrambler (Med Associates) for the delivery of footshocks. A loudspeaker mounted 
on the outside of a grating in one aluminum wall was used to deliver auditory stimuli. 
Locomotor activity was transduced into an electrical signal by a load-cell under the floor 
of the chamber to automatically measure freezing.   
 Approximately one week after surgery, rats underwent fear conditioning, 
extinction (immediate, no-extinction, or delayed) and extinction retrieval sessions using 
an “ABB” design: conditioning occurred in context A and extinction training and retrieval 
testing occurred in context B. Rats were run in squads of eight. For conditioning (context 
A), rats were transported from the vivarium to the behavioral room in black plastic 




hydroxide solution and a metal pan beneath the grid floor contained a thin layer of the 
same solution. The room had red ambient lighting and the sound attenuating cabinet doors 
were closed prior to beginning the session. Conditioning consisted of a 3 min stimulus-
free baseline period followed by 5 tone (10 sec, 2 kHz, 80 dB)-shock (2 sec, 1 mA) 
pairings (shock onset occurred at tone offset) with a 1 min inter-trial interval (ITI) between 
each tone presentation. Rats remained in the chamber for 3 min following the last 
footshock.  
For the extinction, no-extinction, and retrieval sessions (context B), the rats were 
transported in white plastic boxes. Chambers were cleaned with a 1% acetic acid solution 
and a metal pan beneath the grid floor contained a thin layer of the same solution. House 
lights and ventilation fans within each chamber were turned on and the room containing 
the chambers was illuminated with overhead white fluorescent lights. The doors of the 
sound attenuating cabinets were left open. After a 3 min baseline period, rats received 45 
tone-alone trials (1 min ITI) and remained in the chamber for 3 min following the last 
tone. The extinction training and retrieval test sessions were identical. Rats in the “no-
extinction groups” underwent an identical procedure except that no tone-alone trials were 
delivered during the initial extinction session (i.e., soon after conditioning and intra-
cranial infusions). 
In Experiment 1, we examined the influence of intra-cranial propranolol infusions on 
immediate extinction (BLA VEH, n=12; mPFC VEH=6; BLA PROP=14; mPFC 
PROP=5). We also included a no-extinction control group (BLA VEH=12; mPFC 




affected consolidation of the conditioning memory (Fitzgerald et al., 2015).  In 
Experiment 2, we examined the effects of intra-cranial propranolol infusions on delayed 
extinction (BLA VEH=6; mPFC VEH=7; BLA PROP=6; mPFC PROP=7).  
3.4.5 Histology 
Rats were overdosed with sodium pentobarbital (100 mg/kg) and perfused transcardially 
with 0.9% saline followed by 10% formalin. Brains were extracted from the skull and 
post-fixed in a 10% formalin solution for 24 hours followed by a 30% sucrose solution 
where they remained for a minimum of 48 hours.  After the brains were fixed, coronal 
sections (40 µm thickness) were made on a cryostat (-20o C), mounted on subbed 
microscope slides, and stained with thionin (0.25%) to visualize cannula placements 
(Figure 1).  Twenty-six rats with cannula placements that were not located within the target 
region were excluded from the analyses.     
3.4.6 Data Analysis 
Data were analyzed with conventional parametric statistics (StatView, SAS Institute).  
Freezing for each trial was determined for each 70-sec interval, which includes both the 
CS (10-sec) and ITI (60-sec). Freezing during the CS+ITI period is highly correlated with 
freezing to the CS itself, but is less susceptible to competition by the CS-elicited orienting 
response (that represents 10-20% of the CS duration).  Two-way analysis of variance 
(ANOVA) and repeated-measures ANOVA were used to assess general main effects and 






4. LOCUS COERULEUS NOREPININEPHRINE DRIVES STRESS-INDUCED 
INCREASES IN BASOLATERAL AMYGDALA FIRING AND IMPAIRS 
EXTINCTION LEARNING  
4.1 Introduction 
Stress contributes to a number of psychiatric disorders and it is well known that stress 
influences aversive learning processes that contribute to the development and maintenance 
of posttraumatic stress disorder (PTSD) (Maren and Holmes, 2016; Milad et al., 2009; 
Raio et al., 2014; Arnsten, 2009; Morilak et al., 2005; Pervanidou and Chrousos, 2010; 
O’Donnell et al., 2004; Parsons and Ressler, 2013; Arnsten, 2015; Arnsten et al., 2015).  
For example, there are numerous studies demonstrating that either acute or chronic stress 
impairs the extinction of fear after Pavlovian conditioning (Raio et al., 2014; Miracle et 
al., 2006; MacPherson et al., 2013; Raio and Phelps, 2015; Merz et al., 2014; Izquierdo et 
al., 2006; Chang and Maren, 2009; Wilber et al., 2011; Maren and Holmes, 2016).  
Extinction learning is thought to mediate, in part, cognitive-behavioral therapies for PTSD 
including exposure therapy, and patients with PTSD exhibit deficits in extinction learning 
(Wessa and Flor, 2007; Maren and Holmes, 2016; Garfinkel et al., 2014; Giustino et al., 
2016b; Pitman et al., 2012). In the laboratory, we, and others, have shown that extinction 
learning is impaired in humans and rodents when it occurs within minutes to hours of fear 
conditioning (Maren and Chang, 2006; Fitzgerald et al., 2015; Maren and Holmes, 2016; 
Chang et al., 2010; Kim et al., 2010; Hollis et al., 2016; Merz et al., 2016).  Considerable 
evidence suggests that this “immediate extinction deficit” (IED) is mediated by footshock 




Chang et al., 2010; Giustino et al., 2017; Fitzgerald et al., 2015).  Importantly, the IED 
models extinction learning impairments in both rodents and humans in the aftermath of 
acute trauma, as well as extinction impairments associated with symptomatic stress in 
patients with PTSD  (Raio et al., 2014; Merz et al., 2016; Maren and Chang, 2006; Wessa 
and Flor, 2007; Giustino et al., 2016b; Milad et al., 2009; Rauch et al., 2006; Giustino et 
al., 2017; Fitzgerald et al., 2015).  
Previous work indicates that stress-induced extinction deficits are mediated by 
forebrain norepinephrine release in the medial prefrontal cortex and amygdala (Giustino 
and Maren, 2018; Giustino et al., 2016b; Arnsten, 2015; Giustino et al., 2017; Kim et al., 
2010; Arnsten, 2009). Indeed, individuals suffering from PTSD and related disorders 
present with elevated amygdala activity as well as heightened levels of neuromodulators, 
including norepinephrine (Milad et al., 2009; Giustino et al., 2016b; Krystal et al., 2018; 
Southwick et al., 1999a, 1999c).  The locus coeruleus-norepinephrine (LC-NE) system 
heavily innervates the amygdala and is highly responsive to stress (McCall et al., 2017, 
2015; Naegeli et al., 2017; Giustino and Maren, 2018; Fallon et al., 1978; Foote et al., 
1980; Jodo et al., 1998; Passerin et al., 2000; Loughlin et al., 1986; Quirarte et al., 1998; 
Buffalari and Grace, 2007; Chen and Sara, 2007). Past work has demonstrated that LC 
projections to the amygdala are associated with increased fear and anxiety-like behavior 
(McCall et al., 2017; Uematsu et al., 2017), and noradrenergic blockade in the amygdala 
is sufficient to rescue stress-induced deficits in fear extinction (Giustino et al., 2017).  
These data suggest the LC-NE system critically regulates amygdala activity, which 




(Giustino et al., 2019). To address this possibility, we combine single-unit BLA recordings 
with systemic pharmacology in freely moving rats to examine whether beta-adrenoceptors 
mediate stress-induced changes in amygdala firing rates. We next combined single-unit 
amygdala recordings with LC-specific chemogenetic manipulations to determine if LC-
NE drives changes in amygdala activity. Lastly, we directly examine the contribution of 
the LC-NE system to the immediate extinction deficit.  
4.2 Results 
4.2.1 Propranolol reduces footshock-induced freezing and mitigates BLA firing 
Recent work suggests that intra-BLA propranolol reduces the IED and enables extinction 
learning under stress (Giustino et al., 2017). We sought to examine if footshock stress 
alters single-unit firing in the BLA and contributes to extinction deficits (Figure 1a shows 
the experimental design).  Animals were implanted with a 16-channel microelectrode 
array targeting the amygdala (example histology and schematic representation of electrode 
placements shown in Figure 1b). Animals were transported to the recording room for fear 
conditioning (Context A). After a 3-min stimulus-free baseline period, animals were 
injected with either vehicle (VEH, n = 5) or propranolol (PROP, n = 5). The animals 
remained in the chamber for 20 min to allow sufficient time for drug to take effect. 
Animals then received 5 CS-US pairings (see methods for details) and remained in the 
chamber for 60 min following the last footshock. As expected, vehicle-treated animals 
exhibited sustained increases in freezing behavior and this was limited by propranolol 
treatment [Figure 2a, main effect of drug, F(1,8) = 19.30, p  = 0.0023]. During this session, 




rate = 2.89 ± 0.16; PROP: n = 137; baseline firing rate = 3.00 ± 0.15).  Propranolol 
treatment prior to fear conditioning did not influence spontaneous firing rate among these 
neurons.  However, fear conditioning produced a dramatic increase in spontaneous firing 
rate in the population of neurons recorded in the BLA, an effect that was attenuated by 




Figure 4.1 Experimental design and representative histology. A) Experimental design. 
B) Nissl stained tissue showing representative electrode placement in the amygdala 
alongside schematic histology depicting location of the center of the recording array for 
all rats split by recording experiment. C) Experimental approach for the recording 
experiment paired with LC-NE activation alongside representative LC viral histology. 
(HA = HA-tag immunolabeled for viral expression, TH = tyrosine hydroxylase, OV = 




 Although footshock stress increased the average firing rate data of BLA neurons, 
there was considerable heterogeneity in the response of individual BLA neurons.  We 
therefore divided the single-units into two populations based on the direction of their post-




neurons were classified as either “excited” (z > 0) or “suppressed” (z < 0) immediately 
after the last footshock.  Figure 2c demonstrates that no difference was observed when 
comparing drug treatment in terms of the proportion of neurons showing shock-induced 
increases or decreases in firing rate [χ2 (1) = 0.94, p = 0.33]. However, we did observe 
differences in the magnitude of both “excited” [Figure 2e, main effect of drug, F(1,133) = 
13.92, p = 0.0003] and “suppressed” [Figure 2f, main effect of drug, F(1,143) = 4.92, p = 
0.028] population activity based on drug treatment. These differences are further 
demonstrated by the heatmaps (Figure 2d) depicting each neuron across the entire session.  
That is, propranolol treatment limited both shock-induced increases and decreases in BLA 
firing rates. These data suggest that footshock-stress induces rapid and sustained changes 
in the magnitude of BLA spontaneous firing rates and this is regulated by the action of 








Figure 4.2 Propranolol reduces footshock-induced freezing and mitigates changes in 
BLA firing. A) Percentage of freezing (mean ± SEM) across the duration of the session. 
PROP treatment produced a reliable decrease in post-shock freezing throughout the 
session B) Average firing rate over the course of the session split by drug treatment (20 
sec bins). Footshock produced rapid and sustained changes in amygdala firing rates which 
were mitigated by propranolol treatment (t = 0 is immediately after the last conditioning 
trial). C) Pie charts showing the percentage of neurons (split by drug) that increased or 
decreased in firing rate after the last conditioning trial. No difference between drug 
treatment was observed in the proportion of single-units showing footshock-induced 
changes in firing rate. D) Heatmaps depicting normalized firing rate for every neuron 
recorded split by drug treatment. E, F) Average firing rate over the course of the session 
split by drug comparing “excited” and “suppressed” neuronal populations (20 sec bins). 




4.2.2 LC-NE activation paired with weak footshocks induces sustained freezing and 
BLA firing 
Because propranolol mitigated stress-induced alterations in BLA firing and past work has 
shown a role for LC projections to the amygdala in fear conditioning (Uematsu et al., 
2017), we hypothesized that the LC-NE system was driving changes in BLA activity. In 




weaker, and presumably less stressful, footshock (see methods for details) would 
recapitulate our previous findings. Animals received bilateral infusions of Gq coupled LC-
specific DREADD (AAV9-PRSx8-hM3Dq-HA) to selectively activate LC-NE release 
(Figure 1c shows experimental approach and representative histology). We, along with 
others, have previously validated this virus in vivo (Giustino et al., 2019; Vazey and 
Aston-Jones, 2014). Animals were also implanted with a 16-channel microelectrode array 
targeting the BLA (Figure 1b shows placements). We used an identical protocol to the 
previous experiment except the shock parameters (Figure 1a). Animals were transported 
to the recording room and after a 3 min stimulus free baseline period, injected with either 
VEH (n = 5) or CNO (clozapine N-oxide, the DREADD ligand, n = 5). Twenty minutes 
was allowed for drug to enter the brain. Animals then received 5 CS-US pairings and 
remained in the chamber for an additional 60 min. Vehicle treated animals showed 
elevated freezing levels that dissipated throughout the session. However, CNO treated rats 
exhibited prolonged freezing behavior in the post-shock period [Figure 3a; main effect of 
drug, F(1,8) = 6.27, p = 0.037].  During this session, we recorded from a total of 233 
single-units in the BLA (VEH: n = 117; baseline firing rate = 2.34 ± 0.21;CNO: n = 116; 
baseline firing rate = 2.57 ± 0.26). Differences in footshock-induced freezing 
corresponded with differences in BLA spontaneous firing rates. As shown in Figure 3b, 
single-units recorded from vehicle-treated rats showed a moderate increase in average 
firing rates over the course of the session and this was markedly enhanced in the CNO 






Figure 4.3 LC-NE activation paired with weak footshocks induces sustained freezing 
and BLA firing. A) Percentage of freezing (mean ± SEM) across the duration of the 
session.  Animals treated with CNO (to activate LC-NE release) showed sustained 
freezing relative to vehicle controls. B) Average firing rate over the course of the session 
split by drug treatment (20 sec bins, t = 0 is immediately after the last conditioning trial). 
Neurons recorded from vehicle treated rats showed moderate levels of increased BLA 
firing whereas CNO rats showed a marked increase in firing rate for the duration of the 
session. C) Pie charts showing the percentage of neurons (split by drug) that increased or 
decreased firing rate after the last conditioning trial. CNO treatment resulted in a larger 
proportion of recorded units showing increased firing rate in the post-shock period. 
Heatmaps depicting normalized firing rate for every neuron recorded split by drug 
treatment. E, F) Average firing rate over time split by drug comparing “excited” and 
suppressed” neuronal populations. CNO treatment produced a marked increase in the 




In order to determine if LC-NE activation altered the proportion of neurons 
showing increased amygdala firing we classified neurons as described above. Single-units 
were considered to be either “excited” or “suppressed” if they showed an increase or 
decrease following the last footshock, respectively. A chi-square analysis revealed that 
CNO-mediated LC-NE activation resulted in a larger proportion of BLA neurons showing 




10.83, p = 0.001]. Moreover, LC-NE activation resulted in a larger magnitude of stress-
induced BLA firing in the “excited” neuronal population [Figure 3e; main effect of drug, 
F(1,158) = 10.35, p = 0.0016] but not the “suppressed” population (Figure 3f). The 
heatmaps showing each recorded neuron across the entire session further demonstrate this 
observation (Figure 3d). These data suggest that the LC-NE drives stress-induced 
increases in amygdala firing rates as well as freezing behavior. 
4.2.3 LC-NE activation induces an immediate extinction deficit 
While the above data show the LC-NE system critically regulates amygdala firing rates 
and freezing behavior, the LC has not been directly implicated in extinction deficits. We 
next attempted to induce an immediate extinction deficit with a conditioning protocol that 
would not otherwise produce extinction deficits. Animals received bilateral infusions of 
the Gq-coupled LC-specific DREADD. Animals were conditioned with a single, weak 
CS-US trial (same shock parameters as the weak shock above). Animals received either 
vehicle (n = 11) or CNO (n = 12, to activate LC-NE) approximately 10 min prior to 
conditioning (Context A). All groups exhibited similar levels of conditioning as confirmed 
by a repeated measures ANOVA which revealed only a main effect of time [Figure 4a; 
main effect of time, F(1,21) = 92.54, p < 0.0001]. Approximately 15-20 min after 
conditioning, animals underwent immediate extinction (45 CS alone trials) in an alternate 
context (Context B). Vehicle treated animals showed reduced freezing throughout the 
session whereas LC-NE activation resulted in sustained freezing for the duration of 
extinction training [Figure 4b; main effect of drug, F(1, 21) = 93.37, p < 0.0001]. Animals 




animals returned to Context B for drug-free extinction retrieval testing (45 CS-alone 
trials). Vehicle treated animals showed little CS-evoked freezing, indicating successful 
extinction retrieval (i.e., no extinction deficit). However, CNO treated rats that displayed 
a marked increase in CS-evoked freezing. This observation was confirmed with a repeated 
measures ANOVA [Figure 4c; main effect of drug, F(1, 21) = 13.67, p = 0.0013].  
Of course, it is possible that pre-conditioning manipulations may be altering fear 
memory consolidation, rather than affecting extinction learning per se. In order to test this 
possibility, a set of rats received identical behavioral protocols except that they underwent 
no-extinction procedures (i.e., context exposure only).  Both groups (VEH v CNO, n = 8 
per group) showed similar levels of fear conditioning which was confirmed by a repeated 
measures ANOVA which revealed only a main effect of time [Figure 4d; main effect of 
time, F(1, 14) = 91.33, p < 0.0001]. Approximately 15-20 min after conditioning, these 
animals underwent no extinction procedures (context B exposure only, no CS 
presentation). As expected, vehicle treated animals showed low levels of freezing to this 
distinct context. However, CNO treated rats showed a marked elevation of freezing 
throughout the session [Figure 4e; main effect of drug F(1, 14) = 21.78, p = 0.0004].  
Forty-eight hours later these animals returned to context B for a drug-free session 
consisting of 45 CS-alone trials. No difference was observed in CS-evoked freezing 
between the two drug groups (Figure 4f), suggesting that LC-NE activation did not simply 
strengthen the fear memory. These data show that LC-NE stimulation is sufficient to 
induce an immediate extinction deficit. Because there were differences in baseline 




normalized the first 9-trial block by subtracting baseline freezing. Figure 5a depicts the 
normalized data and further confirms that LC-NE activation promoted an extinction deficit 
[extinction x drug interaction, F(1,35) = 6.45, p = 0.016]. Importantly, these data show 
that this stress-induced extinction deficit is not due to LC-NE activation simply creating a 
stronger fear memory insofar as both VEH and CNO NO-EXT groups show similarly 










Figure 4.4 LC-NE activation induces an immediate extinction deficit. A) Percentage 
of freezing (mean ± SEM) is shown for all sessions. Animals were injected with VEH or 
CNO approximately 10 min prior to conditioning. Both groups showed similar levels of 
conditioned freezing. B) Freezing during immediate extinction training. CNO treated rats 
showed elevated freezing levels throughout the session. C) Freezing during the drug-free 
extinction retrieval test. VEH rats showed little CS-evoked freezing, indicative of 
successful extinction retrieval. However, prior CNO treatment increased levels of CS-
evoked freezing, suggesting LC-NE drives extinction deficits. D) Conditioned freezing 
behavior for a separate set of animals that underwent identical procedures except they 
received no-extinction training. Both groups showed similar levels of conditioned freezing 
behavior. E) Freezing behavior during the no-extinction session (i.e., context exposure 
only, no CS presentation). VEH treated rats showed low levels of freezing behavior in this 
distinct context; however, CNO treated rats displayed elevated freezing levels throughout 
the session. F) Drug-free test session which consisted on 45 CS-alone trials. No difference 
was observed in CS-evoked freezing between drug groups suggesting that LC-NE 








Figure 4.5 Proposed circuit schematic by which LC-NE drives extinction deficits. A) 
Normalized (baseline subtracted) percentage of freezing (mean ± SEM) for the first 9 trial 
block of the drug-free extinction retrieval session which further depicts CNO-induced LC-
NE activation resulted in an extinction deficit. That is, the CNO, EXT group showed 
comparable CS-evoked freezing to both the no-extinction groups, indicative of an 
extinction deficit. B) Proposed circuit mechanism underlying stress-induced extinction 
deficits. Under low levels of stress, the LC-NE system is minimally engaged. This enables 
successful extinction learning via IL mediated feedforward inhibition of the BLA. In 
contrast, this circuit reverses under high levels of stress and this reversal is driven by LC-
NE. Activation of the BLA results in shunted IL firing via feedforward inhibition thereby 
interfering with extinction learning. Abbreviations: LC – locus coeruleus, NE – 





Here we show that footshock stress induces rapid and sustained increases in the 
spontaneous firing rate of BLA single-units. These increases in BLA firing were blocked 
by systemic propranolol administration and potentiated by chemogenetic activation of LC-
NE, suggesting a key role for beta-adrenoceptors. These stress-related changes in BLA 
activity persisted for up to an hour after footshock, a time window that corresponds with 
stress-induced deficits in extinction learning. Lastly, we demonstrate that LC-NE 




fear expression at the expense of extinction learning (see Figure 5b for a proposed circuit 
mechanism).  
 We, along with others, have suggested that stress acts to impair extinction learning 
by  altering medial prefrontal cortex (mPFC) function, and this may be mediated by NE 
(Chang et al., 2010; Maren and Holmes, 2016; Kim et al., 2010; Fitzgerald et al., 2015).  
Activity in the infralimbic (IL) subdivision of the mPFC is thought to regulate successful 
extinction learning (Giustino and Maren, 2015; Maren and Quirk, 2004; Milad and Quirk, 
2002). We have previously shown that noradrenergic blockade enables extinction learning 
under stress and initially hypothesized that this was mediated by footshock-induced 
changes in mPFC single-unit activity (Fitzgerald et al., 2015). Consistent with this, we 
observed that footshock-stress resulted in rapid and sustained decreases in IL firing rates, 
and this could be blocked by systemic propranolol. We surmised that this decreased IL 
activity was an underlying factor in the immediate extinction deficit, but intra-IL infusions 
of propranolol had no effect on stress-induced extinction deficits (Giustino et al., 2017). 
However, both the mPFC and BLA are highly sensitive to stress and it has been suggested 
that stress impairs prefrontal function while enhancing BLA activity, a state that may limit 
extinction learning (Giustino and Maren, 2018; Arnsten, 2009; Arnsten et al., 2015; 
Arnsten, 2015).  Indeed, intra-BLA propranolol, on the other hand, rescued the immediate 
extinction deficit (Giustino et al., 2017). We now show that footshock-stress dramatically 
increases spontaneous firing rates among neurons in the BLA and this is dependent upon 




 Past work has demonstrated that BLA projections to the mPFC are involved in 
both the conditioning and extinction of fear (Senn et al., 2014; Klavir et al., 2017; Burgos-
Robles et al., 2017). It is possible that the observed NE dependent changes in BLA firing 
also mediated stress-induced decreases in IL firing via these direct projections. Senn and 
colleagues (2014) showed differing levels of activity in BLA projections to PL and IL 
influence extinction retention. This is in line with our current and past work in which we 
show footshock-induced suppression of IL firing that outlasts changes in PL firing rates 
(Fitzgerald et al., 2015). Our current data now demonstrate that footshock stress produces 
rapid and prolonged activation of the BLA, a change in firing that is opposite to that 
observed in IL after footshock. These data suggest a circuit mechanism by which BLA 
projections to the IL may mediate extinction deficits (Fig 5B). It is possible that LC-NE 
drives increases and decreases in BLA and IL via direct projections, respectively. In line 
with this idea, a recent study has shown that LC projections to the mPFC mediate aversion 
and increase anxiety-like behavior, though it is not known if this was due to a suppression 
of mPFC activity (Hirschberg et al., 2017). Another possibility is that in addition to direct 
projections, LC-NE may be acting to enhance BLA firing in amygdala neurons that project 
to IL and synapse on inhibitory interneurons to promote feedforward inhibition, thus 
resulting in impaired extinction. Indeed, BLA neurons projecting to the IL have been 
shown to dampen IL firing via a feedforward inhibitory mechanism (McGarry and Carter, 
2016) and IL projections to the BLA mediate both the acquisition and recall of extinction 




circuits are tilted in favor of BLA mediated suppression of IL, thus promoting a high fear 
state while simultaneously leading to poor extinction.  
 Extinction deficits may be mediated, in part, by the LC-NE system prioritizing 
consolidation of the recent fear memory at the expense of a new extinction memory, 
particularly when extinction learning occurs soon after fear conditioning. Indeed,  NE has 
long been implicated in fear memory consolidation (Giustino and Maren, 2018; McGaugh 
and Roozendaal, 2002; Roozendaal et al., 2006a; McIntyre et al., 2012; Cahill et al., 1994; 
McGaugh, 2000).  Along these lines, recent work has shown that optogenetic stimulation 
of LC projections to the BLA mediate fear consolidation whereas inhibiting this pathway 
reduced the strength of fear memories (Uematsu et al., 2017). However, it is unknown 
how these manipulations affected single-unit and population level dynamics in both the 
BLA and mPFC.  McCall and colleagues (2017) demonstrated that optogenetic activation 
of LC projections to the BLA resulted in a majority of responsive BLA neurons showing 
increased firing, whereas a smaller proportion of BLA neurons were suppressed (McCall 
et al., 2017). These data align nicely with our current findings, which show an overall 
excitatory population response in the BLA that is amplified by synthetic LC activation. 
Interestingly, others have shown that footshock as well as infusion of adrenoceptor 
agonists into the BLA suppress firing rates in anesthetized animals (Buffalari and Grace, 
2007; Chen and Sara, 2007). However, these authors also noted that a small subpopulation 
of neurons in the BLA showed increased spiking in response to stimulation of amygdala 
adrenoceptors.  Of course, it  is has been shown that anesthesia  influences basal NE 




receptors within the BLA (Vazey and Aston-Jones, 2014). In addition, pharmacological 
manipulations, whether locally infused or systemically administered, may not entirely 
replicate synthetic activation of the LC or its terminals in downstream brain regions, which 
may help explain some of these discrepant findings.  Our current work shows a robust 
footshock-induced increase in population activity within the BLA, although a number of 
neurons were also suppressed. When these footshocks were then paired with LC-NE 
stimulation this further augmented BLA excitability in terms of the magnitude as well as 
the proportion of neurons showing increased firing suggesting that elevated levels of NE 
facilitate BLA spiking. 
 In humans, individuals suffering from PTSD and related disorders present with 
heightened amygdala activity (Milad et al., 2009; Debiec and LeDoux, 2006; Rauch et al., 
2006; Giustino and Maren, 2018), elevated NE (Arnsten, 2009; Southwick et al., 1999a; 
Krystal et al., 2018; Yehuda et al., 1992; Giustino and Maren, 2018; Giustino et al., 
2016b), and extinction impairments (Milad et al., 2009; Garfinkel et al., 2014; Giustino et 
al., 2016b).  The current data strongly suggest that extinction deficits may result from 
elevated LC-NE activity that, in turn, increases BLA firing rates. Recent advantages in 
neuroimaging technology now allows researchers to measure activity in the human LC, 
an advance that will further our understanding of the role of LC-NE in PTSD (Krystal et 
al., 2018; Priovoulos et al., 2018; Liu et al., 2017). Although pharmacological 
manipulations of NE transmission have shown some promise for the treatment of PTSD, 
the literature is largely split on their efficacy and utility (Giustino and Maren, 2018). Our 




the LC and BLA interact to influence extinction learning; this interaction is critical for 
designing interventions that are appropriately timed to yield the most effective clinical 
outcomes. Future work in humans will likely shed light on the role of the LC-NE system 
on an individual-to-individual basis, which may better allow us to appreciate when and 
why NE-altering drugs may be useful for reducing PTSD symptomatology.  
 Overall, we demonstrate that stress induces prolonged increases in BLA 
spontaneous firing rates and this is highly sensitive to manipulations of the NE system. 
That is, reducing the action of NE via propranolol eliminated these changes in firing rate 
whereas selective LC-NE activation via chemogenetics enhanced stress-induced increases 
in BLA activity. We also show that stress and LC-NE activation induces extinction 
deficits, most likely due to the observed increases in amygdala firing. These data have 
important clinical implications for individuals suffering from stress- and trauma-related 
disorders, such as PTSD and suggest the LC-NE system may be a key regulator of 
heightened amygdala activity which is observed in those with PTSD.  
4.4 Materials and Methods 
4.4.1 Subjects 
Fifty-nine experimentally naïve adult male Long-Evans Blue Spruce rats (weighing 200-
224 g; 50-57 days old) were obtained from a commercial supplier (Envigo, Indianapolis, 
IN).  Upon arrival and throughout the experiments, rats were individually housed in cages 
within a humidity- and temperature-controlled vivarium, and kept on a 14:10 hr light/dark 
cycle (lights on at 7 am) with ad libitum access to food and water.  All experiments were 




for 5 days to habituate them to the experimenter before any behavioral testing or surgical 
procedures were carried out.  All procedures were conducted at Texas A&M University 
and were performed in strict accordance with the guidelines and regulations set forth by 
the National Institutes of Health and Texas A&M University with full approval from its 
Animal Care and Use Committee. 
4.4.2 Surgeries 
Rats were anesthetized with isoflurane (5% induction, 2% maintenance) and placed in a 
stereotaxic apparatus (Kopf Instruments, Tujunga, CA) for implantation of microelectrode 
arrays targeting the amygdala and viral infusions targeting the LC. The scalp was incised 
and retracted. For rats receiving viral infusions of the LC-specific DREADD, the head 
was tilted downward at a 15 degree angle such that bregma skull surface was 2mm below 
intersectional lambda in the horizontal plane. The skull overlying the LC was removed in 
both hemispheres and were then separately infused with LC-DREADDs (AAV9-PRSx8-
hM3Dq-HA). The PRSx8 promoter is a synthetic dopamine-beta hydroxlyase promoter 
that restricts expression to noradrenergic neurons (Vazey and Aston-Jones, 2014). Viral 
infusions were made with a hypodermic injector (Small Parts/Amazon, Seattle, WA) that 
was connected to a Legato 101 infusions pump (KD Scientific, Holliston, MA) and a 10 
µl syringe (Hamilton Company, Reno, NV) using polyethylene tubing (Braintree 
Scientific, Braintree, MA). Virus was infused at a rate of 0.25 µl/min and the injector was 
removed 5 min after the infusion ended to allow for adequate diffusion. The coordinates 
for each infusion (relative to intersection lambda) were as follows: AP: -3.8, ML: +/- 1.4, 




to the specificity of the virus and variability from animal to animal in terms of the DV 
location of the LC. At least two weeks were allowed following viral infusions prior to 
beginning experiments. 
 For rats that received a microelectrode array targeting the BLA (regardless if this 
was preceded by LC viral infusions) the skull was leveled in the horizontal plane. Three-
five burr holes were drilled for anchor screws. A portion of the skull overlying the BLA 
in the right hemisphere was also removed. The animal was then implanted with a 16 
channel microelectrode array (Innovative Neurophysiology, Durham, NC). The 4x4 array 
was constructed of 16 individual 50-µm diameter tungsten wires of equal length (10.5 
mm). The wires in each row and the rows themselves were spaced 200 µm apart (center-
to-center). The array was positioned with its long axis parallel to the anteroposterior plane. 
Coordinates for the center most wires relative to bregma skull surface were as follows: 
AP: - 2.9, ML: + 4.8, DV: -8.55. One electrode was selected to be used as a ground to 
optimize recordings, resulting in a maximum of 15 channels per animal. The array was 
then secured to the skull with dental acrylic. Animals were given at least one week (two 
if viral manipulations were involved) to recover prior to behavioral and recording 
procedures.  
4.4.3 Behavioral apparatus and in vivo electrophysiology in freely moving rats 
A modified rodent behavioral chamber (30x24x21 cm, Med Associates, St. Albans, VT) 
enclosed in a sound-attenuating cabinet was used for recording experiments. This chamber 
was modified to allow for freely moving electrophysiological recordings as well 




rear wall, a hinged Plexiglas door, and an open top.  The grid floor consisted of 19 stainless 
steel rods (4 mm diameter) spaced 1.5 cm apart (center-to-center).  A loudspeaker attached 
to the outside of a grating in one aluminum wall was used to play auditory 
tones.  Locomotor activity of the rat was transduced by a load-cell under the floor of the 
chamber, and the output of the load-cell was recorded by an OmniPlex recording system 
(Plexon, Dallas, TX).  Thus, all behavioral and neural activity was recorded automatically 
with this system.   
 Each rat was individually fear conditioned in context A.  In this procedure, the rat 
was transported to the room in a black plastic box, connected to a headstage with a flexible 
cable (Plexon) and placed in the behavioral chamber.  The chamber had been cleaned with 
1% ammonium hydroxide to provide a distinct olfactory cue, and a black pan containing 
a thin layer of the same solution had been placed under the grid floor.  The room was 
illuminated with red ambient lights (Context A). After a 3-min stimulus-free baseline 
period, the system was briefly paused while the animal remained plugged in and was 
injected with either vehicle or propranolol (10 mg/kg, i.p.), or CNO (3 mg/kg, i.p. – for 
the LC DREADD experiment). The rat was placed back in the chamber for 20 min to 
allow adequate time for drug to take effect. The rat then received five auditory tone-
footshock pairings. Recordings did not occur during shock presentation due to electrical 
noise. The tones (conditioned stimuli; CS) were 2 sec, 80 dB, 2 kHz; the shocks 
(unconditioned stimuli; US) were 0.5 sec and 1 mA (for the propranolol experiment), and 
0.5 sec, 0.5 mA for the LC-DREADD weak-shock experiment, where shock onset 




session continued for 60 min after the final shock, and then the rat was returned to its home 
cage. 
 Extracellular single-unit activity was recorded with a multichannel 
neurophysiological recording system (OmniPlex, Plexon, Dallas, TX).  Wideband signals 
recorded on each channel were referenced to one of the recording wires (resulting in a 
maximum of 15 channels of activity per rat), amplified (8,000x), digitized (40 kHz 
sampling rate), and saved on a PC for offline sorting and analysis.  The recording reference 
wire we chose for each session was selected to optimize the quality of the recordings.  
After high-pass filtering the signal at 600 Hz, we sorted waveforms manually using 2-
dimensional principal component analysis (Offline Sorter, Plexon).  Only well-isolated 
units were used in our analysis.  If two units with similar waveforms and identical time 
stamps for their action potentials appeared on adjacent electrodes, we only used one unit. 
We then imported sorted waveforms and their timestamps to NeuroExplorer (Nex 
Technologies, Madison, AL) for further analysis. 
4.4.4 Behavioral procedures 
For the behavioral experiment, animals underwent similar procedures as described above 
for the recording experiments. On Day 1, rats were transported to the conditioning context 
(Context A) in squads of eight. Rats received either vehicle or CNO (3 mg/kg, i.p.) 
approximately 5-10 minutes before fear conditioning. After a 3 min stimulus free baseline 
period, all animals were conditioned with a single CS-US pairing (0.5 sec, 0.5 mA shock). 
Rats were removed from the conditioning chambers and underwent immediate extinction 




Rats were transported to Context B in white transport boxes. The chamber was cleaned 
with 3% acetic acid and a metal pan containing a thin layer of the same solution had been 
placed under the grid floor. Ambient white lights illuminated the room. For animals 
undergoing immediate extinction, 45 CS-alone trials were presented (30 sec ITI) after a 3 
min stimulus free baseline period. Rats undergoing no-extinction procedures remained in 
the chambers for the same amount of time, but no CS was presented. Animals were 
returned to their home cages at the end of the session. Animals were tested for extinction 
retrieval 48 hrs later. This extinction retrieval test was identical to the initial extinction 
session.  
4.4.5 Drugs 
D,L-propranolol hydrochloride was obtained from a commercial supplier (Sigma-Aldrich). 
The drug was dissolved in distilled water and injected systemically (10 mg/kg, i.p.). 
Clozapine N-oxide was obtained from the NIH and dissolved in 2.5% DMSO in distilled 
water and injected systemically (3 mg/kg i.p.).  
4.4.6 Histology 
After completion of the experiments, the rats were overdosed with pentobarbital.  For rats 
implanted with a BLA array, electrolytic lesions were created by passing electrical current 
(80 µA, 10 sec; A365 stimulus isolator, World Precision Instruments, Sarasota, FL) 
through four of the recording wires (the 4 corners of the 4x4 array).  Rats were then 
perfused transcardially with 0.9% saline followed by 10% formalin.  Brains were extracted 
from the skull and post-fixed in a 10% formalin solution for 24 hours, followed by a 30% 




of the BLA (40 µm thickness) were cut on a cryostat (-20o C, Leica Microsystems, Buffalo 
Grove, IL), mounted on subbed microscope slides, and stained with thionin (0.25%) to 
visualize electrode placements.   
 To visualize LC viral expression using immunohistochemistry, the following steps 
were carried out.  First, brains were coronally sectioned (40 µm thickness) with a cryostat 
and stored in a 0.01% sodium azide solution until further processing.  Sections were 
blocked in PBS with 0.1% Triton X-100 (TX) and 3% normal donkey serum (NDS, 2 
ml/well) for one hour. All steps occurred in this PBS-TX-NDS solution at room 
temperature. Sections were then incubated in primary antibodies (mouse anti-tyrosine 
hydroxylase (TH) [1:2000] and rabbit anti-HA [1:1000]) for 24 hours.  Sections were then 
rinsed three times (10 min each).  Sections were then incubated in secondary antibodies 
(donkey anti-mouse Alexa Fluor 488 [1:500; for TH] and donkey anti-rabbit Alexa Fluor 
594 [1:500; for HA]) for three hours.  Afterward, sections were rinsed three times (10 min 
each).  Next, the sections were mounted on microscope slides using PBS, and coverslipped 
using fluoromount (Diagnostic BioSystems, Pleasanton, CA). Images were obtained using 
a Zeiss AXIO Imager M2. The following suppliers were used for the above materials: 
NDS (EMD Millipore, Billerica, MA), Triton X (Sigma-Aldrich, St. Louis, MO), mouse 
anti-TH (ImmunoStar, Hudson, WI), rabbit anti-HA (Cell Signaling Technology, 
Danvers, MA), donkey anti-mouse IgG (H+L) Alexa Fluor 488 (Thermo Fisher 
Scientific/Invitrogen, Waltham, MA), donkey anti-rabbit IgG (H+L) Alexa Fluor 594 






The data were analyzed with conventional parametric statistics (StatView, SAS Institute).  
One-way and two-way analysis of variance (ANOVA) and repeated-measures ANOVA 
were used to assess general main effects and interactions (α = 0.05). Results are shown as 
mean ± SEM. Chi-square analyses were used to examine differences in neuronal 
populations.  
* Reprinted with permission from PNAS Giustino TF, Fitzgerald PJ, Ressler RL, and Maren S. (2019). 
Locus coeruleus toggles reciprocal prefrontal firing to reinstate fear. Proc. Natl. Acad. Sci. USA.  
doi:10.1073/pnas.1814278116. 
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5. LOCUS COERULEUS TOGGLES RECIPROCAL PREFRONTAL FIRING TO
REINSTATE FEAR* 
5.1 Introduction 
Learning to inhibit or “extinguish” fear when danger has passed is not only adaptive, but 
also central to behavioral therapies for many psychiatric disorders. However, the 
extinction of fear is short-lived and relapse occurs under a variety of conditions, including 
psychological stress.  Considerable data indicate that the prelimbic (PL) and infralimbic 
(IL) subdivisions of the medial prefrontal cortex (mPFC) serve to regulate the expression 
and inhibition of learned fear, respectively (Giustino and Maren, 2015; Milad and Quirk, 
2012).  Projections from the locus coeruleus (LC) to the mPFC have a prominent role in 
stress-induced modulation of mPFC function (Giustino and Maren, 2018; Arnsten, 2009, 
2015).  Moreover, noradrenergic transmission mediates stress-induced decreases in IL 
spike firing and impairments in extinction learning (Fitzgerald et al., 2015; Giustino et al., 
2017). This work suggests that noradrenergic neurons in the LC may trigger relapse by 
altering mPFC firing dynamics to drive fear expression while weakening fear inhibition.  
Here we explored this possibility using selective pharmacogenetic manipulation of LC 
noradrenergic neurons and mPFC single-unit recordings in rats undergoing relapse of 





5.2.1 Prefrontal correlates of low and high fear states 
To characterize the neuronal correlates of extinction retrieval and fear relapse in the 
mPFC, we implanted animals with a single microelectrode array targeting both PL and IL 
and recorded single-unit activity using a novel within-subject behavioral design (Figure 
5.1a, b). In this design, animals underwent standard auditory fear conditioning and 
extinction in distinct contexts; freezing behavior served as the index of fear (Figure 5.2).  
To facilitate the relapse of fear after extinction, animals received an unsignaled footshock 
unconditioned stimulus (US) in the conditioning context to reinstate the fear memory 
(Bouton, 2002).  Single-unit recordings were then made in both the extinction context 
(where rats retrieved an extinction memory and expressed low levels of conditional 
freezing behavior) and a third distinct context (where rats retrieved a fear memory and 
expressed relatively higher levels of freezing behavior).  Hence, this design combines two 
procedures that drive relapse of extinguished fear:  reinstatement (re-exposure to the US) 
and renewal (a context-shift during retrieval testing); we refer this to as a “renewalment” 
procedure (Bouton, 2002; Goode and Maren, 2014). Importantly, the animals remained 
connected to the recording interface throughout these sessions so that the same mPFC 
neurons could be recorded during both retrieval tests (i.e., extinction retrieval and fear 
relapse).   
During the test sessions, we recorded a total of 333 PL neurons and 288 IL neurons 




CS bin (200ms) relative to the firing rate in the 1-sec pre-CS period; these z-scores were 





Figure 5.1 Extinction retrieval and fear relapse bidirectionally engage mPFC 
signaling. a) Representative histology of electrode placements in PL and IL. b) 
Schematized behavioral design. c, d) CS-evoked firing from PL and IL neurons in retrieval 
and renewal. e) Percentage of freezing (gray circles, mean ± SEM) across days; Freezing 
is overlaid with the 10-second summary of the CS-evoked firing responses. f, g) Pie charts 
displaying the proportion of PL and IL neurons in one of four categories based on how 
neurons responded to presentation of the CS in both retrieval and renewal. h) Vector plots 
depicting CS-evoked firing. The tips of the arrows point to the mean CS-evoked 
responding for a particular quadrant. The thickness of the arrow is proportional to the total 








Figure 5.2 CS presentation outside the extinction context produces fear relapse. a) 
Percentage of freezing (mean ± SEM) from the conditioning and extinction sessions. 
Freezing is averaged across CSs and ITIs for all trial blocks in each session. All rats 
showed an increase in freezing behavior following conditioning [main effect of time, F(1, 
11) = 25.35,  p < 0.001].  The following two days rats showed a reduction in CS-evoked 
freezing behavior throughout extinction [main effect of time, F(1, 11) = 44.05, p < 
0.0001]. b) Rats next underwent a dual retrieval-relapse test session. Rats showed low CS-
evoked freezing in the retrieval context relative to the relapse context.  The baseline 
freezing and the trial x trial data for the test session further illustrating that CS-evoked 
freezing was higher in relapse than in extinction retrieval [main effect of test, F(1, 11) = 




As shown in Figure 5.1, single-unit activity recorded in PL (Figure 5.1c) and IL (Figure 
5.1d) exhibited a reciprocal relationship in response to an identical auditory conditioned 
stimulus (CS) presented in the two distinct test contexts.  Neurons in PL exhibited reliably 
higher CS-evoked firing in the relapse context relative to the extinction context, whereas 
the inverse was true among IL single-units. This observation was confirmed in an ANOVA 
which revealed a significant test context X brain region interaction on the average 




0.001].  The reciprocal firing in PL and IL mirrored CS-elicited freezing behavior 
(normalized to the 3-min pre-CS baseline), which was low in the extinction context and 
high in the relapse context [Figure 5.1e, F(1, 11) = 6.05, p < 0.05].   
Because we recorded the activity of the same prefrontal neurons during both 
retrieval tests, we were able to classify units according to four firing phenotypes defined 
by the direction of their CS-evoked response [excitatory (+, z > 0 for the 10-sec CS 
averaged across 5-trials) or inhibitory (-, z < 0 for the 10-sec CS averaged across 5-trials)] 
in each of the two contexts (extinction or relapse).  As shown in Figure 1, these firing 
phenotypes were differently represented among the populations of neurons recorded in PL 
and IL (Figure 5.1f, g).  A chi-square analysis revealed differences between PL and IL in 
terms of the proportion of neurons responding to the CS during extinction retrieval and 
fear relapse such that a larger proportion of PL neurons showed increased firing during 
relapse, whereas IL neurons were proportionately more active during extinction retrieval 
[χ2 (3) = 9.04, p < 0.05]. Figure 5.1h depicts these data as population vectors that represent 
both the number of neurons in each phenotype (represented by arrow thickness) and the 
population mean of the average CS-evoked activity in each test context (indicated by the 
x,y coordinate of the arrow tip). These plots confirm that PL units fire preferentially in the 
relapse context, whereas IL units fire preferentially in the extinction context. Collectively, 
these data reveal that IL neurons showed more robust firing in response to the CS in the 
extinction context compared to the relapse context, whereas PL activity was higher 





5.2.2 LC-DREADD validation 
Given that noradrenergic transmission mediates stress-induced decreases in IL 
spike firing and impairments in extinction learning (Fitzgerald et al., 2015; Giustino et al., 
2017), we hypothesized that noradrenergic neurons in the LC would drive fear relapse.  
To selectively target noradrenergic LC neurons (Figure 5.3a), we used custom excitatory 
and inhibitory DREADD vectors whose receptor expression is under control of the 
synthetic dopamine-ß-hydroxylase PRSx8 promoter (Vazey and Aston-Jones, 2014). To 
confirm the in vivo functional efficacy of these LC-specific DREADDs, animals 
expressing either AAV9-PRSx8-hM3Dq-HA (Figure 5.3c, an excitatory DREADD) or 
AAV9-PRSx8-hM4Di-HA (Figure 5.3d, an inhibitory DREADD) were anesthetized and 
implanted with a recording array for acute LC recordings. We used a within-subject design 
to record the activity of the same neurons (n = 54, hM3Dq; n = 100, hM4Di) in response 
to both vehicle (VEH) and clozapine N-oxide (CNO, 3 mg/kg, i.p.). After a 10 min 
baseline period rats were injected with VEH and recording continued for 30 min, upon 
which rats were then injected with CNO followed by recording for an additional 60 min 
to observe the changes in firing rate.   
The spontaneous baseline LC firing rates prior to drug administration were as 
follows (mean ± SEM): hM3Dq (2.09 ± 0.12 Hz) and hM4Di (1.83 ± 0.09 Hz). To assess 
CNO-induced changes in spike firing, we normalized the post-injection firing rates (60-
sec bins across the entire 100 min recording session) to the 10-min baseline period. As 





Figure 5.3 Locus coeruleus (LC)-specific DREADD functionality. a) Representative 
microelectrode placement in the LC (left) and a schematic (right) indicating the placement 
of electrodes and DREADDs in the LC. b) CNO administration bidirectionally regulates 
LC firing rates in animals expressing inhibitory (hM4Di) or excitatory (hM3Dq) 
DREADDs in the LC. c, d) Immunohistochemical localization (OV, overlay) of LC-
DREADDs (HA, purple) in tyrosine hydroxylase-positive neurons (TH, green). CNO 
administration produced robust increases (c) and decreases (d) in LC spike firing 
illustrated in both the raw recording traces and the average firing rate of all neurons 
recorded. e) Percentage of freezing (mean ± SEM) for each group across days. CNO 
produced fear relapse in the hM3Dq group (black circles) whereas LC inhibition via 
hM4Di (white circles) had minimal effects on freezing in the extinction retrieval and fear 
relapse. Background colors within the freezing graphs correspond to each sessions context 





rate [Figure 5.3b, drug x virus interaction, F(1, 122) = 117.7, p < 0.0001].  It significantly 
increased LC firing in 76% (n = 41 of 54) of the neurons recorded in hM3Dq expressing 
rats [Figure 5.3c, main effect of time, F(69, 3657) = 22.00, p < 0.0001] and decreased LC 
firing in 65% (n = 65 of 100)of the neurons recorded in hM4Di expressing animals [Figure 
5.3d, main effect of time, F(69, 6831) = 15.11, p < 0.0001].   
5.2.3 LC-NE induces fear relapse 
After confirming the functional efficacy of the LC DREADDs, we next determined 
whether manipulating LC activity would influence extinction retrieval and fear relapse in 
the within-subject “renewalment” design. As shown in Figure 5.3e, VEH-treated rats 
expressing inhibitory or excitatory LC DREADDs showed low levels of CS-elicited 
freezing (normalized to baseline) in the extinction context, but a marked increase in 
freezing in the relapse context.  Interestingly, pharmacogenetic activation of noradrenergic 
neurons in the LC was sufficient to induce fear relapse; CNO administration in hM3Dq-
expressing rats dramatically increased freezing in the extinction context.  Inhibiting LC 
activity, however, did not prevent fear relapse [drug x context x virus interaction, F(1, 40) 
= 5.17, p < 0.05]. This is not surprising insofar as relapse associated with a context shift 
is independent of contextual fear (Maren et al., 2013). In addition to increasing freezing 
to the CS, CNO administration also produced significant increases in freezing prior to 
delivery of the CS (during the baseline period) in animals expressing hM3Dq in the LC 
(Figure 5.4). Note that this increase in baseline freezing was independent of the relapse 
effect, which was manifest as an increase in CS-evoked freezing normalized to the 




consistent with recent work showing that LC activation induces anxiety-like behavior 
(McCall et al., 2017; Hirschberg et al., 2017). These results reveal that pharmacogenetic 
activation of noradrenergic LC neurons promotes the relapse of extinguished fear.   
 
 
Figure 5.4 LC-NE activation produces fear relapse. a) Percentage of freezing (mean ± 
SEM); freezing is averaged across CSs and ITIs for all trial blocks in each session. Rats 
expressing either hM3Dq or hM4Di in the LC conditioned similarly as evidenced by an 
increase in freezing behavior from the baseline period to the post shock period [main effect 
of time, F(1, 40) = 285.61, p < 0.0001]. Likewise, both groups extinguished fear to the CS 
over the course of the extinction sessions [main effect of time, F(1, 40) =  64.62, p < 
0.0001]. After extinction, the animals received within-subject retention tests to the CS in 
either the extinction context or a familiar, alternate relapse context after administration of 
either VEH or CNO. b) The 3 min baseline (BL) freezing is shown as well as the freezing 
for each trial. While CNO produced a nonspecific increase in baseline (BL) freezing prior 
to CS onset (in the hM3Dq group) this does not account for the differences in CS-evoked 




5.2.4 LC-NE drives changes in PL and IL firing to promote fear relapse 
The relapse of extinguished fear is associated with the suppression of activity in 
IL-amygdala circuits involved in the inhibition of fear (Marek et al., 2018a; Knapska and 
Maren, 2009).  Based on previous work showing that noradrenergic transmission mediates 




driven fear relapse is mediated by a suppression of IL spike firing in the mPFC.   To test 
this hypothesis, microelectrode-implanted rats (targeting PL and IL) expressing either 
AAV9-PRSx8-hM3Dq-HA or an AAV9-PRSx8-mCherry control virus (Figure 5.5) in the 
LC (Figure 6a) underwent fear conditioning, extinction, and retrieval tests in the extinction 
context after either VEH or CNO administration (Figure 5.6b, Figure 5.7).  The number 
of neurons recorded in each group and brain area are as follows: VEH-mCherry [PL, n = 
160; IL, n = 135]; CNO-mCherry [PL, n = 134; IL, n = 136]; VEH- hM3Dq [PL, n = 131; 
IL, n = 105]; CNO- hM3Dq [PL, n = 105; IL, n = 116]. As shown in Figure 5.6c-f, 
pharmacogenetic activation of noradrenergic LC neurons increased CS-evoked spike 
firing in PL and suppressed that in IL.  In other words, LC activation shifted mPFC firing 
from a low-fear (IL>PL) to a high-fear profile (PL>IL) [Figure 5.6d, f; drug x virus x 
region interaction, F(1,1010) = 6.80, p < 0.01] and drove fear relapse [Figure 5.6d, f (gray 
circles), F(1,11) = 7.93, p < 0.05].   
 
Figure 5.5 Control viral expression is restricted to the locus coeruleus. 
Immunohistochemical localization (OV, overlay) of the blank mCherry control virus 
(mCh, purple) in tyrosine hydroxylase-positive neurons (TH, green) in the LC. Scale bar 





Figure 5.6 LC-NE drives PL CS-evoked activity and fear relapse. a) Schematic 
representation of experimental approach. b) Schematized behavioral design. c) CS-evoked 
responses in PL and IL during extinction retrieval following either VEH or CNO 
administration in animals expressing the blank mCherry vector. d) Percentage of freezing 
(gray circles, mean ± SEM) across test days; freezing is overlaid with the 10-second 
summary of the CS-evoked firing responses for each brain region. e) CS-evoked responses 
in PL and IL in animals expressing hM3Dq in the LC following either VEH or CNO 
administration. f) Percentage of freezing (gray circles, mean ± SEM) across test days; 
freezing is overlaid with the 10-second summary of the CS-evoked firing responses for 







Figure 5.7 LC-NE induced fear relapse is independent of increases in baseline (pre-
CS) freezing. a) Percentage of freezing (mean ± SEM) from the conditioning and 
extinction sessions.  Animals expressing either hM3Dq or a blank mCherry virus in the 
LC showed similar increases in freezing from the pre-conditioning baseline period [main 
effect of time, F(1,11) = 90.73, p < 0.0001]. Both groups extinguished at a similar rate 
[main effect of time, F(1,11) = 13.59, p < 0.01].  b) The 3 min baseline (BL) freezing is 
shown as well as the freezing for each trial for the extinction retrieval sessions (each rat 
underwent one session after VEH or CNO administration). While CNO produced a 
nonspecific increase in baseline freezing in rats expressing hM3Dq, this does not account 
for the observed differences in CS-evoked freezing [time x drug x virus interaction, 




Collectively, these results reveal that LC activation toggles reciprocal firing in the mPFC 
by decreasing CS-evoked spike firing in IL on the one hand while increasing PL spike 
firing on the other.  This inversion of extinction-related mPFC firing results in the relapse 
of extinguished fear. 
5.2.5 LC-NE acts both directly in the PL and through the BLA to promote fear 
relapse 
 Although the previous data strongly implicate a role of LC-NE modulation of 
mPFC CS-evoked firing, they do not causally implicate LC projections to mPFC in the 




determine whether the propensity of CNO-induced LC activation to cause fear relapse 
could be antagonized by pharmacologically reducing NE release in the PL with 
intracranial infusions of clonidine, an alpha2 agonist).  Because it has been suggested that 
LC actions in the BLA might also come to influence the mPFC (Giustino and Maren, 
2018; Arnsten, 2009, 2015), we also included animals in which we reduced NE release in 
the amygdala.  To this end, animals expressing AAV9-PRSx8-hM3Dq-HA were 
implanted with bilateral cannula targeting either the PL or BLA to examine if CNO-
induced LC activation mediates its behavioral effect via one of these targets. Animals 
underwent fear conditioning, extinction, and retrieval tests in the extinction context 
(Figure 5.8). Using a within-subject design (Figure 5.9a), animals received intracranial 
infusions of either vehicle or clonidine (order counterbalanced) in either the PL or BLA 
(Figure 5.9b). After intracranial infusions, animals were injected with systemic VEH or 
CNO (order counterbalanced) and approximately 20 min later underwent extinction 
retrieval as in the previous experiments. In this design, each rat underwent four separate 
extinction test sessions. As shown in Figure 5.9c, intracranial clonidine infusions reduced 
CNO-induced increases in CS-evoked freezing relative to VEH controls [systemic drug x 
intracranial drug interaction, F(1,18) = 8.04, p < 0.05]. This effect was similar whether 
clonidine was infused in PL or BLA. These data reveal that NE release in both the PL and 
BLA mediate the behavioral effects of pharmacogenetic activation of the LC.  This 
suggests that NE release in the BLA might drive, at least in part, the neuronal correlates 





Figure 5.8 Local infusions of clonidine into either PL or the BLA block CNO-induced 
fear relapse independent of increases in baseline (pre-CS) freezing. a) Percentage of 
freezing (mean ± SEM) from the conditioning and extinction sessions split by brain region.  
Animals from both groups showed a similar increase in conditioned freezing from the 
baseline to the post conditioning period [main effect of time, F(1,18) = 65.11, p < 0.0001]. 
Both groups extinguished at a similar rate [main effect of time, F(1,18) = 106.35, p < 
0.0001].  b) The 3-min baseline (BL) freezing is shown as well as the freezing for each 
trial for the extinction retrieval sessions (each rat underwent four total retrieval sessions). 
We replicate our finding where CNO-induced increases in LC-NE produce non-specific 
effects on baseline freezing, but this does not account for the differences in CS-evoked 
freezing. Local infusions of clonidine (alpha2-noradrenergic receptor agonist) into either 
the PL or BLA limit CS-evoked freezing in the presence of CNO [systemic drug x local 





Figure 5.9 Local infusions of clonidine in either the PL or BLA block CNO-induced 
fear relapse to a previously extinguished CS. a) Schematic representation of the 
experimental approach. b) Schematic histology displaying location of cannula tips in 
either PL or BLA.  c) Percentage of freezing (mean ± SEM) across test days split by brain 
region. Data are normalized by subtracting the 5-trial CS-evoked averages from the 3 min 
stimulus-free baseline period. Background colors depict systemic injections (orange = 






Collectively, these experiments uncover a novel role for LC modulation of mPFC spike 
firing in the relapse of extinguished fear. Specifically, we demonstrate that DREADD-
induced increases in LC firing toggle reciprocal spike firing in the mPFC and drive relapse 
of extinguished fear. In particular, LC activation increased CS-evoked responding in PL 
while decreasing that in the IL, an inversion of the IL-dominated firing observed after 
extinction (Giustino and Maren, 2015; Quirk and Mueller, 2008; Maren et al., 2013). 
These data reveal that noradrenergic neurons in the LC modulate mPFC signaling to 
induce neuronal firing signatures associated with high fear states, which in turn drives 
relapse.   
 The current data confirm and extend previous work revealing dissociable roles of 
PL and IL in conditioned fear (Giustino et al., 2016a; Sotres-Bayon and Quirk, 2010; 
Quirk et al., 2000; Milad and Quirk, 2002; Milad et al., 2004; Vidal-Gonzalez et al., 2006; 
Ye et al., 2017). We demonstrate that CS-evoked firing in IL is most pronounced in the 
extinction context (where fear is low), whereas it is reliably lower in the relapse context 
(where fear is high).   In contrast, this pattern is inverted in PL, where CS-evoked spike 
firing is relatively higher in the relapse compared to the extinction context.  Although it is 
well established that PL and IL firing correlate with high and low fear states respectively, 
the neural circuitry and transmitter systems driving these differences is relatively 
unknown. We now demonstrate a critical role for the LC-NE system in driving differential 
responses in PL and IL: pharmacogenetic activation of the LC increased PL firing (relative 




projections excite PL pyramidal cells which in turn inhibit the IL; others have shown that 
PLIL connections can influence freezing behavior (Marek et al., 2018b). A second 
possibility is that these differences are driven by indirect pathways from the LC to the 
mPFC via the amygdala. Past work has shown that BLA projections to PL and IL mediate 
high and low fear states, respectively (Senn et al., 2014). The fact that reducing NE release 
in either the PL or BLA prevented LC-induced fear relapse suggests it may be a 
combination of these pathways that mediates the effects of LC activation on fear.  
 The LC-NE system has been widely studied in the context of stressor- and trauma-
related disorders, such as PTSD (Bremner et al., 1996; Strawn and Geracioti, 2008; 
Koenigs and Grafman, 2009; Giustino and Maren, 2018). For example, prazosin, an 
alpha1-adrenoceptor antagonist, has had some success in  reducing nightmares associated 
with PTSD (Taylor et al., 2008; Writer et al., 2014; Koola et al., 2014; Keeshin et al., 
2017; Raskind et al., 2018). In addition, guanfacine and clonidine (alpha2-adrenoceptor 
agonists) as well as propranolol (beta1,2-adrenoceptor antagonist) have shown promise in 
alleviating PTSD symptomatology (Arnsten, 2015; Giustino and Maren, 2018; Giustino 
et al., 2016b). However, here we show no effect of pharmacogenetic inhibition of the LC 
on either extinction retrieval or fear relapse. This suggests that noradrenergic antagonists, 
such as propranolol, might not be effective in reducing the acute relapse of extinguished 
fear.  Of course, it is possible that the degree of inhibition we obtained with inhibitory 
DREADDs was not sufficient to prevent NE release in LC terminals in the forebrain. 
Overall, these data have important clinical implications insofar as elevated 




underlie, at least in part, the pathophysiology of this disorder (O’Donnell et al., 2004; 
Southwick et al., 1999c, 1999a; Giustino et al., 2016b). Consistent with this, noradrenergic 
transmission causes stress-induced decreases in IL firing and impairs extinction learning 
(Arnsten, 2009; Giustino and Maren, 2015; Milad and Quirk, 2012), which may underlie 
extinction learning deficits in individuals suffering from PTSD (Giustino et al., 2016b; 
Wessa and Flor, 2007; Milad et al., 2009; Arnsten, 2009, 2015). We now show that 
noradrenergic neurons in the LC influence mPFC spike firing to drive the return of fear 
once it has been extinguished. As such, noradrenergic tone along with mPFC activity may 
serve as a reliable biomarker to predict fear relapse.  Moreover, pharmacotherapeutic 
interventions that moderate LC hyperactivity in PTSD might be particularly effective in 
promoting long-lasting extinction learning and preventing its relapse once learned  
(Giustino et al., 2016b; Fitzgerald et al., 2015; Giustino et al., 2017). 
5.4 Materials and Methods 
5.4.1 Subjects 
Eighty-seven experimentally naïve adult male Long-Evans Blue Spruce rats (weighing 
200-224 g; 50-57 days old) were obtained from a commercial supplier (Envigo, 
Indianapolis, IN).  Upon arrival and throughout the experiments, rats were individually 
housed in cages within a humidity- and temperature-controlled vivarium, and kept on a 
14:10 hr light/dark cycle (lights on at 7 am) with ad libitum access to food and water.  All 
experiments were conducted in the daytime during the light phase.  Rats were handled for 
~30 seconds a day for 5 days to habituate them to the experimenter before any behavioral 




A&M University and were performed in strict accordance with the guidelines and 
regulations set forth by the National Institutes of Health and Texas A&M University with 
full approval from its Animal Care and Use Committee. 
5.4.2 Locus coeruleus-specific DREADDs and behavioral procedures  
Rats were bilaterally infused with a locus coeruleus (LC)-specific DREADD (Designer 
Receptors Exclusively Activated by Designer Drugs).  For viral infusion surgery, rats were 
anesthetized with isoflurane (5% induction, 2% maintenance) and placed in a stereotaxic 
apparatus (Kopf Instruments, Tujunga, CA).  The scalp was incised and retracted, the head 
was tilted 15 degrees downward such that bregma skull surface was 2 mm below 
intersectional lambda skull surface in the horizontal plane. The skull overlying the left and 
right hemispheres of LC was removed.  Both hemispheres of LC were then separately 
infused with either the LC-specific excitatory DREADD (AAV9-PRSx8-hM3Dq-HA), 
with an inhibitory one (AAV9-PRSx8-hM4Di-HA), or a blank control virus (AAV9-
PRSx8-mCherry), using a hypodermic injector (Small Parts/Amazon, Seattle, WA) that 
was coupled to a Legato 101 infusion pump (KD Scientific, Holliston, MA) and 10 µl 
syringe (Hamilton Company, Reno, NV) using polyethylene tubing (Braintree Scientific, 
Braintree, MA).  The coordinates for each infusion (relative to intersectional lambda skull 
surface) were as follows: AP: -3.8, ML: +/-1.4.  Since these were LC-specific 
DREADDs(Vazey and Aston-Jones, 2014) and the depth of the LC is variable across rats, 
virus was infused at three separate depths from lambda skull surface (first infusion: -7.0, 
second: -6.5, third: -6.0), 0.5 µl was infused at each depth. The infusion rate was 0.25 




to allow the virus to diffuse more effectively at the infusion site.  At least two weeks were 
allowed for recovery, and for the virus to express in the LC, before experiments began. 
 A modified rodent behavioral chamber (30x24x21 cm, Med Associates, St. 
Albans, VT) enclosed in a sound-attenuating cabinet was used for most days (i.e., the two 
extinction sessions, two dual retrieval-renewal tests) of these behavioral experiments.  
This chamber was modified to allow for freely moving electrophysiological recordings as 
well (described later).  The chamber comprised two aluminum side walls, a Plexiglas rear 
wall, a hinged Plexiglas door, and an open top.  The grid floor consisted of 19 stainless 
steel rods (4 mm diameter) spaced 1.5 cm apart (center-to-center).  A loudspeaker attached 
to the outside of a grating in one aluminum wall was used to play auditory 
tones.  Locomotor activity of the rat was transduced by a load-cell under the floor of the 
chamber, and the output of the load-cell was recorded by an OmniPlex recording system 
(Plexon, Dallas, TX).  Thus, all behavioral activity (and neural activity, for the freely 
moving recordings) was recorded automatically with this system.  A separate but very 
similar (i.e., enclosed top) behavioral chamber (context A), located in an adjacent room, 
was used for fear conditioning and to deliver a reminder shock in a later session (see 
below); having a separate room for context A helped reduce fear generalization across 
contexts.  No electrophysiological recordings took place in this chamber, and locomotor 
activity was recorded automatically using a computerized load-cell system.  The rods 
comprising the grid floor were connected to a shock source and solid-state grid scrambler 




 On Day 1 of behavioral testing, each rat was individually fear conditioned in 
context A.  In this procedure, the rat was transported to the room in a white plastic box 
and placed in the behavioral chamber.  The chamber had been cleaned with 70% ethanol 
to provide a distinct olfactory cue, and a metal pan containing a thin layer of the same 
solution had been placed under the grid floor.  The room was illuminated with white 
ambient lights, although the chamber house light was off and the sound attenuating 
chamber doors were closed, with a small window in one of the doors to allow some light 
in.  A fan mounted within one wall of the sound-attenuating chamber was also turned on 
to provide constant, ambient background noise (context A). After a 3-min stimulus-free 
baseline period, the animal received three auditory tone-footshock pairings.  The tones 
(conditioned stimuli; CS) were 10 sec, 80 dB, 2 kHz; the shocks (unconditioned stimuli; 
US) were 2 sec and 1 mA, where shock onset occurred at tone offset.  There was a 1-min 
inter-trial interval (ITI) between shocks.  The behavioral session continued for 1 min after 
the final shock, and then the rat was returned to its home cage. 
 On Day 2, the first of two fear extinction sessions took place, in the recording room 
adjacent to where fear conditioning was administered.  The rat was transported to the room 
in a black plastic box and placed in the behavioral chamber.  The chamber had been 
cleaned with 3% acetic acid to provide a distinct olfactory cue, a black plastic pan 
containing a thin layer of the same solution had been placed under the grid floor, the grid 
floor was covered with a transparent rubber mat, the back wall was covered with 
alternating black and white stripes, and the room was illuminated with ambient red lights 




45 tone-alone trials (30-sec ITI); the rat remained in the chamber for 3 min after the final 
tone, and movement was recorded automatically throughout the session.  Day 3 consisted 
of a second extinction session, identical to that of Day 2.  On Day 4, the rat received an 
unsignaled (i.e., no tone was presented) reminder shock in the conditioning chamber 
(context A).  After a 3-min baseline, this weaker shock (0.5 mA, 2 sec) was delivered, 
followed by a 3-min stimulus-free period.  As in the Day 1 session, movement was 
recorded automatically. 
 On Day 5 (and Day 6 for experiments that had 2 test days), the rat received a dual 
retrieval-renewal test. For animals that received LC DREADDs and an mPFC array, the 
DREADD ligand, clozapine N-oxide (CNO; 3 mg/kg, i.p.) or a vehicle (VEH; 2.5% 
dimethyl sulfoxide [DMSO] in distilled water) injection was given 30 min before the start 
of testing.  In this within-subjects design, each rat received CNO one day and VEH the 
other day of testing, with drug sequence counterbalanced across rats.  For a given rat, 
whether retrieval or renewal came first within the test was held constant across Days 5 
and 6, and this was also counterbalanced across rats.  The following is a description of the 
behavioral procedure if retrieval took place first.  The rat was transported to the recording 
room in a black plastic box and placed in the behavioral chamber (context B).  After a 3-
min stimulus-free baseline period, the animal was presented with 5 tone-alone trials (30-
sec ITI) and remained in the chamber for 10 min after the final tone.  The rat was then 
immediately placed in a large white plastic bucket with a layer of bedding in the bottom.  
The contextual cues were then rapidly (within approximately 5 min) altered as follows to 




grid floor, no rubber mat, no striped walls, white ambient lighting (context C).  The 
renewal protocol was the same as in retrieval: 3-min baseline, 5 tone-alone trials, 10-min 
stimulus-free period after the last tone.  The rat was then returned to its home cage.    
5.4.3 Electrophysiological characterization of LC DREAADs 
Rats were anesthetized with isoflurane (5% induction, 2% maintenance) and placed in a 
stereotaxic apparatus (Kopf Instruments).  The scalp was incised and retracted, the head 
was tilted downward 15 degrees as described above, and the skull was cleaned to allow 
for the acute insertion of the electrode array into LC.  The microelectrode array (Innovative 
Neurophysiology, Durham, NC) comprised 16, 10.5 mm long wires.  This 4 x 4 wire array 
had 200 µm center-to-center spacing of adjacent wires.  Each wire was 50 µm in diameter 
and the conductor was tungsten.  Using the same coordinates as described above for viral 
infusion in LC, the array was slowly lowered to a depth of 6-7 mm, while the 
experimenters listened to an audio output of the neural activity through our Plexon 
recording system.  After lowering the electrode array into LC, we allowed the signal to 
stabilize for at least 30 min, and then the recording session began.  After a 10 min baseline 
period, the rat was gently injected (i.p.) with VEH (the Plexon file was briefly paused for 
this), followed 30 min later by CNO (Plexon file again briefly paused); the recording 
session continued for 60 more minutes.  Immediately afterward, the rat was deeply 
anesthetized with pentobarbital and perfused transcardially (see Histology section below). 
   Extracellular single-unit activity was recorded with a multichannel 
neurophysiological recording system (OmniPlex, Plexon, Dallas, TX).  Wideband signals 




maximum of 15 channels of activity per rat), amplified (8,000x), digitized (40 kHz 
sampling rate), and saved on a PC for offline sorting and analysis.  The recording reference 
wire we chose for each session was selected to optimize the quality of the recordings.  
After high-pass filtering the signal at 600 Hz, we sorted waveforms manually using 2-
dimensional principal component analysis (Offline Sorter, Plexon).  Only well-isolated 
units were used in our analysis.  If two units with similar waveforms and identical time 
stamps for their action potentials appeared on adjacent electrodes, we only used one unit. 
We then imported sorted waveforms and their timestamps to NeuroExplorer (Nex 
Technologies, Madison, AL) for further analysis. 
5.4.4 In vivo electrophysiology in freely moving rats 
For surgeries in the animals that were implanted with a chronic microelectrode array 
targeting the mPFC, the rat was anesthetized with isoflurane and secured in a stereotaxic 
apparatus (Kopf Instruments).  Some of these animals also received bilateral infusions of 
LC virus prior to mPFC array implantation:  the scalp was incised and retracted, the head 
was tilted 15 degrees downward, and either the excitatory or blank control virus was 
bilaterally infused into LC as described above.  The head was then returned to horizontally 
level for the rest of the surgery. The following description applies to all of the mPFC 
recording rats.  Next, three-five burr holes were drilled for anchor screws.  The region of 
the skull overlying mPFC was removed to allow for microelectrode implantation. The 
animal was then implanted with a 16-channel microelectrode array (Innovative 
Neurophysiology) targeting both PL (8 wires) and IL (8 wires) in the right hemisphere. 




wires of two different lengths (PL, 6.9 mm; IL, 8.0 mm; see below for dorsal-ventral 
coordinates); the wires in each row and the rows themselves were spaced 200 µm apart 
(center-to-center).  The array was positioned with its long axis parallel to the 
anteroposterior plane.  Coordinates for the centermost wires of the array were (relative to 
bregma skull surface):  +2.7 mm AP, +0.55 mm ML, -4.0 mm DV for PL; and +2.7 mm 
AP, +0.35 mm ML, -5.1 mm DV for IL.  The array was secured to the skull with dental 
acrylic and at least two weeks were allowed for recovery and viral expression before in 
vivo recordings began. 
 As described above, a standard rodent behavioral chamber (Med Associates) 
enclosed in a sound-attenuating cabinet was modified to allow for electrophysiological 
recordings.  Neural activity and locomotor output was recorded automatically by an 
OmniPlex recording system (Plexon).  The behavioral procedure for these rats took place 
across five (mPFC only recording rats) or six (LC virus + mPFC recording rats) 
consecutive days, and was the same as described above except that neural recordings were 
obtained on the two test days (Days 5 and 6).  For the recording days, the rat was connected 
to a headstage with a flexible cable (Plexon) before the session began, and then placed in 
the recording chamber.  Immediately after the session, the rat was unplugged from the 
headstage and returned to its home cage.  For the initial mPFC recording experiment (i.e., 
rats that did not receive LC DREADDs), the rat remained plugged in between the retrieval 
and renewal sessions while placed in the large white plastic bucket with a layer of bedding 
in the bottom, while the contexts were rapidly changed.  For the LC virus + mPFC 




following either VEH or CNO administration. Neural data were collected and analyzed as 
described above for the anesthetized recordings.  The recording reference electrode we 
chose was typically one of the eight wires located in PL.  The analysis of neural activity 
focused on CS-evoked activity during the Day 5 and 6 test sessions.  For analysis of the 
CS-evoked activity, firing rate was binned in 200-msec increments around the time of the 
tones for individual neurons, and the evoked responses were z-score normalized to the 1-
sec period prior to tone onset, averaged across the five tones.  
5.4.5 Cannula implantation for intracranial infusions 
For surgeries in animals that were implanted with bilateral cannula targeting PL or BLA, 
rats were anesthetized with isoflurane and secured in a stereotaxic apparatus (Kopf 
Instruments).  They first received bilateral infusions of the AAV9-PRSx8-hM3Dq-HA 
virus in the LC as described above.  After viral infusions, the head was placed in the 
horizontal plane for implantation of bilateral guide cannulae in the PL (8mm, 26 gauge; 
Plastics One; AP: + 2.7, ML: +/- 2.0 (insertion point), DV: -3.8 at a 20-degree angle) or 
the BLA (10mm, 26 gauge; Plastics One; AP: - 2.9, ML: +/- 4.8, DV: -8.55); all 
coordinates relative to bregma. Three-five burr holes were drilled in the skull for jeweler’s 
screws and dental acrylic was applied to the skull to secure the cannula in place. Dummy 
cannula (33 gauge) were placed into the guide cannula upon completion of the surgery.  
After recovery from surgery, intracranial infusions were performed as previously 
described (Giustino et al., 2017). Briefly, rats were transported to the infusion room in 5-
gallon buckets. Dummies were removed and stainless steel injectors (33 gauge) were 




Hamilton syringes mounted in an infusion pump and connected to the injectors with 
polyethylene tubing.  The infusions were made approximately 25-30 minutes before the 
behavioral procedures. Clonidine hydrochloride (Sigma-Aldrich, St. Louis, MO) was 
dissolved in saline (5.83 ug/ul) and infused into either PL or BLA (0.3 ul/side at 0.25 
ul/min); this dose (1.75 ug/side) has previously been shown to reduce conditioned freezing 
behavior (Schulz et al., 2002; Holmes et al., 2017).  Injectors remained in place for 1 min 
after the infusion to allow for drug diffusion. After the infusions, clean dummies were 
inserted in the guide cannulas and the rats were injected with either systemic VEH or CNO 
in a counterbalanced fashion. Extinction retrieval tests commenced approximately 20 min 
following the systemic injections.  
5.4.6 Histology 
After completion of the experiment, the rats were overdosed with pentobarbital.  For rats 
implanted with an mPFC array, electrolytic lesions were created by passing electrical 
current (80 µA, 10 sec; A365 stimulus isolator, World Precision Instruments, Sarasota, 
FL) through six of the recording wires (anterior, middle, posterior wires in both PL and 
IL).  Rats were then perfused transcardially with 0.9% saline followed by 10% formalin.  
Brains were extracted from the skull and post-fixed in a 10% formalin solution for 24 
hours, followed by a 30% sucrose solution, where they remained for a minimum of 48 
hours.  Coronal brain sections of the mPFC (40 µm thickness) were cut on a cryostat (-20o 
C, Leica Microsystems, Buffalo Grove, IL), mounted on subbed microscope slides, and 




 To visualize LC viral expression using immunohistochemistry, the following steps 
were carried out.  First, brains were coronally sectioned (40 µm thickness) with a cryostat 
and stored in a 0.01% sodium azide solution until further processing.  Sections were 
blocked in PBS with 0.1% Triton X-100 (TX) and 3% normal donkey serum (NDS, 2 
ml/well) for one hour. All steps occurred in this PBS-TX-NDS solution at room 
temperature. Sections were then incubated in primary antibodies (mouse anti-tyrosine 
hydroxylase (TH) [1:2000] and rabbit anti-HA [1:1000]) for 24 hours.  Sections were then 
rinsed three times (10 min each).  Sections were then incubated in secondary antibodies 
(donkey anti-mouse Alexa Fluor 488 [1:500; for TH] and donkey anti-rabbit Alexa Fluor 
594 [1:500; for HA]) for three hours.  Afterward, sections were rinsed three times (10 min 
each).  Next, the sections were mounted on microscope slides using PBS, and coverslipped 
using fluoromount (Diagnostic BioSystems, Pleasanton, CA). Images were obtained using 
a Zeiss AXIO Imager M2. The following suppliers were used for the above materials: 
NDS (EMD Millipore, Billerica, MA), Triton X (Sigma-Aldrich, St. Louis, MO), mouse 
anti-TH (ImmunoStar, Hudson, WI), rabbit anti-HA (Cell Signaling Technology, 
Danvers, MA), donkey anti-mouse IgG (H+L) Alexa Fluor 488 (Thermo Fisher 
Scientific/Invitrogen, Waltham, MA), donkey anti-rabbit IgG (H+L) Alexa Fluor 594 
(Thermo Fisher Scientific/Invitrogen, Waltham, MA). 
5.4.7 Statistics 
We analyzed the data with conventional parametric statistics (StatView, SAS Institute).  
Two-way analysis of variance (ANOVA) and repeated-measures ANOVA were used to 
assess general main effects and interactions (α = 0.05). Results are shown as mean ± SEM.
* Parts of this chapter have been reprinted with permission from Frontiers in Behavioral Neuroscience 
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6. CONCLUSIONS*
6.1 Norepinephrine as a target for PTSD and extinction deficits 
Noradrenergic modulating drugs are used to treat an array of neuropsychiatric disorders, 
though the only two FDA approved drugs for PTSD are selective serotonin reuptake 
inhibitors (Tawa and Murphy, 2013; Arnsten et al., 2015; Steckler and Risbrough, 2012; 
Fitzgerald et al., 2014a). Drugs that either elevate or reduce NE transmission have been 
studied and used off-label for the treatment of PTSD and its symptoms with varying 
success (Holmes and Quirk, 2010; Giustino et al., 2016b; Bukalo et al., 2014; Southwick 
et al., 1999a, 1997, 1999c, 1999b). It has recently been shown that threat is associated with 
increased LC activity in healthy human volunteers and this acts to strengthen prioritized 
memory representations (Clewett et al., 2018). This suggests that heightened states of 
arousal may promote fear memory formation and maintenance. In addition, a number of 
studies have demonstrated that elevated NE plays a major role in the pathophysiology of 
PTSD (Geracioti et al., 2001; Strawn and Geracioti, 2008; Naegeli et al., 2017; Yehuda et 
al., 1992; Southwick et al., 1999a, 1997, 1999c; Bremner et al., 1996; Southwick et al., 
1999b; Kosten et al., 1987). Despite this link, success with pharmacological erasure of 
fear memories and/or enhancement of extinction based cognitive behavioral therapies has 




 It has been proposed that individuals with PTSD may “hypercondition” to fearful 
stimuli and this is coupled with impaired extinction, ultimately resulting in a heavy bias 
towards fearful responses in inappropriate situations (Blechert et al., 2007; Wessa and 
Flor, 2007; Guthrie and Bryant, 2006; Lissek et al., 2005; Orr et al., 2000; Pitman et al., 
2012; VanElzakker et al., 2014; Milad et al., 2009, 2008; Norrholm et al., 2015). While 
the LC-NE system plays an important role in learning and memory, including extinction 
learning, (Sterpenich et al., 2006; Sara, 2015, 2009; Arnsten, 2009, 2015; Arnsten et al., 
2015; Ramos and Arnsten, 2007), stress (and elevated NE beyond optimal levels) may 
only exacerbate these effects by impairing extinction learning and/or increasing 
generalization (Raio and Phelps, 2015; Raio et al., 2017, 2014; Hartley et al., 2014; Maren 
and Holmes, 2016; Dunsmoor et al., 2017). Indeed, yohimbine has been used in healthy 
human subjects to enhance fear learning and it also has been shown to hinder extinction 
learning (Soeter and Kindt, 2011b, 2012; van Stegeren et al., 2010; Visser et al., 2015).  
Despite this, there has been some interest in yohimbine as a pharmaceutical agent to 
augment the treatment of PTSD, which has yielded mixed results (Wangelin et al., 2013; 
Holmes and Quirk, 2010; Powers et al., 2009).   
 Clonidine and guanfacine are two α2-AR agonists that are used to treat a number 
of conditions. While the evidence for the efficacy of either drug is somewhat limited, these 
drugs may have some use in the treatment of PTSD and related disorders (Belkin and 
Schwartz, 2015; Arnsten et al., 2015). These NE-reducing agents have been shown to 
reduce symptoms of hyperarousal associated with PTSD as well as sleep disturbances 




Barnhill, 1996; Kinzie and Leung, 1989). Importantly, both compounds have also shown 
safety and promise for treating PTSD in children (Harmon and Riggs, 1996; Connor et al., 
2013).  Unfortunately, some studies have found little evidence for the efficacy of α2-AR 
agonists in the treatment of PTSD (Davis et al., 2008; Neylan et al., 2006). It remains 
possible that these, or related drugs, may only be effective for individuals who have 
dysregulated/elevated NE signaling which may explain discrepant findings. Further 
research is warranted on the efficacy of these compounds.  
Results with noradrenergic receptor antagonists, such as propranolol, have yielded 
mixed results in both healthy human volunteers and individuals with PTSD. Propranolol 
is already used safely in humans for other conditions and has been shown to reduce long-
term memory for an emotionally arousing story (Cahill et al., 1994) and reduced the 
strength of context conditioning in healthy human subjects (Grillon et al., 2004). These 
data suggest that β-AR activation underlies memories for emotional events. However, 
some have suggested that propranolol treatment soon after trauma has no effects, although 
this was done in the absence of any extinction based therapy (McGhee et al., 2009; Nugent 
et al., 2010; Stein et al., 2007). In addition, one report found that propranolol has no effects 
on the acquisition or retention of extinction learning (Orr et al., 2006). Others have shown 
that propranolol impairs extinction learning in healthy subjects (Bos et al., 2012). At first 
glance, these conflicting reports would imply that researchers and clinicians alike should 
look elsewhere for the pharmaceutical adjunct for exposure therapy. However, we have 
argued that the timing of propranolol administration coupled with behavioral therapy is an 




extinction learning (Giustino et al., 2016b). This may be due to differences in the 
prevailing level of noradrenergic arousal at the time of administration. There is some 
empirical evidence to support this idea in humans though more research coupling 
propranolol and extinction soon after trauma is needed (Pitman et al., 2002; Vaiva et al., 
2003).  
One area that has shown promise centers on blocking the reconsolidation of a 
fearful memory. Several studies in both healthy human volunteers and individuals with 
PTSD have suggested that propranolol can be used to disrupt reconsolidation (Poundja et 
al., 2012; Brunet et al., 2011, 2008; Lonergan et al., 2013; Brunet et al., 2014; Kindt et al., 
2009; Soeter and Kindt, 2011a, 2012; Schwabe et al., 2012). As discussed previously, 
effects on reconsolidation may be subject to certain boundary conditions and memories 
do not necessarily even undergo reconsolidation unless new learning occurs (Sevenster et 
al., 2012).  Moreover, many of these reconsolidation effects have not been replicated 
which further complicates approaches focusing on reconsolidation blockade as an 
effective treatment strategy for PTSD (Spring et al., 2015; Wood et al., 2015; Tollenaar et 
al., 2009; Bos et al., 2014). It seems unlikely that acute administration of propranolol, or 
any drug, would effectively eradicate a long-standing fear memory, such as those observed 
in individuals suffering from PTSD. However, this does not preclude the idea that 
propranolol may reduce fear under some circumstances and thus has utility moving 
forward (Giustino et al., 2016b; Kroes et al., 2016b, 2016a).  
 Another noradrenergic receptor antagonist that has been used primarily to combat 




shown promise in ameliorating nightmares and sleep disturbances associated with PTSD 
(Keeshin et al., 2017; Taylor et al., 2008; Raskind et al., 2003; Short et al., 2017; Writer 
et al., 2014; Miller et al., 2017; Koola et al., 2014; de Dassel et al., 2017). However, a 
recent clinical trial demonstrated that prazosin did not ameliorate sleep-related 
disturbances in military veterans with PTSD (Raskind et al., 2018).  Less is known about 
how prazosin affects other aspects of PTSD symptomatology. A recent study in healthy 
human subjects suggests that prazosin delivered prior to fear conditioning enhanced future 
discrimination between fearful and safe stimuli during extinction (Homan et al., 2017). 
Further work is needed to examine the effects of prazosin as well as other NE-altering 
drugs in both healthy human volunteers and those with PTSD.  
Overall, the LC-NE system critically regulates most aspects of emotional learning 
and memory in rodent models, healthy human subjects, and individuals suffering from 
trauma- and stressor-related disorders. Recent advances in technology for basic science 
research will be crucial to further our understanding of how stress and the LC-NE system 
regulate these effects in rodent models. Target-specific approaches have led to a new 
appreciation of LC function and while the precise effects of distinct LC subpopulations 
are not well characterized several recent papers have pinpointed unique contributions to 
learning and memory as well as anxiety in rodents (Uematsu et al., 2015, 2017; McCall et 
al., 2017; Li et al., 2016; Hirschberg et al., 2017; Schwarz and Luo, 2015; Schwarz et al., 
2015).  
An important area of research moving forward may center around individualized 




imaging protocols have improved to better isolate the LC (Betts et al., 2017; Song et al., 
2017; Priovoulos et al., 2018; Tona et al., 2017; Krebs et al., 2017; Brooks et al., 2017; 
Murphy et al., 2014; Keren et al., 2009; Langley et al., 2017).  Understanding if and how 
LC-NE is contributing to an individual’s symptomatology will likely improve therapeutic 
outcomes. Patients often undergo several “rounds” of drug treatment as they (and their 
doctor) search for either a single or combination of agents that ameliorate their condition. 
An improved appreciation of how the LC-NE system contributes to aversive learning and 
memory and its subsequent extinction may help improve empirically driven treatment 
options. 
Given technological and surgical limitations, the vast majority of therapeutic 
options for the treatment of human disease has been limited to systemic delivery of 
pharmacological agents. However, preclinical research has suggested that “therapeutic-
like” effects observed on various learning and memory tasks can be localized to distinct 
brain regions or circuits, as we have observed throughout my doctoral work. Of particular 
interest when looking at manipulations of the stress system, is that both epinephrine and 
NE do not cross the blood-brain barrier (Weil-Malherbe et al., 1959). Because of this, a 
therapeutic target that serves as an interface or a gateway between the peripheral and 
central nervous system may serve as an interesting therapeutic approach. Indeed, the vagus 
nerve has been identified as a key player in relaying peripheral information to the central 
nervous system. In fact, vagal nerve stimulation is currently being examined as a 
therapeutic option for a number of disorders including epilepsy and depression (Sackeim 




attention for the treatment of stressor- and trauma- related disorders, such as PTSD (Noble 
et al., 2019). 
The vagus nerve expresses beta-adrenoceptors (Lawrence et al., 1995; Miyashita 
and Williams, 2006; Schreurs et al., 1986). We have shown that beta adrenoceptors, 
particularly in the amygdala, play a critical role in extinction deficits. Interestingly, it has 
been shown that stimulation of the adrenal nerves or systemic administration of 
epinephrine results in increased evoked firing rates in the vagus nerve, an effect that is 
blocked by propranolol (Miyashita and Williams, 2006). Moreover, systemic epinephrine 
produces increased levels of NE in the amygdala suggesting the vagus nerve may act as 
an interface to relay information to and from the central nervous system (Williams et al., 
1998; O’Carroll et al., 1999; Hurlemann et al., 2005; Chen and Williams, 2012).  
Indeed, vagus nerve stimulation has shown promise as a therapeutic option for 
individuals suffering from PTSD. Rodent research has demonstrated that systemic 
injections of epinephrine have memory enhancing effects, thought to be mediated by the 
vagus nerve (Mccarty, 1981). Interestingly, these memory enhancing effects are sensitive 
to manipulations of the central norepinephrine system. That is, reducing or blocking NE 
transmission in the amygdala, with propranolol, mitigates the effects of systemic 
epinephrine (Liang et al., 1986, 1995; Williams et al., 1998, 2000; Hassert et al., 2004). 
The vagus nerve is well suited to serve as an interface between the periphery and the 
central nervous system in terms of anatomy.  Past work has shown that vagal nerve 
projections synapse on the nucleus tractus solitarius, a brain stem nucleus that produces 




solitarius in turn sends noradrenergic projections that innervate the BLA as well as the LC 
(Williams et al., 2000; Fallon et al., 1978; Riche et al., 1990; Van Bockstaele et al., 1999). 
Overall, the anatomy coupled with the interaction of peripheral epinephrine driving NE 
release in the amygdala make the vagus nerve an attractive and promising therapeutic 
target for the treatment of stress- and trauma- related disorders.  
6.2 Next generation treatment approaches 
Neuroscience research has seen an unprecedented wave of new technological advances 
for selectively isolating and manipulating both cell-specific and circuit-specific neuronal 
populations.  While many obstacles remain before these technological advances may 
become clinically viable, these advanced approaches have begun a new wave of 
possibilities. Optogenetics and chemogenetics are virally-mediated techniques allowing 
for cell- and circuit-specific manipulations to selectively excite or suppress precise 
neuronal populations.  Optogenetics requires the expression of exogenous light-sensitive 
ion channels to modulate neuronal activity with high temporal precision (Boyden et al., 
2005; Fenno et al., 2011). A difficult obstacle to overcome for use in humans (beyond use 
in the retina) is the invasive manner in which certain wavelengths of light need to reach 
the tissue expressing these ion channels. One chemogenetic approach makes use of 
DREADDs (Designer Receptors Exclusively Activated by Designer Drugs), which are 
synthetic G-protein coupled receptors that respond selectively to the systemic injection of 
an inert ligand, clozapine-N-oxide (CNO) (Dong et al., 2010; Urban and Roth, 2015). 




neural circuits and delineate the causal contribution of specific neuronal subtypes to 
behavior, and perhaps the treatment of human disorders. 
 An obvious problem to address before use in humans is the invasive nature of 
delivering these viral constructs (currently done via stereotaxic infusions in rodents). 
However, recent advances in our understanding of adeno-associated viruses may allow for 
noninvasive delivery methods, such as intravascular administration. For example, recent 
work has begun to delineate varying serotypes and viral constructs that, when delivered 
systemically, are capable of penetrating the blood-brain barrier (BBB) and expressing in 
central tissue (Merkel et al., 2017; Zhang et al., 2018; Hudry et al., 2018; Bourdenx et al., 
2014). Perhaps most intriguing related to my doctoral work is a recent report 
demonstrating that the serotype AAV9 can reach and express in central tissue after 
intravascular administration (Merkel et al., 2017). This is particularly noteworthy given 
that the LC-DREADD constructs used in my work are also AAV9, suggesting the 
possibility that LC-NE activity can be up and downregulated in a noninvasive manner. Of 
course, an additional issue for implementing this technology to treat human disease lies in 
the specificity of the exogenous ligands. DREADDs are activated by a designer ligand, 
clozapine N-oxide (CNO), though recent work has brought into question the use of CNO. 
In particular, it has been shown that CNO does not even cross the BBB and is actually 
“back metabolized” into clozapine, an atypical antipsychotic that has been used to treat 
schizophrenia (Gomez et al., 2017). While this downfall can be worked around in basic 
research through the use of appropriate controls, this creates a major issue for translation 




the FDA approved drug olanzapine (Weston et al., 2019).  The combination of BBB 
penetrating AAVs as well as an FDA approved ligand may be a major breakthrough for 
restricting DREADD expression in a cell-specific manner. The next frontier will be 
discovering ways to implement these approaches in noninvasive, circuit-specific manners.  
 As mentioned above, tremendous progress has been made with imaging 
technology. We are now able to selectively isolate the LC with more precision in standard 
human imaging techniques which will allow for more informative treatment options based 
on LC activity. In basic research, a number of biosensors have been developed and are 
continuing to be optimized for the in vivo detection of fluctuations in calcium dyanmics 
(GCaMP), acetylcholine (GACh), dopamine (GRABDA, dLight), and norepinephrine 
(GRABNE) (Feng et al., 2019; Patriarchi et al., 2018; Akerboom et al., 2012; Jing et al., 
2018; Sun et al., 2018). GRABNE is a modified adrenoceptor that can be used to measure 
NE dynamics with 1,000-fold specificity from dopamine (Feng et al., 2019). While not 
yet developed, a future avenue for improving our understanding of NE in humans may be 
radioligands that can be used in positron emission tomography (PET) studies for the in 
vivo detection and visualization of the LC-NE system and its downstream targets, such as 
the mPFC and BLA, which have been heavily implicated in PTSD. We have delineated a 
circuit in which the LC-NE system dynamically regulates mPFC and BLA activity, in 
opposing manners, and these changes correspond with the long-term success of extinction 
learning. While these techniques are still in their scientific infancy, the rapid development 
and improvement of these advances are likely to be 0applied for the treatment of human 




techniques in humans may allow for real-time monitoring of aberrations and then 
corrections (whether via DREADDs or pharmacology or both) to these circuits in an 
attempt to improve therapeutic outcomes and improve the efficacy of behavioral therapies.  
6.3 Parallels with Reward Circuitry 
In appetitive paradigms, initial performance reflects goal-directed behavior which can 
shift to habitual behavior with extended training. Overlapping circuits and brain regions 
have been heavily examined in the context of reward and addiction. The mPFC and BLA 
are thought to play important roles in the acquisition, expression, extinction, and relapse 
of addictive behaviors. For example, a similar dichotomy of function has been proposed 
to regulate addiction in the mPFC (Peters et al., 2009), in which PL serves to drive drug 
seeking behavior (Capriles et al., 2003; McFarland and Kalivas, 2001)  whereas IL acts to 
suppress this behavior following extinction (Moorman et al., 2015; Peters et al., 2009). 
Similar to fear, drug seeking also faces relapse phenomenon, which may in part, reflect 
mPFC dysfunction. Typically, it has been thought that PL activity is required for the 
execution of goal-direct behavior (“go”). In contrast, IL activity is thought to regulate 
behavioral inhibition (“stop”).  It has been demonstrated that rats with PL lesions exhibit 
no sensitivity to goal value after initial or extensive training.  IL lesions yield an opposing 
deficit in which rats show sensitivity to goal value independent of the level of training 
(Killcross and Coutureau, 2003).  These data suggest that PL promotes flexibility whereas 
IL inhibits flexibility and promotes behavioral rigidity.  Overall, there is an abundance of 
literature discussing the potential functional opposition of PL and IL in reward and drug 




 The opposing roles of the PL and IL in addiction and reward seeking-behavior 
suggest some symmetry between the circuits driving high and low fear states. For instance, 
my doctoral work suggests an important interaction between the BLA and the mPFC 
underlying extinction learning as well as fear relapse. Recent work has shown that the 
amygdala is a critical hub for reward learning (Tye et al., 2008; Murray, 2007; Janak and 
Tye, 2015; Tye and Janak, 2007; Luo et al., 2013; Burgos-Robles et al., 2017). Under most 
circumstances it appears that amygdala lesions or inactivation impair reward based 
behavior (Ishikawa et al., 2008; Maren, 1999; Cador et al., 1989; Hatfield et al., 1996; 
Hiroi and White, 1991; McDonald and White, 1993). Mirroring fear conditioning studies, 
it has been shown that LA synaptic plasticity is critical for cue reward learning (Tye et al., 
2008; Tye and Janak, 2007; Schoenbaum et al., 1998).  Some have suggested that the 
amygdala encodes valence insofar as it shows evoked responding to both pleasant and 
aversive stimuli (Young and Williams, 2010; Belova et al., 2007). It is not entirely clear 
if these neurons are distinct populations or overlapping. Past work suggests it may be a 
combination of the two and this may be task specific. For example, in a study examining 
BLA activity in response to stimuli that predict either positive or negative outcomes, it 
was found that distinct neuronal populations with the amygdala responded primarily to 
either positive or negative stimuli, but not both (Tye and Janak, 2007; Paton et al., 2006). 
In contrast, others have found some evidence for neurons that respond to aversive, safety, 
or reward cues which suggests some overlapping populations respond to multiple stimuli 
and may generally encode salience (Sangha et al., 2013; Shabel and Janak, 2009). 




and Williams, 2010). Overall, there is compelling evidence to suggest that the circuitry 
we have examined during my doctoral work is not limited to aversive learning and 
memory procedures. In fact, our findings may have broad implications for the treatment 
of neuropsychiatric disorders associated with dysregulated NE, mPFC, and/or BLA 
activity such as addiction (Ebrahimi et al., 2019; Somerville et al., 2006; Johnsrude et al., 
2000).  
6.4 Summary 
Overall, my doctoral work has demonstrated that the LC-NE system dynamically 
regulates the acquisition, extinction, and relapse of fear and these effects are dependent 
upon the prevailing level of stress (and NE) at the onset of learning. LC-NE likely 
influences learning and memory processes in a manner described by an inverted-U 
function, albeit acting in different brain regions/circuits to regulate learning and memory 
retrieval. We suggest that low levels of NE release prior to delayed extinction may enhance 
extinction learning by promoting mPFC function, which would, in turn, inhibit BLA 
output to enable extinction learning. In contrast, high levels of NE released under stress 
(such as that accompanying footshock) promotes fear expression while inhibiting new 
learning (as is observed with immediate extinction procedures) by strengthening BLA 
function and simultaneously impairing mPFC function via target-specific LC 
subpopulations. As such, understanding the involvement of the LC-NE system and its 
dynamic regulation of prefrontal and amygdala circuits may serve as a previously 
underappreciated therapeutic target for individuals suffering from stressor-and trauma-
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